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Abstract 
 Artificial enzymes have the potential to aid in the production of pharmaceuticals 
and facilitate basic biomedical research. There are two methods for making artificial 
enzymes: rational design and de novo selection. Rational design utilizes detailed 
knowledge of enzyme catalysis to design an enzyme active site, and then introduces this 
active site into a protein. However, due to the limited understanding of protein folding 
and structure-function relationships this approach is still extremely challenging and far 
from routine. In contrast, we utilize a directed evolution approach to isolate de novo 
artificial enzymes from a large library of protein variants by in vitro selection. Each of 
the trillions of proteins in a library are tested in a single experiment to determine if any 
have the desired activity. The artificial enzymes are created when the library is made so a 
high quality library is important for success. My thesis research focuses on two goals: (1) 
Construct a library built on the robust (β/α)8 barrel enzyme scaffold for future enzyme 
selections and (2) Characterize a thermostable artificial RNA ligase and develop an 
application for this enzyme.  
 The (β/α)8 fold is used to catalyze a wide range of chemical reactions in nature. 
We used this fold to create a library containing > 10
14
 unique proteins by replacing loops 
of the catalytic face with randomized codons via PCR. Small sub-libraries were subjected 
to a protease-based folding selection to improve library quality by enriching for folded 
sequences. The final folding-enriched library contained > 10
12
 folded proteins 
representing an up to 50-fold improvement relative to a control library. These libraries 
will provide a valuable source of new enzymes for future in vitro selections. 
 The previously generated artificial RNA ligases join 5’-triphosphate RNA to the 
3’-hydroxyl of a second RNA substrate; a reaction not observed in nature. However the 
enzymes were also highly dynamic, which prevented the solving of the protein structure 
by NMR or X-ray crystallography. A more structured enzyme, called ligase 10C, was 
isolated by performing the ligase selection at 65°C and its structure was solved revealing 
a novel primordial fold. Here, we describe the detailed biochemical characterization of 
ligase 10C. Using a variety of RNA substrates, we also determined how ligation rates 
  iv 
change with sequence composition revealing an enzyme with broad sequence specificity. 
We developed a method for the specific ligation and sequencing of 5’-triphosphorylated 
RNA. These results highlight ligase 10C as an attractive tool for the selective isolation of 
5’-triphosphate RNA from a complex mixture, something which is difficult with current 
methods.  
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Chapter 1 
 1 
Chapter 1:  
Introduction 
 Sections 1.3 and 1.4 were adapted from the article: Golynskiy, M. V., Haugner 
III, J. C., Morelli, A., Morrone, D., and Seelig, B. (2013) In vitro evolution of enzymes. 
Meth. Mol. Biol. 978, 73-92. The article is reproduced here with kind permission from 
Springer Science and Business Media. The article was written in collaboration with Dr. 
Misha Golynskiy, Aleardo Morelli and Dr. Dana Morrone with all authors having 
significant contributions to each section. Dr. Burckhard Seelig planned, reviewed and 
edited the manuscript prior to submission. 
 
Hyperlink to original publication 
http://link.springer.com/protocol/10.1007%2F978-1-62703-293-3_6 
 
 Figure 1.3 was reprinted from Kries, H., Blomberg, R., and Hilvert, D. (2013) De 
novo enzymes by computational design. Current Opinion in Chemical Biology 17, 221-
28. with permission from Elsevier. Figures 1.4, 1.5, 1.6 and 1.7 were reprinted from 
Seelig B, Szostak JW (2007) Selection and evolution of enzymes from a partially 
randomized non-catalytic scaffold. Nature 448:828-831. with permission from Macmillan 
Publishers Ltd. 
 
1.1 Thesis overview 
 Chapter 1 contains an overview of the field of artificial enzymes. The chapter 
begins by demonstrating the significance of artificial enzymes and showing the benefits 
of new enzymes to numerous fields of biotechnology and the limits of existing methods 
of enzyme development. A review of emerging methods for in vitro enzyme evolution is 
included to highlight the capabilities of in vitro evolution and its advantages over in vivo 
methods. The two general methods for making new artificial enzymes, rational design 
and de novo selection, are then introduced and compared. This leads into a summary of 
previous work by Dr. Burckhard Seelig describing the use of the in vitro method mRNA 
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display to isolate artificial enzymes de novo from a highly diverse library. The chapter 
ends with an in-depth look at the potential of mRNA display selections, discussing the 
advantages and possible pitfalls in the method. 
 Chapter 2 describes the design and synthesis of a new protein library based on the 
(β/α)8 fold. Nearly all (β/α)8 proteins found in nature are enzymes covering 5 out of 6 
enzyme classes making it an attractive fold for the evolution of new enzymes. The library 
was constructed by randomizing the amino acids that commonly compose the active site. 
To preserve the protein fold, sub-libraries were constructed first and enriched for folded 
proteins through a protease-resistance assay, and then these sub-libraries were ligated 
together. The final folding-enriched library contained approximately 10
12
 unique and 
folded proteins. 
 Chapter 3 details the isolation of a thermostable variant of 5’-triphosphate 
dependent RNA ligase. Additional rounds of mRNA display selection were performed at 
65°C with substrates modified to maintain the RNA-RNA duplex at the high temperature. 
The best ligase variant identified, called ligase 10C, had a melting temperature of 72°C 
representing a 24-35°C increase in stability relative to two closely related clones isolated 
from the original, room temperature selection. In addition, ligase 10C is more active at 
both room temperature and 65°C than the previous enzymes. While ligase 10C had been 
isolated in previous work, the detailed characterization was carried out as part of this 
thesis. 
 Chapter 4 describes the structure of the artificial RNA ligase 10C generated in 
chapter 3. Like the parent scaffold, ligase 10C binds two zinc ions which are essential for 
function. However, 10C adopts a unique fold not previously observed in nature and 
substantially different from the original protein scaffold. The region corresponding to 
loop 2 of the original library, which was highly conserved among all active ligases, was 
identified as a substrate interaction region and putative active site. 
 Chapter 5 contains the characterization of the sequence specificity of the artificial 
RNA ligase 10C. While 10C had been evolved to ligate a single RNA sequence, the 
ligase had comparable levels of activity on all substrates tested which showed the enzyme 
has broad sequence specificity. To probe the capabilities of the ligase further, the ligase 
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was challenged with a pool of 3 PPP-RNA substrates to determine if a specific substrate 
could be ligated using a specific complementary splint. Despite sharing some sequence 
similarity, all 3 PPP-RNAs could be ligated specifically in the mixture which suggests a 
potential role for isolating PPP-RNAs.  
 Chapter 6 demonstrates the application of the artificial RNA ligase for the 
sequencing of PPP-RNAs from a complex mixture. The ligase was characterized to 
determine the optimize ligation conditions and to indentify common chemicals that 
would inhibit ligation. A protocol was then developed that should enable easy sequencing 
of PPP-RNA utilizing Illumina’s TruSeq platform.  
 Finally, the thesis concludes with a section of conclusions and future directions 
for mRNA display and artificial enzyme selections. 
 
1.2 Significance 
1.2.1 The benefits of new enzymes 
 Enzymes are nature’s catalysts, driving chemical reactions necessary to sustain 
life. Enzymes are used metabolize various compounds, breaking them down into simple 
components and harvesting chemical energy. They can also be used to construct new 
complex molecules to serve roles including structure, signaling and defense. [1] 
Moreover, they have been shown to exhibit exquisite chemical selectivity and highly 
efficient catalysis in mild aqueous environments; something that few chemical 
transformations can boast. [2] For these reasons, enzymes hold the potential to improve 
many scientific fields by making existing chemical processes more efficient and by 
enabling new chemical transformations. 
 In recent years, the pharmaceutical industry has been utilizing enzymes to reduce 
the cost of drug synthesis by replacing inefficient steps in the chemical synthesis. 
Compared to organic synthesis of small molecules, enzymes and biocatalysis can offer a 
route to make enantiopure compounds cheaply and with fewer environmentally 
hazardous wastes. Enzymes such as ketone reductases and transaminases have been used 
extensively to create chiral products directly instead of relying on separation of 
enantiomers by a chiral column. [2, 3] Success stories, such as the improved synthesis of 
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Sitagliptin by replacing a critical step with an enzymatic catalysis, demonstrate that 
enzymatic catalysis can be both good science and a good business practice. [4] For these 
applications, the most valuable enzymes have excellent enantioselectivity, can accept a 
wide range of substrates and are active in partial organic solvent solutions or two-phase 
systems to promote substrate and product solubility. [2, 3] The pharmaceutical industry is 
increasingly expanding the types of enzymes used in drug synthesis as more new 
enzymes become available, but the field still relies heavily on chemical transformation 
for most synthetic steps where enzymatic transformation isn’t yet feasible. 
 Enzymes can also be very efficient, cheap and bio-compatible catalysts for the 
transformation of bulk compounds. A common application is the use of hydrolases to 
breakdown polysaccharides and proteins into shorter fragments. [5] In the food and 
fermentation industry, amylases are utilized in the brewing of beer and the baking of 
leavened bread to promote the growth of yeast. Traditionally the amylases found in the 
raw flour or grain would be used to hydrolyze starch into simple sugars but the modern 
industry will frequently supplement with exogenous enzymes to improve the processes. 
[6] More recently, the rising cost of fuel and diminishing supply of petroleum has 
promoted new interest for the production of biofuels, plastics and other traditional 
petrochemicals from cellulose as an alternative and cheap source of carbon. [7, 8] As 
cellulose is a highly crystalline polysaccharide, many efforts have been made to develop 
the enzymes needed to hydrolyze it into fermentable sugars. While many such enzymes 
exist in nature, development is still ongoing to improve the stability and decrease costs of 
the enzyme production to make the process economically viable. [9, 10] 
 Finally, enzymes also have important research applications, allowing scientists to 
specifically modify and synthesize complex biomolecules in ways that would otherwise 
be impossible with chemical catalysts. Enzymes that act on nucleic acid substrates helped 
usher in the modern age of molecular biology. Seemingly simple techniques like PCR 
amplification of DNA became far more efficient with the development of thermostable 
polymerases as previously fresh enzyme had to be added each cycle. [11] Restriction 
enzymes and proteases allow researchers to make highly specific cuts within DNA and 
protein respectively. [12, 13] Enzymes such as peroxidases and luciferase play vital roles 
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as easy to use reporter systems for blots and enzyme assays. [14, 15] For these types of 
enzymes, specificity and efficiency are generally the two most important features as off-
target reactions would obscure the results. Much of the commercial development in this 
field focuses on expanding currently known enzyme classes into new applications, such 
as evolving DNA polymerases to accept fluorescently labeled nucleotides for sequencing 
[16], but there are many additional areas of science that would benefit from new entirely 
enzymes. 
 
1.2.2 Limits of established methods for enzyme development 
 In all these examples, there is a desire for an efficient enzyme catalyst that is well 
suited for the application. While many enzymes have been developed as commercially 
available products, this represents only a small fraction of the chemistries available in 
natural enzymes. [2] Moreover, even if enzymes exist in nature than can catalyze the type 
of reaction desired, there is no guarantee that any of them will be able to act on the 
desired substrates. [2, 3] While it may be desirable to have an enzyme to catalyze a 
specific reaction, obtaining that enzyme might involve a substantial amount of effort and 
time. 
 The development of purified enzymes for commercial applications began at the 
start of the 20
th
 century which utilized essentially unmodified proteins isolated from 
various plant or microbial sources. [6, 17] Scientists relied primarily on finding the 
enzymes they needed already in nature both in terms of available chemistry and enzyme 
efficiency. Many different species and strains would be screened in search for the 
organism that produced the enzyme in large amounts and preferably with an easy 
purification method. [17] Enzyme evolution was possible in a limited fashion, but 
mutations were introduced through a mutagen which often compromised the host 
organism.  
 By the end of the 20
th
 century, when the tools necessary to clone and manipulate 
genes had been developed, scientists were able to intentionally drive the evolution of sub-
optimal enzymes to become more efficient for the desired application through a process 
called directed evolution. [18] In directed evolution, mutations are introduced specifically 
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into desired protein creating a library of protein variants. The variants are then each 
tested for activity to determine which mutations are beneficial. Evolution can then be 
continued by taking the best variants and introducing more mutations in an attempt to 
find even better versions of the enzyme. [19, 20] Today directed evolution is a well 
established method utilized extensively in both industry and academia to improve the 
properties of virtually any protein or enzyme.  
 Most enzyme evolution is performed either fully or partially in vivo: either inside 
cells or through the use of cells. [20] These in vivo methods take advantage of the intact 
machinery of a living cell to produce large amounts of protein from DNA transformed 
into the cells. In vivo methods are generally favored because they are cheap to use and 
utilize well established methods for cloning and DNA manipulation. The enzymes can be 
expressed inside the cytoplasm, within a specific compartment of the cell or even 
connected to the cell surface depending on the final application. [21, 22] However, there 
are limitations to these in vivo methods which lead scientists to develop in vitro platforms 
for enzyme evolution. 
 
1.3 Evolving enzymes in vitro 
 In vitro enzyme evolution offers a means to engineer enzymes by exploring 
enormous libraries of protein variants that exceed the capabilities of in vivo methods. The 
development of cell-free protein production systems made it possible to evolve enzymes 
outside of cells, in a test tube. In vitro evolution techniques have been used to improve 
existing enzymes and, in addition, have enabled the generation of biocatalysts de novo 
from a non-catalytic protein library. [23]  
 All methods used for enzyme evolution require that each protein in a pool of 
mutants can be traced back to its encoding gene for identification, and potentially for the 
purpose of amplification, expression and further evolution. [24] A stable genotype-
phenotype linkage allows for many enzyme variants to be mixed in a single reservoir 
while maintaining the ability to amplify genes of individual desired variants. Those 
variants are isolated from the reservoir using suitable screening or selection approaches. 
In the case of in vivo evolution methods, the genotype and phenotype are linked as the 
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protein and its gene are contained in the same cell. With partial in vitro methods, proteins 
are translated by the host’s cellular machinery and then displayed in an extracellular 
fashion, for example on the surface of a phage in the phage display approach. In contrast, 
the methods described here are carried out entirely in vitro and do not require any step to 
be performed inside a host cell. The crucial genotype-phenotype link is maintained 
through either a direct physical link or through artificial compartmentalization.  
 
1.3.1 Benefits of in vitro evolution 
 In vitro methodologies have several advantages over in vivo and partial in vitro 
methods because they are not limited by cell survival, growth, or function. The three 
main advantages are: (1) the ability to work with larger libraries of variants, (2) the 
tolerance to conditions that would be deleterious to cell survival, and (3) the ability to 
directly manipulate the DNA after each round of evolution.  
 As in vitro evolution is not dependent on library transformation into a host, the 
number of unique sequences that can be evaluated in a single experiment exceeds in vivo 
approaches. The largest reported in vitro libraries contain 10
14
 DNA sequences. [25] By 
comparison, phage display libraries produce up to 10
10
 unique variants in a single 
transformation. [26] Library sizes up to 10
12
 variants were reported for phage display by 
the pooling of dozens of separate transformations, but such scale-up may not be feasible 
for most laboratories. [27] Most typical library sizes for in vivo selections are between 
10
6
 and 10
8
 variants. Because in vitro evolution can search a larger sequence space, it is 
particularly well suited for isolating beneficial enzyme mutations that may be very rare. 
 The evolution of enzymes in vitro greatly expands the range of substrates and 
environmental conditions that can be investigated. The presentation of substrate to the 
enzymes is simplified as no cell walls have to be crossed, which are impermeable to 
many potential substrates. Most importantly, substrates and enzymes can be used that 
would be toxic to a cell. [28] Furthermore, enzymes can be engineered with in vitro 
methods for increased stability under extreme conditions of pH, temperature, ion 
concentration, or in the presence of denaturants or organic solvents. In vitro evolution 
also allows for a more accurate representation of enzyme performance. Cellular 
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evolution, in contrast, can generate complex phenotypes that falsely suggest increased 
activity through increased enzyme accumulation, rather than improved catalysis. [29] 
 Finally, in vitro evolution allows for direct manipulation of the DNA library 
between each round of evolution. Unlike in vivo methods that require time-consuming 
purification of the target gene, DNA from in vitro evolution is amplified directly through 
PCR. This facilitates the introduction of diversity through methods like error-prone PCR 
or in vitro recombination. In comparison, in vivo methods may introduce genetic diversity 
by using microbial strains deficient in DNA repair pathways to eliminate the need for 
DNA purification. However, these mutations may occur anywhere in the genome, 
necessitating a low mutation rate for continued survival. [30] Thus, by combining a 
selection or screen with methods to add genetic diversity, full Darwinian evolution can be 
carried out more conveniently in vitro. 
 While in vitro evolution greatly expands the tools available for the creation and 
engineering of new enzymes, in vivo approaches have certain advantages, too. As in vitro 
methods require purification of the genotype/phenotype components, in vivo evolution 
may involve fewer discrete steps. Furthermore, some enzymes are being developed for in 
vivo use, such as enzymes that need to function within a metabolic pathway. Those 
enzymes could initially be evolved in vitro, but ultimately need to be evolved in their 
native environment to optimize their intracellular compatibility. Thus, the two approaches 
can complement each other. 
 
1.3.2 General workflow for in vitro methods  
 All in vitro directed evolution methods follow a similar scheme. The initial DNA 
library encoding the protein variants is transcribed and translated, either sequentially or in 
a one-pot reaction. Next, the genotype-phenotype link and then genotype-phenotype-
substrate link is established. This may be accomplished through a physical connection 
(ribosome display, mRNA display, and DNA display), or through compartmentalization 
(IVC, IVC-based DNA and microbead displays) (Figure 2.1). Active enzyme variants 
that convert substrate to product result in co-localization of genotype-phenotype with 
product and are then isolated by screening or selection. Finally, the genotype is recovered 
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and either analyzed directly by sequencing or subjected to additional diversification for 
subsequent rounds of evolution. 
 
Figure 1.1 - Overview of methods for the in vitro selection or screening of proteins discussed in this 
review. (A) The top row shows different strategies to establish the crucial linkage between gene and 
protein. (B) The bottom row illustrates the introduction of substrate into the selection scheme to enable the 
evolution of enzymes. 
 
1.3.3 Library construction 
 In any directed evolution procedure, the size and quality of the starting DNA 
library are of great importance as they affect the probability of finding the desired 
mutant. Although in vitro selection methods can sift through comparably large libraries 
of trillions of mutants, the sheer size of the protein sequence space prevents us from 
sampling more than an exceedingly small fraction of all possibilities. For example, the 
largest protein libraries used to date contain about 10
13
 variants (Table 2.1). This vast 
number of mutants will just be enough to include one molecule of all possible 
combinations for a sequence of ten amino acid positions. In comparison, most natural 
proteins are more than 100 amino acids in length. Therefore, libraries of mutants should 
be designed wisely to increase the chances of success in a directed evolution experiment. 
Accordingly, one should consider randomizing specific amino acid positions by using 
degenerate codons. Instead of randomizing positions with NNN codons (N=A,C,G,T), 
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NNK codons (K=G,T), NNS codons (S=C,G) or even a reduced alphabet of NDT codons 
(D=A,G,T) can be used to reduce oversampling caused by codon degeneracy [32]. The 
use of degenerate codons can also reduce the likelihood of introducing unintended stop 
codons. For example, the NNN codon includes three stop codons whereas the NNK or 
NNS codons include only one. Alternatively, a given library can be assembled from 
fragments that have been pre-selected to decrease the occurrence of premature stop 
codons. [25] More recently, DNA synthesis via phosphoramidite trinucleotides has 
become commercially available. [31] Codon by codon synthesis using trinucleotides 
offers full control of the library composition by defining the set of desired amino acid 
mutations at any position while avoiding stop codons. [32] 
 
Table 1.1 - Comparison of in vitro technologies.  
Method Genotype-phenotype 
link 
Reported variants 
in single experiment 
Results 
Ribosome display Non-covalent complex 
of mRNA-ribosome-
protein  
~10
13
 Proof of concept selections for 
sialyltransferase [33], beta-
lactamase [34], dihydrofolate 
reductase [35], DNA ligase [36] 
and sortase [37]  
mRNA display Covalent fusions of 
mRNA-protein via 
puromycin 
~10
13
 Selection for de novo RNA ligase 
[38, 39] 
DNA display  Covalent or non-
covalent complex of 
DNA-protein  
~10
12
 Proof of concept selection of 
binders, but no enzymes [40, 41] 
In vitro 
compartment-
talization (IVC) 
Spatial confinement ~10
9
 (selection) 
~10
6
-10
8
 (screening 
by 
FACS/microfluidics) 
Selection for methyltransferase 
[42] and restriction nuclease [43];  
Proof of concept screening for β–
galactosidase [44, 45] 
IVC & microbead 
display 
Non-covalent complex 
of DNA-microbead-
protein  
~10
9
 (selection) 
~10
6
-10
8
 (screening 
by 
FACS/microfluidics) 
Screening for phosphotriesterase 
[46]; 
Proof of concept screening for 
hydrogenase [47]; 
Proof of concept selection of 
biotin ligase [48] 
IVC & DNA 
display  
Covalent or non-
covalent complex of 
DNA-protein  
~10
8
-10
9
 
 
Selection of antibodies as 
heterodimers, but no enzymes [49] 
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 In order to use a DNA library for a specific in vitro evolution technique, the 
sequences at both termini of the DNA have to be made compatible to the method of 
choice. The 5’-end includes promoter and enhancer sequences necessary to facilitate 
transcription and translation, respectively. The nature of these sequences depends on the 
type of transcription and translation system used. Other sequence elements might be 
included such as a terminator, stabilizing hairpins, affinity purification tags or sequences 
that are specific to the particular in vitro evolution method [50].  
 
1.4 Methods for in vitro directed evolution 
1.4.1 Ribosome display.  
 The ribosome display technology creates the genotype-phenotype linkage through 
a ternary complex of a stalled ribosome, the translated protein and its encoding mRNA 
(Figure 2.1). The complex is stabilized by high magnesium concentrations and low 
temperatures. Ribosome display was initially described for the purification of specific 
mRNA sequences based on immunoprecipitation of the encoded protein. [51] 
Subsequently, this method was developed further to select and evolve peptides and 
proteins. [52, 53] Although ribosome display has mostly been used for selection of 
binders, several model selections for enzymatic activity have been reported and will be 
reviewed here in more detail.  
 Several criteria must be met in order to generate ribosome-displayed proteins. 
Most importantly, the terminal stop codon of the gene of interest must be removed. This 
will prevent the ribosome from dissociating and releasing the nascent protein and will 
instead promote stalling of the ribosome and therefore maintain the ternary complex. 
Stem-loop structures are often added to flank the gene on both termini to increase RNA 
stability during translation and subsequent manipulations. Since the protein is not 
released from the ribosome, a C-terminal protein spacer (>100 amino acids) is added to 
ensure that the displayed protein has exited the protein-conducting channel of the 
ribosome and can fold properly. Typically, ribosome-displayed proteins are generated 
through sequential transcription and translation, as coupled transcription/translation 
systems can result in 100-fold reduced protein yield. [53, 54] The translation is stopped 
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by decreasing the temperature and increasing the Mg
2+
 concentration to stabilize the 
ternary complex. To maintain the genotype-phenotype linkage, the subsequent selection 
process also has to be performed at low temperatures and in presence of elevated Mg
2+
 
concentrations. The ribosome-displayed proteins are mostly used in selections without 
any additional purification. The RNA is recovered after the selection by dissociating the 
ternary complex through chelation of Mg
2+
 with EDTA. 
 Ribosome display has been utilized in a number of model selections for enzymatic 
activity. Most selections were performed by selecting for binding to an immobilized 
substrate, substrate analog, or inhibitor. These model selections demonstrated enrichment 
of the desired enzyme (10 to 100-fold per round of selection) compared to an inactive 
control (Table 2.1). [33-35, 37] While enzyme selection strategies based on binding can 
be successful in isolating enzymes with known properties (e.g. searching through 
metagenomic libraries for a desired activity), they are not well suited for changing 
substrate specificity or substantially improving activity. [20, 55] In one example of a 
truly product-driven model selection, ribosome display has been employed for isolation 
of a T4 DNA ligase. [36] Active enzymes able to ligate a DNA adaptor to the 3’-end of 
their encoding mRNA were selectively amplified via an adaptor-specific primer and were 
enriched 40-fold over known inactive mutants. Similar to this selection approach, the 3’-
end of the mRNA could be used for the attachment of alternative substrates which would 
allow for a selection of other catalysts by ribosome display.  
 
1.4.2 mRNA display. 
  mRNA-displayed proteins are covalently attached to their encoding mRNA via 
the small linker molecule puromycin (Figure 2.1). [56, 57] Central to the mRNA display 
method is the modification of the stop codon-free 3’-end of the messenger RNA with a 
puromycin-containing DNA linker prior to translation. [58, 59] During the subsequent in 
vitro translation, the ribosome synthesizes the polypeptide until it reaches the DNA-
puromycin-modified 3’-end of the mRNA where it stalls. Puromycin, which is an 
antibiotic that mimics the aminoacyl end of tRNA, enters the ribosome and becomes 
covalently attached to the C-terminus of the nascent polypeptide. The resulting mRNA-
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displayed proteins are typically purified from unfused proteins and mRNA using 
purification tags. The mRNA-displayed proteins are reverse transcribed to produce the 
cDNA. Reverse transcription also minimizes potential RNA secondary structure and 
increases RNA stability. Detailed protocols on mRNA display have been published 
recently. [39, 60, 61] Through slight modifications of the mRNA display protocol, 
covalent fusions of protein and encoding cDNA can be generated (cDNA display). [62, 
63]  
 There is only one published report of researchers using mRNA display to evolve 
an enzyme. Unlike all other examples of in vitro enzyme evolution, the starting library 
was based on a non-catalytic scaffold and a new artificial enzyme was selected de novo. 
[38] This evolution of an artificial enzyme is discussed in greater detail later in this 
chapter as it forms the basis of my thesis. 
 
1.4.3 In vitro compartmentalization (IVC). 
  Directed evolution by in vitro compartmentalization mimics in vivo evolution 
inside a cell by using water-in-oil emulsions to enclose proteins and their encoding DNA 
within the same droplet compartment thereby creating the genotype-phenotype link 
through spatial confinement. [64] IVC has been employed not only in several model 
enzymes selections, but also to improve the performance of existing enzymes through 
screening and selection methods. 
 Compartmentalization by droplet formation is achieved by stirring an aqueous 
solution of genes and a coupled transcription/translation (TS/TL) system into a mixture of 
mineral oil and surfactants. [65] The DNA concentration is chosen such that the average 
droplet contains no more than a single gene. The low volume of the droplets (5-10 
femtoliters) corresponds to a low nanomolar concentration of the single DNA molecule, 
which is efficiently transcribed and translated inside the droplet. [45, 64, 66] Although 
droplet composition is similar across different IVC experiments, in some cases the 
oil/surfactant mixtures need to be optimized for compatibility with the specific TS/TL 
solution used and the enzymatic activity that is being evolved. [64, 67] It has been shown 
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that the droplets are stable up to 100°C for many days and do not exchange DNA or 
protein between each other. [64, 68]  
 IVC-based selections have been used to evolve enzymes that process nucleic acid 
substrates. Here, the encoding DNA is also the substrate for the enzyme and the selection 
is dependent on successful DNA modification. In one approach, the activity of the 
methyltransferase (M.HaeIII) was improved toward a non-native, although already 
recognized, DNA sequence. [42] A library of variants of M.HaeIII was made by mutating 
the DNA contacting residues. The 3’-end of the DNA library was modified with a biotin 
moiety and connected to the remaining gene via the target methylation site that can be 
cleaved by endonuclease NheI unless the site is has been methylated by M.HaeIII. 
Therefore, only methylated genes were not cleaved by NheI and were captured on 
streptavidin beads. A similar approach was used for the model selection of a restriction 
endonuclease activity from a randomized library of the restriction enzyme FokI. Three 
specific residues were randomized in the catalytic domain, and cleavage sites for FokI 
were introduced in the 3’-UTR. [43] Only the genes coding for an active FokI variant 
were cleaved and captured on beads after incorporation of biotinylated deoxyuracil 
triphosphate at the cohesive ends generated by the restriction enzyme. 
 The IVC methodology has also been used in combination with screening 
approaches. This allows for the evolution of enzymes for non-nucleic acid related 
reactions, but also reduces the number of mutants that can be interrogated compared to 
selection strategies. In the screening approach, either fluorescence activated cell sorting 
(FACS) or microfluidics-based droplet sorting are used to separate active and inactive 
enzymes based on the conversion of non-fluorescent substrate into fluorescent product. 
For FACS mediated screening, water-in-oil-in-water emulsions (double emulsions) are 
generated since FACS instrumentation is incompatible with oil as the main medium. [69] 
Exploiting this principle, the very low β-galactosidase activity of the Ebg enzyme from E. 
coli was increased at least 300-fold by in vitro evolution using a commercially available 
fluorogenic substrate. [45] Recently, the same researchers reported a model enrichment 
of β-galactosidase using a home-made microfluidic system. [44] Although the throughput 
in the microfluidic system is about 10-fold less than in FACS-based screening, this loss is 
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offset by other advantages. First, the microfluidic system generates highly monodisperse 
droplets, enabling quantitative kinetic analysis. [44, 70] Second, the authors utilized 
microfluidic components that allowed them to fuse droplets together and introduce new 
content into droplets. This conferred multiple benefits as the authors were able to perform 
emulsion PCR in droplets and then merge them with droplets containing the TS/TL mix. 
By generating about 30,000 gene copies per droplet prior to TS/TL, low enzymatic 
activity is more likely to be detected due to the elevated enzyme concentration. [44] 
Furthermore, reagents can be readily added to the droplets after translation, in case the 
translation conditions are not compatible with enzymatic assay. [71] The use of 
microfluidics is a promising route for IVC-based enzyme engineering due to the 
modularity and potential for customization of individual components. However, in 
contrast to commercially available FACS instruments, assembly of microfluidics devices 
still requires substantial expertise. 
 IVC has also been used in conjunction with in vivo enzyme evolution by 
generating compartments that contain cells. To keep the focus of this review we are not 
discussing this in vivo application. 
 
1.4.4 DNA display.  
 Strategies that either directly or indirectly establish a physical link between the 
DNA and the encoded protein are referred to as DNA display (Table 2.2). Although 
several different DNA display methods have been developed, only the IVC-mediated 
microbead display has been used to evolve enzymes. This method generates the 
genotype-phenotype link through the capture of DNA and its translated protein onto the 
same streptavidin-coated microbeads inside a droplet (Figure 2.1). [46, 47] This approach 
requires multiple biotinylated reagents such as primers, antibody and reaction substrate in 
order to capture the template DNA, the protein modified with an epitope tag and the 
substrate onto the microbead, respectively.  
 Using microbead display, Tawfik and Griffiths improved the catalytic 
performance of an already very efficient phosphotriesterase enzyme 63-fold (kcat > 10
5
 s
-1
) 
through FACS-based screening. [46] This work demonstrated the ability to generate, 
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break and regenerate the IVC droplets and purify the genotype-phenotype-product 
attached to the microbeads. Furthermore, a substrate was used that carried a photo-caged 
biotin. Therefore, the substrate stays in solution until the biotin is uncaged, which causes 
the immobilization of substrate and resulting product on the beads. Incubation with a 
fluorescent product-specific antibody enabled the specific labeling and isolation by FACS 
of only those microbeads to which functional enzymes and their coding DNA were 
attached. [46] 
 In a different proof of concept experiment, a modified microbead display protocol 
was performed as a selection instead of a screen, thereby potentially harnessing larger 
library sizes. [48] In this experiment, an active biotin ligase was enriched from a mixture 
of inactive genes. Following product formation and immobilization, the purified 
microbeads were incubated with product-specific antibodies that were conjugated to a 
cleavable, gene-specific PCR primer instead of a fluorophore. Re-emulsification and 
droplet PCR with a solution lacking this primer resulted in a 20-fold enrichment of the 
desired genes.  
 Another microbead display model screen employing FACS used an indirect 
readout for activity to isolate [FeFe] hydrogenases. [47] Because the hydrogenase activity 
(H2 breakdown) is difficult to measure directly, the authors employed a redox-sensitive 
dye that can generate a fluorescent signal. Purified microbeads carrying the immobilized 
DNA and enzymes were re-compartmentalized in the presence of the redox dye. This dye 
was modified with a C12-alkyl chain and therefore interacts non-specifically with the 
hydrophobic polystyrene beads. Hydrogenase activity resulted in fluorescence of the dye 
and enabled flow cytometric sorting of the microbeads to recover the DNA of active 
enzymes, yielding a 20-fold enrichment over inactive genes. This proof of concept study 
used microfluidics to generate mono-disperse droplets and microbeads with a larger 
diameter (5.6 µm rather than 1 µm) to increase the bead surface allowing more 
fluorescent substrate to bind, thereby improving the signal to noise ratio. The indirect 
readout as described here could be applied to other screening strategies if 
environmentally sensitive fluorophores are available (pH, redox potential). 
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 Presently, only microbead display has been employed to evolve enzymes. Yet 
other DNA display methods could potentially be used for this purpose. In contrast to 
microbead display, all other DNA display methods directly attach the protein to its 
encoding gene via a fusion protein which binds to a specific DNA sequence within the 
parent gene or to a small molecule attached to the parent gene (Table 2.2). The IVC 
method is often used in conjunction with DNA display as the physical genotype-
phenotype linkage allows for the microcompartments to be broken up and generated 
again in order to introduce new components into the system (e.g. substrates). However, 
two proof-of-concept studies conducted without IVC demonstrated the production of 
DNA-displayed proteins solely by incubating templates with the E. coli cell extract. [40, 
41] 
 
Table 1.2 - DNA display methods. Only the microbead display has been used to evolve enzymes. 
Method Principle of attachment  DNA - point of 
attachment 
Protein fusion 
partner 
Microbead 
display [46-48] 
Non-covalent binding of DNA to 
streptavidin microbead and of HA-tagged 
protein via anti-HA antibody to same bead, 
IVC is needed 
Biotinylated  HA-tag 
STABLE  
[49, 72] 
Non-covalent attachment of protein to 
DNA,  
IVC is needed  
Biotinylated  Streptavidin 
CIS-display 
[40] 
Non-covalent attachment of protein to 
DNA 
 
RepA gene DNA replication 
initiator (RepA) 
Covalent DNA 
display [73, 74] 
Covalent attachment of enzyme to suicide 
inhibitor that is linked to DNA, IVC is 
needed 
Modified with  
5-fluoro-
deoxycytidine  
HaeIII 
methyltransferase 
Covalent 
antibody display 
[41] 
Covalent attachment of enzyme to DNA 
 
P2A gene Endonuclease P2A 
SNAP display 
[75, 76] 
Covalent attachment of enzyme to suicide 
inhibitor that is linked to DNA, IVC is 
needed 
Modified with 
benzyl guanine  
SNAP-tag 
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1.4.5 General principles and comparison of different in vitro methods  
 The types of reactions catalyzed by enzymes can be divided into transformation 
reactions, bond-forming reactions and bond-breaking reactions (Figure 2.2A). Depending 
on the reaction type, the strategy by which enzymes can be selected varies slightly. In 
general, affinity selections are used to isolate enzymes by methods that create a physical 
link between phenotype and genotype such as ribosome display, mRNA display and 
DNA display (Figure 2.1 and Figure 2.2B). To enable an enzyme affinity selection, the 
substrate has to be linked to the gene-enzyme complex. Enzymes for a transformation 
reaction can then be isolated if a product-specific affinity reagent, such as an antibody, is 
available (reaction type 1). Via the antibody, the ternary complex of product, active 
enzyme and gene is separated from inactive variants through immobilization. In the case 
of an affinity selection for bond-forming enzymes (reaction type 2), the second substrate 
carries a selectable moiety. Only proteins that catalyze the bond formation between two 
substrates will attach this moiety to the gene-protein-substrate complex and can therefore 
be isolated. For bond-breaking reactions (reaction type 3), the whole complex of gene, 
protein and substrate is immobilized via the substrate and only variants that cleave the 
bond will be released and selected. In contrast to affinity selections, the IVC 
methodology mostly employs fluorescent screening to isolate evolved enzyme variants 
either by FACS or microfluidics (Figure 2.2C and D). This can be achieved if the product 
of the reaction becomes fluorescent or a fluorescent product-specific antibody is available. 
Alternatively, the second substrate, which will be attached in a bond-forming reaction to 
the gene-microbead-substrate-complex, is fluorescent.  
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Figure 1.2 - Isolation of enzymatic activities using in vitro technologies. (A) Types of enzymatic 
activities that can be evolved using in vitro approaches. (B) Affinity selection of physically linked gene-
substrate/product conjugates. The enzyme itself is also linked to the gene-substrate complex, but is omitted 
from the figure for improved clarity. (C) Screen of IVC droplets that become fluorescent as a result of 
catalysis by the enzyme (not shown) contained in same compartment. Separation is achieved through 
fluorescence activated cell sorting (FACS) or microfluidics. (D) Screen for enzyme catalysis by FACS of 
IVC droplets containing microbeads. The enzyme contained in each compartment is not shown to improve 
clarity. Numbers in brackets refer to the type of activity as shown in (A).  
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 For any enzyme evolution experiment regardless of which methodology is used, 
the specific selection or screening strategy has to be customized with respect to the 
underlying reaction. In the case of affinity selections, the need to link the substrate to the 
gene-complex without substantially changing the nature of the substrate can be 
challenging especially for small substrates. On the other hand, suitable fluorophores that 
enable the screening of IVC droplets might not be compatible with some types of 
chemical reactions.  
 Two important questions have to be considered when deciding on which enzyme 
evolution strategy to use: Is the desired mutant potentially very rare such as a mutant 
exhibiting a novel activity? Or, alternatively, is the goal of the evolution experiment to 
generate a highly proficient enzyme? Selection strategies can search larger libraries and 
are therefore more likely to discover rare mutants, compared to screening approaches. At 
the same time, affinity selections only select for a single turnover event and cannot 
evolve an enzyme for high substrate affinity as the substrate is linked to the enzyme and 
therefore present at a high local concentration. In contrast, IVC-based screening methods 
can directly evolve an enzyme for high turnover and substrate affinity, yet, the library 
size of screening methods is several orders of magnitude smaller than those of selections. 
Therefore, it might be most beneficial to combine the two strategies and first use an 
affinity selection method to isolate potentially rare enzyme variants with altered activity 
or substrate specificity and then switch to an IVC-based screening method to optimize 
enzymatic proficiency. 
 
1.5 General considerations for constructing artificial enzymes 
 A prerequisite for enzyme evolution is to first find an enzyme that can catalyze 
the desired reaction, even if it does so poorly. Previously, when no enzyme was available 
for a given reaction, enzymatic catalysis had to be abandoned as creating new enzymes 
de novo was not yet possible. Recently, a new field in biochemistry has emerged to 
develop the tools necessary to make artificial enzymes to meet this need. [23, 77] 
 Here, we define artificial enzymes as proteins that scientists have manipulated to 
introduce a new catalytic activity. This new activity bears no resemblance to the original 
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activity of the protein and is generated without first creating an intermediate. [23, 77] To 
date there have only been a few reports of successfully creating artificial enzymes (Table 
1.3) as this field is still new. Two general strategies have been shown to create artificial 
enzymes: rational design and de novo selection. While there are significant differences 
between these methods, they share the same basic 3 steps to make artificial enzymes: 
identifying a target scaffold, manipulating the protein scaffold, testing and refinement of 
candidates.  
 
Table 1.3 - Artificial enzymes created by rational design and de novo selection 
Artificial enzyme Parent protein(s) Method utilized 
Esterase [78, 79] Many 
[a]
  Rational design 
Retro-aldolase [80] Xylanase, IGPS (lyase)  Rational design 
Kemp Eliminase [81] IGPS (lyase), Aldolase, HisF 
(cyclase) 
Rational design 
Diels Alderase [82] Phosphatase, Isomerase  Rational design 
Metallo-hydrolase  [83] Many 
[b]
 Rationally designed metal 
binding site 
[b]
 
5ꞌ-triphosphate dependent RNA 
ligase [38] 
Transcription factor (non-
catalytic)  
De novo selection 
[a] Numerous protein scaffolds were able to be turned into esterases including both enzymes and non-
catalytic proteins 
[b] While many proteins have been engineered to have metal-dependent hydrolysis activity, the catalysis is 
typically performed entirely by the bound metal ion with little to no participation from the protein scaffold. 
These are not typically considered to be “true” artificial enzymes. 
 
1.5.1 Identifying a starting scaffold 
 Protein scaffolds are native or artificial proteins that will be mutated to generate 
the new artificial enzyme. Scaffolds often have a well characterized 3 dimensional 
structure which is crucial to identify where beneficial mutation could be introduced. 
Enzymes with active sites similar to that of the desired activity are often used as scaffolds 
to reduce the number of necessary mutations. Thermostable proteins are frequently used 
because the strong intermolecular contacts are thought to better tolerate destabilizing 
mutations, although mesophile proteins have been used successfully too. [77] Some 
researchers chose to use multiple scaffolds in their experiments to make artificial 
enzymes, which offers greater protein diversity but can be more time consuming and 
expensive to generate all the desired constructs. 
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1.5.2 Manipulating the protein scaffold 
 During scaffold manipulation, the amino acid sequence of the starting protein 
scaffold is changed to generate many protein variants in an attempt to create the desired 
artificial enzyme. The amino acid changes tend to be centered in and around the 
enzyme’s active site to promote the interactions necessary for the desired catalysis. While 
there are many approaches which influence how to generate these variants, a universal 
feature of both methods is that most variants will not have the desired activity. Even 
when a fully rational approach is taken to protein design, the limited understanding of 
protein folding and dynamics makes it impossible to reliably predict whether a particular 
amino acid sequence will catalyze the desired reaction. While many groups are working 
to improve this predictive capability [77], others are seeking to use combinatorial 
approaches to create artificial enzymes without relying on such predictions. [23] 
 
1.5.3 Testing and refinement of candidates 
 Once a library of artificial enzyme candidates has been made, they are then 
expressed and assayed for the desired activity. If no active enzymes are identified, the 
process starts over either with selection of a new scaffold or by choosing to introduce 
different mutations into the existing scaffold. However, if active enzymes are found, they 
will be investigated and refined to improve activity. This refinement is often necessary as 
the first generation artificial enzymes typically have poor activity. [23, 77] Refining these 
artificial enzymes is useful not only to increase the activity, but it also helps us 
understand how they work. This in turn promotes the further refinement of the criteria for 
scaffold selection and mutations. 
 
1.6 Rational design of artificial enzymes 
 In rational design, scientists use computational modeling of protein folds to find a 
set of mutations which would introduce a new active site into a particular protein 
scaffold. The first step is to use the known or predicted transition state to create a 
theozyme, the ideal locations of amino acids to stabilize the transition state independent 
of a protein fold. (Figure 1.3) Second, the theozyme is compared to known protein folds 
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to see which folds could accommodate the proposed active site. If suitable folds are 
found, the active site is then modeled into the protein scaffold. Third, the models undergo 
additional refinement to better stabilize the active site and promote substrate binding. In 
total, more than 10
19
 constructs are able to be examined in silico but this is many orders 
of magnitude larger than what could be reasonably examined in the laboratory. [82] The 
final step is to rank the different constructs with a quality score so the top candidates can 
be expressed and characterized for the desired activity. [77] The calculations and 
refinements necessary to find artificial enzymes by this approach are not trivial and 
generally inaccessible to most biochemists and enzymologists.  
 
Figure 1.3 – General workflow for creating an artificial enzyme by rational design [77]. 
 
 One example of rational design of an artificial enzyme is the creation of an 
enzyme capable of catalyzing the Diels-Alder reaction from organic synthesis. [82] The 
Diels-Alder reaction is a cycloaddition reaction between a diene and a dienophile forming 
two carbon-carbon bonds and up to four stereocenters. To design this enzyme, the authors 
utilized mechanistic knowledge of the Diels-Alder reaction to stabilize the transition state 
as well as molecular docking to promote binding of the substrate in a productive 
conformation. Of the vast number of scaffolds considered in silico, only 80 were chosen 
to be expressed in E.coli and screened for activity. Of these 80, only 2 had measureable 
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Diels-Alderase activity. These two hits were optimized using directed evolution further to 
increase catalytic activity. The best enzyme, DA_20_10 had reasonably good 
enantioselectivity for the desired product (>94% ee) and was capable of numerous 
turnovers. [82] This enzyme was eventually optimized further by additional rational 
design to improve the catalytic efficiency about 18 fold. Notably this improvement came 
from players of the online game Foldit, a game where players try to optimize protein 
folding utilizing intuition instead of sophisticated modeling or calculations. [84] 
 
1.7 De novo selection of artificial enzymes 
 De novo selection of artificial enzymes uses the validated methods of directed 
evolution with an in vitro selection to isolate artificial enzymes. Directed evolution is 
based on the simple principle that beneficial mutation exist within protein sequence space 
and the experiment simply needs to sample enough mutations to find them. To evolve an 
existing enzyme, sampling thousands to millions (10
3
-10
8
) of unique variants is usually 
enough to find an improved enzyme. With the advent of methods for the in vitro enzyme 
evolution that can sample trillions (10
12
-10
13
) of variants in a single experiment, it is now 
possible to isolate new artificial enzymes from sequence space de novo.  
 In a 2007 publication by Dr. Burckhard Seelig, he described the first example of 
artificial enzymes made by de novo selection which catalyzed the 5ꞌ-triphosphate 
dependent ligation of two RNA strands forming a native 5ꞌ-3ꞌ linkage (Figure 1.4). [38] 
There are no natural enzymes known to catalyze this reaction, but artificial ribozymes 
and deoxyribozymes had been generated utilizing de novo selection from random pools 
of RNA and DNA respectively. [85-88] The 5ꞌ-triphosphate dependent ligation was used 
here as a model system to test whether protein enzymes could also be selected de novo 
from diverse protein libraries. 
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Figure 1.4 - Splinted ligation of RNA with a 5’ triphosphate releasing pyrophosphate [38]. 
  
 The artificial RNA ligases were generated by a selection scheme where product 
formation was directly linked to immobilization on a solid support (Figure 1.5). A DNA 
library containing >10
12
 unique variants was transcribed in vitro to make RNA followed 
by modification of the 3’ end of the RNA with puromycin. The RNA library was then 
translated in vitro to create the mRNA displayed fusions through the action of puromycin 
which covalently links each protein to its encoding mRNA. Fusions were then purified 
and reverse transcribed with a primer modified with 5’-triphosphate RNA substrate. After 
purification, a biotinylated substrate with the 3’-hydroxyl RNA was then introduced and 
splinted to the other substrate with a complementary oligonucleotide. If an enzyme could 
join these two RNA strands together, it will form a continuous covalent linkage between 
its cDNA and biotin allowing for it to be purified by a streptavidin column. The isolated 
cDNA was then PCR amplified to reintroduce the promoter to the 5’ UTR which was lost 
during in vitro transcription, enabling another round of enzyme selection. Performing 
multiple rounds of selection enables the isolation of enzymes that might be rare in the 
starting library and allows for the evolution of better variants. 
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Figure 1.5 - A general scheme for the selection enzymes that catalyze bond-formation. [38] When the 
active enzyme forms a bond between A and B, it forms a covalent link between the anchor group and the 
enzyme’s cDNA. The anchor group allows for the cDNA of active enzymes to be purified away from the 
cDNA of inactive enzymes which lack the anchor group. 
 
 The protein library used to isolate the artificial RNA ligase was based on the 
transcription factor hRxRα. The scaffold protein contained two zinc finger domains with 
a Zn
2+
 ion coordinated by four Cysteine residues each. Diversity was introduced into this 
protein fold by randomizing two loops of 9 and 12 amino acid positions between the two 
zinc finger domains, leaving the zinc coordination sites intact. [89] During the course of 
evolution and selection additional mutations were introduced into the constant regions of 
the scaffold (Figure 1.6). The artificial RNA ligases isolated had undergone significant 
remodeling of the protein scaffold including the loss of some of the Cys residues 
responsible for zinc coordination in the native scaffold. Some clones also contained large 
deletions of more than 10 amino acids. Nevertheless the artificial RNA ligases are 
dependent on zinc for activity suggesting the proteins were still capable of binding zinc 
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Figure 1.6 - Sequences of starting library and select artificial RNA ligases [38]. Each random loop 
(blue) is flanked by two Cys residues (orange) which compose the Zn
2+
 binding site of the zinc finger. For 
many enzymes, the scaffold has undergone substantial rearrangement as seen by the large deletions (gray 
dots) and loss of Cys residues responsible for Zn
2+
 coordination. Loop 2 was highly conserved among all 
active enzymes isolated suggesting it plays a key role in the new enzyme. 
 
 The direct selection of an artificial RNA ligase was significant milestone for the 
field of enzyme development. Not only did it demonstrate that directed evolution could 
be used to isolate artificial enzymes without using rational design, but it isolated an 
enzyme that could catalyze a reaction not observed in nature. It’s important to note that 
while the selection scheme was responsible for isolating the enzymes, the enzymes came 
from the starting library. Therefore the quality of the starting library is a key determining 
factor in the success of any selection. 
 
1.8 Outlook for de novo selection 
 Compared to rational design, the method for de novo selection of artificial 
enzymes is a more easily accessible to the general field of biochemistry. Product 
formation directly promotes selection of the desired enzyme so little to no knowledge of 
the reaction mechanism is required for success. One of the primary challenges with de 
novo selection is synthesizing the desired substrates with the appropriate modifications 
such that substrate and product can be separated through selective immobilization. There 
are many commercially available methods designed for use by non-chemists to easily and 
covalently link various functional groups that could help in this process. [90] Even in 
cases where a synthetic organic chemist might be needed to effectively synthesize the 
compound, organic synthesis has far fewer uncertainties than rational design of a new 
enzyme. Because rational design only screens a relative few constructs for the desired 
activity, the method could be beneficial for chemical reactions which are difficult to 
adapt to de novo selection. 
 The selection scheme shown in Figure 1.5 is easily amenable to other bond-
formation reactions (carbon-carbon, carbon-nitrogen, carbon-oxygen, etc) as was 
demonstrated with the artificial RNA ligase. This process should be easily modified to 
select for bond breakage as well, for example to select for a protease. [23] To select for 
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bond-breakage, all mRNA displayed fusions would start immobilized to a solid support 
and only those that are able to cleave the substrate would be released from the column 
and amplified for the next round of selection. As any break in the link between cDNA 
and the immobilizing group (biotin) would be selected for, additional rounds of counter-
selection may be beneficial with a linker not containing the substrate.  
 Not all chemical reactions easily fit into this simple bond formation/bond 
breakage reaction scheme, such as isomerization and oxidoreduction style reactions. 
Selections for these types of activity could still be possible, provided a specific way of 
capturing the product could be developed. For example a ketone reductase which reduces 
a ketone to a secondary alcohol could be captured through a second enzyme to attach the 
necessary anchor group. These types of chemistry might also be selected for through the 
use of an antibody specific to the product if one existed with a suitably high affinity.   
 While large libraries have a clear benefit for the evolution of new enzymes by 
increasing the likelihood of finding an active or improved variant, the starting scaffold 
and location of randomization are also important to consider. mRNA display can produce 
up to 10
13
 fusions which is large enough to saturate and fully cover randomization of 10 
amino acid positions simultaneously. However, the successful zinc finger library 
randomized 21 positions with a theoretical diversity of 10
27
, many orders of magnitude 
larger than what is possible to synthesize in a laboratory. Arguably though, randomizing 
21 positions simultaneously allows for researchers to sample a wider spectrum of 
sequence space than saturation of 10 as it allows for novel discoveries in more positions. 
 The artificial RNA ligases selected by in vitro evolution accelerate the 
uncatalyzed background reaction at least two million-fold, but they are slow relative to 
natural enzymes with a turnover of about one per hour. While mRNA display is a 
powerful method for finding the initial rare activity, the method is primarily suited for 
single turnover selections. To improve enzymes to the high levels of activity found in 
nature, selecting or screening for multiple turnovers is necessary which might not be 
practical with mRNA display. However, prior to transitioning to a different evolution 
platform, additional rounds of mRNA display might be beneficial to select for different 
properties. As it is a fully in vitro method, it is easy to change the selection system to 
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select for enzymes that are active at high temperature, in the presence of organic solvents 
or inhibitors, or at acidic or basic pH values. If the final application for the enzyme 
utilizes one or more of these conditions, finding an enzyme that is active under those 
conditions early in the evolution would be highly advantageous to save time and effort 
later in the enzyme development. 
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Chapter 2:  
Highly Diverse Protein Library Based on the Ubiquitous (β/α)8 Enzyme 
Fold Yields Well-Structured Proteins Through In Vitro Folding 
Selection 
 
 The following is a reprint of the article: Golynskiy, M. V., Haugner, J. C., and 
Seelig, B. (2013) Highly diverse protein library based on the ubiquitous (b/a)8 enzyme 
fold yields well-structured proteins through in vitro folding selection. ChemBioChem 14, 
1553-63. The article is reprinted here with permission from John Wiley and Sons. Dr. 
Seelig, Dr. Golynskiy and I designed the library and analyzed the data.  Dr. Golynskiy 
assembled the DNA fragments, performed FACS analysis and screened clones for 
solubility. I characterized GDPDwt and GDPDmut, designed and optimized the protease 
digestion selection and subjected numerous libraries to the folding selection. 
 
Hyperlink to original publication 
http://onlinelibrary.wiley.com/doi/10.1002/cbic.201300326/abstract;jsessionid=8DF048F
37B6DF295C051A508718F3EC0.f04t02 
 
2.1 Overview 
 Proper protein folding is a prerequisite for protein stability and enzymatic activity. 
While directed evolution can be a powerful tool to investigate enzymatic function and to 
isolate novel activities, well-designed libraries of folded proteins are essential. In vitro 
selection methods are particularly capable of searching for enzymatic activities in 
libraries of trillions of protein variants, yet quality libraries of well-folded enzymes with 
such high diversity are lacking. We describe the construction and detailed 
characterization of a folding-enriched protein library based on the ubiquitous (β/α)8 barrel 
fold found in five of the six enzyme classes. We introduced seven randomized loops on 
the catalytic face of the monomeric, thermostable (β/α)8 barrel of glycerophosphodiester 
phosphodiesterase (GDPD) from Thermotoga maritima. We employed an in vitro folding 
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selection based on protease digestion to enrich intermediate libraries containing three to 
four randomized loops for folded variants and then combined them to assemble the final 
library (10
14
 DNA sequences). The resulting library was analyzed using the in vitro 
protease assay and an in vivo GFP-folding assay and contains ~10
12
 soluble monomeric 
protein variants. We isolated six library members and demonstrated that these proteins 
are soluble, monomeric and show TIM barrel fold-like secondary and tertiary structure. 
The quality of the folding-enriched library improved up to 50-fold compared to a control 
library that was assembled without the folding selection. To the best of our knowledge, 
this work is the first example of combining the ultra-high throughput method mRNA 
display with a selection for folding. The resulting (β/α)8 barrel libraries provide a 
valuable starting point to study the unique catalytic capabilities of the (β/α)8 fold, and to 
isolate novel enzymes. 
 
2.2 Introduction 
 Directed evolution experiments have generated numerous commercially valuable 
enzymes and have helped gain insight into the origins and evolution of enzymatic 
function. The success of any directed evolution experiment fundamentally depends on the 
diversity and quality of the starting library of protein variants. A protein library is 
considered of high quality if a substantial fraction of the library consists of well-folded, 
soluble and stable proteins that contain a diverse set of mutations and potential active 
sites for a variety of desired activities. In vitro selection strategies generally outperform 
in vivo or screening approaches by several orders of magnitude with regard to library 
diversity and are preferred for the isolation of potentially very rare mutants, e.g. novel 
enzymes. [1-3] However, high quality enzymatic libraries that can harness the ultra-high 
throughput of in vitro methods are currently lacking.  
 The ubiquitous (β/α)8 or TIM barrel fold is a promising scaffold for a general-
purpose protein library that could be used for the isolation of new enzymatic activities 
and the understanding of the origins of enzymatic function. This versatile fold is utilized 
in five of the six enzymatic classes and is highly favored by natural enzymes to catalyze a 
wide array of different reactions, in some cases at the diffusion rate limit. [4-7] In the 
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(β/α)8 barrel fold, the main structural and catalytic elements are spatially separated. The 
barrel itself is formed by eight alternating alpha helices and beta strands and provides the 
structural foundation while the eight loops connecting helices and strands on one side of 
the barrel are responsible for substrate binding and catalysis and are known as the 
catalytic face of the barrel. These features are favorable for enzyme engineering since 
modification of functional elements is less likely to affect the structural stability of the 
overall scaffold. [8] In a few cases, the catalytic activities of (β/α)8 barrel enzymes were 
successfully swapped through protein engineering to understand how the (β/α)8 barrel 
fold could be recruited to perform new activities. [9-12] Although, in some other cases, 
desired activities could be obtained by altering the substrate specificity of existing 
enzymes via targeted mutagenesis, [13] the introduction of novel activities often 
necessitated more extensive protein remodeling. [2, 3, 14-16] In an effort to enable more 
divergent sequence exploration well beyond point mutations, the tolerance of (β/α)8 
scaffolds to the insertion of different natural (β/α)8 loop fragments was investigated. [17-
21] Furthermore, the enzymatic activity of existing (β/α)8 barrel proteins was improved or 
modified by a combination of rational design and directed evolution similar to proteins of 
other folds. [6, 22-24] In addition, rational design approaches for de novo enzymes 
repeatedly favored the (β/α)8 barrel fold over others, likely due to its ability to 
appropriately position catalytic and substrate binding residues. [25-27] This is 
particularly significant, as despite recent success in the rational re-design of enzymes, the 
de novo design of enzymes is still considered a formidable task. [26, 28-30] In summary, 
the combination of valuable (β/α)8 barrel protein features like catalytic versatility, 
efficiency, stability, structural modularity and plasticity make this fold an ideal scaffold 
for enzyme engineering. 
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Figure 2.1 - General strategy for the stepwise construction of the folding-enriched library based on 
the (β/α)8 scaffold. A selection for folded proteins by protease digestion of unfolded variants is followed 
by recombination of folded variants to generate the final (β/α)8 library with seven randomized loops.  
 Herein we report the construction of a highly diverse (β/α)8 barrel library (~10
14
 
unique DNA sequences) that contains seven randomized loops and is enriched for well-
folded, soluble proteins. Unfortunately, the deleterious effect of mutations on stability is 
a major constraint in protein evolvability [31, 32] and is implicated in limiting the speed 
of evolution in nature. [33] Previous studies predicted that the probability of a protein to 
retain its structure will decline exponentially with the number of mutations. [34] An 
additional concern during the creation of a highly diverse protein library is the 
unavoidable occurrence of frameshifts and unintended stop codons caused by imperfect 
chemical synthesis of the respective DNA library, which can greatly reduce the number 
of full-length library members. [35] To generate a high quality library, we employed two 
complementary strategies. The first strategy removed stop codons and frameshifts from 
shorter library cassettes via in vitro selection by mRNA display. [35] The second strategy 
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selected for folded protein variants using protease digestion, which removed poorly 
folded proteins as they are more susceptible to proteolysis. [36-39] We combined these 
two strategies by assembling our final library in vitro and step-wise from intermediate 
libraries preselected for folded variants and the absence of frameshifts or premature stop-
codons (Figure 2.1). While the selection procedures reduce the number of protein variants 
in the intermediate libraries, the diversity is regenerated in the final library by 
recombining these preselected intermediate libraries. Unlike the prior (β/α)8 library 
construction attempt where 49 amino acids were simultaneously inserted into all eight 
loops in the catalytic face of the (β/α)8 fold and likely caused unfolding of the substantial 
fraction of the final library, [35, 40] our conservative step-wise assembly approach aimed 
to significantly improve the overall library quality. In order to assess the impact of our 
folding selection, we additionally prepared a control library without the folding selection. 
The quality of the two libraries was assessed independently by orthogonal in vitro and in 
vivo folding assays. These libraries will be used for isolating de novo activities as well as 
for studying the origins of enzymatic function, the role of folding on the emergence of 
activity, and the adaptability of the omnipresent TIM barrel fold for different catalytic 
functions. 
 
2.3 Results  
2.3.1 Identification and characterization of a (β/α)8 scaffold protein and an unfolded 
control 
 We first sought to identify a suitable (β/α)8 scaffold candidate as a starting point 
for the library design. We desired a highly stable, cysteine-free, monomeric protein with 
a known crystal structure and chose glycerophosphodiester phosphodiesterase (GDPD) 
from the hyperthermophile T. maritima as the starting scaffold that fits all those criteria 
(Figure 2.2). [41] We hypothesized that the overall structure of the GDPD protein would 
be sufficiently stable to tolerate the replacement of loops on the catalytic face of the 
barrel with random sequences and even the insertion of additional amino acids. The 
GDPD catalytic face consists mainly of short loops and could potentially accommodate 
larger active sites with minimal steric clashes, similar to recent experiments that changed 
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TIM barrel activities. [19] To optimize our protocols for folding assessment and selection 
that are essential to our library assembly strategy, we prepared a destabilized GDPD 
construct (GDPDmut) lacking the native tertiary structure. In particular, two adjacent 
substitutions (G31R/V32E) were introduced to the (β/α)8 barrel to disrupt the parent 
GDPD structure (GDPDwt) via steric clashing and the insertion of unfavorable charge in 
the tightly packed core of the barrel.  
Figure 2.2 - Design of the (β/α)8 library based on the GDPD protein scaffold. A) Side view and top 
down view of crystal structure of the GDPD (β/α)8 scaffold that was used as a starting point for the library 
- -strands are shown in yellow and blue, respectively. B) 
Secondary structure representation and top down view of GDPD scaffold. The loops 1-7 that were 
randomized during library construction are numbered and shown in red. C) Sequence of the GDPD library. 
Positions randomized with the NNG/C codon are depicted as red “X”. Non-native residues added to the 
termini of the GDPD scaffold are shown in grey (purification tags, spacers and puromycin-crosslinking 
region needed for mRNA display). β-strands and α-helices are colored blue and yellow, respectively.  
  
 To ascertain that the mutant construct lacks the parent (β/α)8 structure, GDPDwt 
and GDPDmut were expressed, purified via His6-tag chromatography and characterized 
in solution. Unlike GDPDwt, GDPDmut did not express solubly but could subsequently 
be solubilized through purification under denaturing conditions followed by a refolding 
step. In contrast to the monomeric GDPDwt, GDPDmut exists almost exclusively as 
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oligomeric species in solution, as shown by size exclusion chromatography (Figure 
S3.1A). Analysis of secondary structure by far-UV circular dichroism (CD) demonstrated 
that both constructs possess defined, yet differing, elements of secondary structure based 
on the similarities at 208 nm and differences at 222 nm, wavelengths associated with α-
helical structure in the far-UV CD (Figure S3.1B). In order to gain greater insight into the 
overall folding of the two GDPD constructs, we probed the tertiary structure via 1-
anilinonaphthalene-8-sulfonic acid (ANS) fluorescence and near-UV CD (Figure S3.1C 
and S3.1D). Both methods showed that GDPDmut has substantially less tertiary structure 
and more exposed hydrophobic surface area relative to GDPDwt. After establishing that 
GDPDmut lacks the tertiary and quaternary structure of the parent GDPD scaffold, the 
two constructs were used to establish and optimize the dynamic range of the protease 
digestion folding selection. 
 
2.3.2 Optimization of the folding selection by in vitro protease digestion 
 In order to employ the protease digestion selection to reduce the fraction of poorly 
folded protein variants in our (β/α)8 library, we first optimized the selection conditions to 
successfully discriminate between GDPDwt and GDPDmut. Selections based on protease 
digestion using phage and ribosome display have successfully enriched protein libraries 
for folded members. [36, 38] Although primarily used to improve the stability of a single 
protein, in one case this approach was applied to improve qualities of de novo libraries 
based on specific secondary modules. [37] Throughout our assembly protocol we utilized 
mRNA display, an in vitro selection and evolution method which employs the small 
molecule puromycin to covalently attach proteins to their own mRNA. [42, 43] This 
method had been previously used to isolate an enzyme de novo from a non-catalytic 
scaffold with two randomized loops [2, 3, 44] and is excellently suited for the long term 
goal of isolating enzymatic activities from the large protein libraries described here. 
 In pilot experiments, mRNA-displayed proteins were first treated with several 
proteases (data not shown) known to have preferences for hydrophobic residues, and then 
His6-tag purified by immobilized metal affinity chromatography (Figure S2.2). We 
hypothesized that hydrophobic residues would serve as a good criterion for removing 
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unfolded proteins from the library as such residues are preferentially buried in the protein 
core and less likely to be surface-exposed in well folded proteins. [45] Chymotrypsin, 
which cleaves adjacent to large hydrophobic residues, showed the largest discrimination 
between the two control constructs in the pilot experiments and was further optimized to 
yield ~140-fold enrichment of GDPDwt over GDPDmut (92 ± 1.2% vs. 0.67 ± 0.12% 
survival). Percent survival was defined as the ratio of His6-tag purification yields of 
protease-treated and untreated samples. Furthermore, mRNA-displayed fusions of 
GDPDmut and a GDPDmut control lacking the His6-tag were analyzed via the same 
protocol to determine the level of non-specific background binding. The optimized 
chymotrypsin protocol was utilized for the selection and analysis of the (β/α)8 based 
libraries. 
 
2.3.3 Construction of intermediate libraries with randomized loops 
 Intermediate libraries with several randomized loops were used as building blocks 
during the step-wise assembly of the final folding-enriched library (Figure S2.3). To 
further increase the diversity of the libraries, we also inserted one to four additional 
amino acids into these loops, with the exception of loop 1 (Table 2.1). We generated 
seven libraries with a single randomized loop each, corresponding to loops 1 through 7 
on the catalytic face of the scaffold. In the next step, these libraries were used to assemble 
intermediate libraries with multiple randomized loops (Figure S2.3A). Specifically, 
fragments of the GDPD gene were PCR amplified to introduce two to six NNG/C (NNS) 
randomized codons at the desired loop positions, the resulting fragments were digested 
with restriction enzyme and ligated together to generate the full length libraries 
containing one or two random loops. Next, half-libraries with three or four random loops 
were generated by recombining PCR-amplified fragments of the libraries with one or two 
random loops. Loop 8 was omitted from the library assembly as its location is distant 
from the core of the (β/α)8 barrel and, therefore, loop 8 seemed unlikely to contribute to 
the formation of a potential active site with the rest of the randomized regions. 
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Table 2.1 - Comparison of loop length in the GDPDwt scaffold to the randomized loops used in 
assembling the (β/α)8 libraries 
Loop # 1 2 3 4 5 6 7 8 
GDPDwt loop size 2aa 3aa 1aa 1aa 5aa 2aa 4aa 1aa 
Library loop size 2aa 5aa 4aa 4aa 6aa 6aa 5aa Wild type 
 
 The introduction of multiple loops into the GDPD protein was expected to 
substantially destabilize the starting scaffold and reduce the fraction of folded proteins in 
a given library. To guide the library assembly process and decide at which step to 
perform either the whole folding selection or the mRNA display alone, we first analyzed 
the protease digestion rates of several intermediate libraries as described in the next 
section. The mRNA display procedure removes unintended stop codons from the library, 
which are introduced by the use of NNS codons for randomization, and imperfections 
during DNA primer synthesis. [35] The mRNA display therefore increases the quality of 
a library, which is beneficial for a subsequent folding selection. 
 
2.3.4 Folding selections of the intermediate libraries by in vitro protease digestion 
 
 To evaluate the tolerance of the GDPD scaffold to amino acid insertion and 
randomization, several libraries containing one or two randomized loops were treated 
with chymotrypsin to assess the fraction of surviving library members (Table 2.2). As 
expected, and likely due to steric clashes between random loops from different libraries, 
the survival rate for libraries with two randomized loops was lower than the product of 
the survival rates of the two parent libraries with a single randomized loop each. The 
survival rates observed for the libraries containing one or two randomized loops were 
significantly above the GDPDmut background (Table 2.2). Therefore, to preserve some 
spatial context of the randomized loops, we subjected those libraries only to mRNA 
display to remove stop codons, and then recombined them into the two half libraries, 
termed “L1-4” and “L5-7”, containing randomized loops 1-4 and 5-7, respectively. Our 
goal was to enrich these two libraries for folded proteins until the survival rate was well 
above that of GDPDmut in as few rounds of selection as possible to preserve library 
diversity. These libraries, possessing four and three randomized loops, respectively, were 
therefore subjected to the folding selection (Figure S2.3A). While L5-7 exhibited 52% 
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survival rate, L1-4 showed a significantly lower 1.4% and the surviving variants were 
subjected to a second round of folding selection yielding a final survival rate of 9.2%. 
The increase in survival rates well above background implies that both half libraries were 
indeed enriched for folded sequences. Additional rounds of folding selection would 
decrease the diversity of enriched sequences without necessarily improving folding much 
further (Table 2.2). 
2.3.5 Assembly of the final folding-enriched library 
 The stop-codon free, folding-enriched variants from the libraries L1-4 and L5-7 
that survived the protease digestion selection (~10
9
 and 10
10
 sequences respectively) were 
used to assemble the final folding-enriched library with a total of 32 randomized amino 
acid positions. Although combining these intermediate libraries could theoretically 
produce ~10
19
 unique sequences, the physical amount is limited to sub-milligram 
quantities of DNA that can be synthesized in the lab. Our final library contains 1.6 x 10
14
 
unique DNA sequences and is at the upper limit of library sizes compatible with in vitro 
selection methods such as mRNA and ribosome display.  
3.3.6 Analysis of stability of folding-enriched library and comparison to control library 
using the protease assay (in vitro) 
 In order to assess the benefits of the folding selection, a control library was 
prepared from the same seven single loop libraries used during the construction of the 
folding-enriched library (Figure S2.3B). The resulting library shared the same 
randomized elements and a comparable 2.9 x 10
14
 complexity as the folding-enriched 
library, but had not been pre-selected to maintain the parent (β/α)8 fold. A single round of 
mRNA display was employed to remove the stop codons and frameshifts immediately 
prior to the final recombination step. Rather than using the full length GDPD gene, only 
half-gene fragments of the L1-4 and L5-7 libraries were subjected to the round of mRNA 
display. By using only these fragments instead of the whole parent scaffold, we aimed to 
avoid a bias of the randomized loops towards the folded parent structure and allow 
maximum diversification. To assess the impact of the folding selection by protease 
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digestion, we directly compared a small fraction (~10
10
 sequences) of the control and 
folding-enriched libraries via our protease protocol. The folding-enriched library had a 
6.6% survival rate, which is threefold higher than the control library assembled from the 
L1-4 and L5-7 fragments that had not been selected for folding (Table 2.2). 
 
Table 2.2 - Results of the folding selection by in vitro protease digestion. 
 Digested species % Survival 
[a]
 
Control constructs 
GDPDwt 
GDPDmut 
GDPDmut (-His6) 
[b]
 
L3 (-His6) 
[b]
 
92± 1.2 
0.67± 0.12 
0.4 
0.3 
Analytical selections 
[c]
 
L3 
L4 
L5 
L3-4 
28 
78 
80 
10 
Preparative selections 
[d]
 
L1-4 (1st round) 
L1-4 (2nd round) 
L5-7 (1st round) 
1.4 
9.2 
52 
Final libraries 
Folding-enriched 
Control 
6.6 ± 1.1 
2.2 ± 0.3 
[e]
 
[a] % survival is defined as fraction of mRNA-displayed species that are not digested during the 
chymotrypsin treatment and is calculated as the ratio (Ni-NTA purification yield of chymotrypsin treated 
species)/ (Ni-NTA purification yield of undigested species).  
[b] Constructs lacking the His6-tag needed for Ni-NTA purification.  
[c] Small scale selections to assess tolerance of GDPDwt to the insertion of one or two loops to guide the 
library assembly process.  
[d] Preparative selections performed to generate intermediate libraries used for the assembly of the final 
folding-enriched library.  
[e] The % survival for the control library (loops 1-7 randomized) is higher than for library L1-4. This result 
is counter-intuitive and likely due to an artifact in the protease assay, potentially caused by unfolded 
proteins that escaped the protease digestion by aggregating (false-positives). 
 
2.3.7 Assessment of folding of the final libraries via GFP-fused reporter assay (in vivo) 
 In order to confirm the efficacy of the protease digestion folding selection with an 
independent method, we analyzed a fraction of our libraries using a GFP-fused folding 
reporter system. In this system, the proteins are expressed as N-terminal fusions of GFP. 
The GFP fluorescence of the protein-GFP constructs is dependent on the soluble 
expression of the folded cargo protein and correlates with the stability to intracellular 
degradation. [46-48] This approach had been employed to enrich smaller protein libraries 
(up to 10
8
) for folded variants in vivo and thus is an alternative to our in vitro folding 
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selection. [46] We first analyzed the several intermediate libraries that were used to 
construct the control library and compared them to the GDPDwt and GDPDmut controls 
(Figure S2.4). These intermediate libraries contained one to four randomized loops and 
had not been selected for folding. Since GDPDwt was shown to be solubly expressed and 
well behaved in solution, we were interested in the fraction of our libraries that exhibited 
fluorescence similar to GDPDwt-GFP fusions. In addition, we determined the mode of 
the GFP fluorescence as a qualitative metric for general library trends since GFP 
fluorescence correlates with intracellular stability. Flow cytometric analysis of E. coli 
BL21(DE3) cells expressing GDPD-GFP constructs showed a near base-line separation 
between GDPDwt and GDPDmut, both of which exhibit significantly higher fluorescence 
than cells transformed with an empty vector control plasmid. Analysis of the non-
preselected libraries showed that libraries with randomized loops in the N-terminal half 
of the (β/α)8 barrel (libraries L1-2, L3-4 and L1-4) exhibit a lower GFP fluorescence and 
a lower GDPDwt-like fraction compared to the libraries with randomized loops in the C-
terminal half of the (β/α)8 barrel (libraries L5, L6-7, L5-7) (Figure S2.4, Table S2.1). The 
folding-enriched and control libraries were analyzed in the E. coli BL21(DE3) Rosetta 
strain that provides enhanced eukaryotic protein expression since the assembly process 
potentially enriched for eukaryotic codons that are suboptimal for bacterial expression. 
We observed improvements in the folding-enriched library relative to the control library 
in both the mode of GFP fluorescence and the fraction of GDPDwt-like variants (Figure 
2.3, Table 2.3).  
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Figure 3.3 - Assessment of folding by GFP-fusion assay. Fluorescence histograms of E. coli BL21(DE3) 
Rosetta cells containing library members or control proteins fused to GFP are shown. Empty vector (gray, 
dotted), control library (black, dashed), folding-enriched library (black, solid), GDPDmut (gray, dashed) 
and GDPDwt (gray, solid). The empty vector population was gated out on the histograms of cells 
transformed with the GDPD constructs.  
2.3.8 Isolation of well-folded members of the final libraries by cell sorting  
 To confirm that the soluble expression of GFP fusions is indeed closely correlated 
with the GDPDwt-like GFP fluorescence, control and folding-enriched libraries were 
sorted via fluorescence-activated cell sorting (FACS) (Figure S2.5). We subdivided the 
GDPDwt-like GFP fluorescence window into a low and a high GFP signal during sorting 
as the control library exhibited a discrete peak at high signal within this region (see gate 
H in Figure S2.5B). Cells with such high GFP profile could be false positives due to 
either insoluble aggregates or truncated proteins as noted in previous reports that used the 
GFP reporter system. [46]  
 
Table 3.3 - GFP-fused in vivo folding assessment of the final (β/α)8 fold-based libraries. Constructs 
were transformed into E. coli BL21(DE3) Rosetta cells. Prior to analysis, data were gated to exclude cell 
populations that matched fluorescence and scatter profiles of cells transformed with empty vector control 
plasmid. 
Species Mode of GFP fluorescence 
[a]
 
% cells with GDPDwt-GFP 
fluorescence 
[b]
 
GDPDmut 24.6 0.01 
Control library 15.4 1.4 
Folding-enriched library 19.8 5.4 
GDPDwt 100 98.5 
[a] Values normalized to the mode of GFP fluorescence of GDPDwt-GFP.  
[b] Wild type cells were gated on the forward scatter versus GFP contour plot to include ~98% of all wild 
type cells. 
2.3.9 Analysis of soluble library-GFP fusions by Western blotting and SDS-PAGE 
 The four sorted populations (low and high GFP signal of each of the control and 
folding-enriched libraries in Figure S2.5) were re-grown in liquid culture under sorting 
conditions and the respective amount of soluble full-length library-GFP fusion proteins 
was compared by anti-GFP western blotting (Figure S2.6). A fraction of these cultures 
was also plated to isolate individual GFP-positive clones, express them, and analyze the 
soluble protein fraction of each clone by SDS-PAGE gel (data not shown). The SDS-
PAGE and western blot results showed similar trends and were in good agreement with 
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each other (Table S2.2). The folding-enriched library populations contained a higher 
fraction of soluble GFP fusions in both the low and high populations compared to the 
control library populations. Western blot analysis also showed that the high GFP 
populations for both libraries contained at least ~50% false positive clones that expressed 
GFP alone. Based on the fraction of full length, soluble library-GFP fusions in the FACS-
sorted populations, we calculated that the soluble library members comprise between 1% 
and 1.2% of the folding enriched library and between 0.02% and 0.033% of the control 
library. This corresponds to an overall 35 to 50-fold improvement in the library quality 
based on the fraction of soluble, monomeric and folded sequences. Therefore, the final 
folding-enriched (β/α)8 fold library contains about 10
12
 soluble protein variants (Table 
S2.2).  
 
2.3.10 Biophysical characterization of soluble library clones  
 We sought to further investigate and compare the solubility of protein variants 
from the control and folding-enriched libraries selected at random, as well as the folding-
enriched variants isolated by FACS (above). All constructs were cloned into a protein 
expression plasmid to express the FACS-sorted library-GFP constructs without the GFP. 
Only sequences from the FACS-sorted folding-enriched library produced soluble proteins 
(data not shown), six of which were purified for further characterization. Similar to the 
initial GDPDwt and GDPDmut characterization, we performed size exclusion 
chromatography and measured the near-UV CD and ANS fluorescence to investigate the 
quaternary, secondary and tertiary structure of these library variants (Figure 2.4). All of 
those proteins were monomeric in solution, maintained CD signatures similar to GDPDwt 
and ANS profiles intermediate between GDPDmut and GDPDwt.  
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Figure 2.4 - Biophysical characterization of six soluble folding-enriched library clones from the 
FACS-sorted high GFP population. GDPDwt and GDPDmut data included for reference as dotted and 
dashed lines, respectively. A) Size exclusion chromatography (quaternary structure). B) Far-UV circular 
dichroism spectroscopy (secondary structure). C) 1-Anilinonaphthalene-8-sulfonic acid (ANS) 
fluorescence measurements (tertiary structure). 
2.3.11 Sequence analysis of library clones 
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 To better understand the underlying changes that occurred upon our selection for 
folding, we sequenced randomly chosen individual clones from the control and folding-
enriched libraries, as well as the soluble folding-enriched library clones acquired by 
FACS sorting of the GFP-fused library. We analyzed the amino acid distribution of the 
1,393 sequenced NNS codons and did not observe any stop codon, confirming that they 
were removed during the mRNA display step (Table 2.4). We further grouped the 
sequenced codons into classes of amino acids based on their properties and then 
compared the distributions of these classes for the control library (randomly chosen 
clones) and the folding-enriched library (randomly chosen clones, soluble clones) (Figure 
2.5). To evaluate whether the detected distribution changes were statistically significant 
(p < 0.05), we performed pairwise t-test comparisons of the grouped codons from the 
folding-enriched library sequences (random and soluble clones) against the control 
library sequences (random clones). We observed a significant decrease in aromatic 
residues in the folding-enriched library relative to the control library. The soluble library 
clones from the folding-enriched library, isolated during FACS sorting experiment, 
exhibit the same decrease in aromatic residues, and, in addition, show an increase in polar 
residues at the expense of aliphatic residues. 
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Table 2.4 - Amino acid (aa) distribution for NNS codons, shown in %. 
Amino acid NNS (-stop) 
[a]
 Control library 
[b]
 Folding-enriched library 
[b]
 
   Random clones 
Random 
clones 
Soluble clones 
Polar 
Asn 
Gln 
Ser 
Thr 
3.2 
3.2 
9.7 
6.5 
3.8 
3.2 
7.0 
7.0 
5.3 
3.8 
8.4 
5.1 
3.4 
2.8 
15.5 
6.6 
Basic 
Arg 
His 
Lys 
9.7 
3.2 
3.2 
10.2 
3.2 
5.1 
10.1 
4.2 
5.1 
11.0 
3.1 
3.8 
Acidic 
Asp 
Glu 
3.2 
3.2 
4.0 
2.2 
4.4 
2.7 
4.5 
3.8 
Aliphatic 
Ala 
Ile 
Leu 
Met 
Val 
6.5 
3.2 
9.7 
3.2 
6.5 
6.1 
2.9 
9.7 
4.3 
6.7 
6.9 
2.7 
11.2 
2.9 
5.5 
6.6 
3.1 
8.3 
2.4 
3.1 
Aromatic 
Phe 
Trp 
Tyr 
3.2 
3.2 
3.2 
4.1 
3.0 
2.9 
1.9 
2.9 
1.9 
3.1 
1.4 
2.1 
Structural 
Cys 
Gly 
Pro 
3.2 
6.5 
6.5 
1.3 
5.4 
8.0 
1.3 
6.3 
8.0 
1.4 
8.3 
5.9 
 stop 0 Not observed 
Not 
observed 
Not observed 
Codons 
sequenced 
  628 475 
[c]
 290 
[c]
 
[a] Theoretical aa distribution for NNS(-stop) was calculated from the expected NNS distribution lacking a 
stop codon.  
[b] Experimentally observed values from sequencing analysis of individual library clones.  
[c] Loops containing wild type sequences were omitted from analysis. 
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Figure 2.5 - Amino acid composition of randomized loop regions. Amino acids are grouped according to 
their chemical properties and the compositions were calculated from sequencing data. Control library, 
randomly picked clones (white); folding-enriched library, randomly picked clones (gray); folding-enriched 
library, soluble clones (black). Statistically significant differences, as determined by pairwise t-test, are 
indicated by a star. 
 
2.4 Discussion  
 The objective of this study was to generate and characterize a high quality protein 
library based on the (β/α)8 fold by combining a step-wise assembly with an in vitro 
folding selection. We further sought to evaluate the efficacy of such an approach by 
comparing a representative fraction of members of the libraries using two orthogonal 
methods for the assessment of folding.  
 Our in vitro and in vivo folding assessment methods provided different metrics to 
measure folding stability, which are survival rates during protease digestion, the mode of 
fluorescence of GFP-fused library members, and the fraction of library members that 
behave like GDPDwt in the GFP assay. All three metrics displayed similar trends for the 
intermediate libraries, and showed a substantial improvement in the quality of the 
folding-enriched library compared to the control library, demonstrating the success of our 
folding selection. While those metrics were useful to characterize the libraries in bulk and 
assess the library construction process, they were only indirect measures for determining 
how much the library was enriched for soluble, well-folded protein variants that behaved 
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like the starting (β/α)8 scaffold. To quantify directly the fraction of those desired library 
variants, we cloned and expressed 20 randomly chosen proteins from both libraries in E. 
coli. We did not obtain any soluble proteins from this small sample size, indicating that 
the fraction of soluble variants in each library was below 5%. We therefore sorted a 
fraction of the GFP-fused libraries via fluorescence-activated cell sorting (FACS) and 
were able to isolate library members that readily expressed in bacteria, are monomeric, 
and exhibit behavior similar to the GDPDwt scaffold in solution. Sequencing results 
suggested that the improved solubility correlates, as expected, with the increased 
presence of polar amino acids at the expense of aliphatic residues. Furthermore, the 
occurrence of aromatic amino acids was reduced in the folding-enriched library 
compared to the control library, which might in part be a result of the selection 
disfavoring those residues due to chymotrypsin’s preference to cleave next to aromatic 
amino acids. Based on the number of soluble, GDPDwt-like clones we obtained from the 
sorting experiment, we calculated that these sequences comprise about 1% of the folding-
enriched library (~10
12 
variants), an increase over the control library of up to 50-fold.  
 The in vitro and in vivo folding methods employed in our work required the 
fusion of the (β/α)8 library proteins to either their own mRNA or a GFP reporter protein, 
which could, in principle, alter stability or solubility of the proteins. To minimize this 
potential issue during the in vitro protease digestion, the mRNA was reverse-transcribed 
to generate the linear mRNA-cDNA hybrid thereby preventing the mRNA from folding 
and affecting the digestion by obscuring protease sites. Furthermore, we assessed whether 
the fusion to GFP affected solubility of the library proteins by expressing soluble library-
GFP constructs without the GFP fusion and analyzing them by SDS-PAGE – all proteins 
remained soluble in solution. Notably, during the FACS sorting experiment we 
encountered a substantial number of false-positive highly fluorescent cells resulting from 
clones that had lost their GDPD library cargo, leading to the expression of GFP alone. It 
has been proposed in earlier work that such false positives result from either truncated or 
highly aggregated and insoluble species. [46] We were able to exclude these false-
positives by analyzing the soluble fraction of the expressed proteins by gel 
electrophoresis. The folding selection by protease digestion likely also allowed for some 
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false-positive protein variants to become selected. For example, we could envision 
certain unfolded proteins escaping the protease digest through aggregation as those 
proteins would be inaccessible to the protease enzyme. We counter-acted this possibility 
by including detergents and denaturants (Triton X-100 and SDS) in our buffers. Yet, as 
we cannot rule out a remaining selection bias of this kind, we deliberately chose not to 
further enrich the intermediate libraries L1-4 and L5-7 beyond the initial one or two 
rounds of selection. Finally, the biophysical characterization of individual soluble library 
members confirmed that our protease selection protocol successfully enriched for folded 
variants with a structure similar to the parental (β/α)8 scaffold. 
 The final folding-enriched library contains up to 32 randomized amino acid 
positions distributed over 7 loops. The soluble library variants isolated by FACS 
exhibited some variability in the location and number of loops that were randomized. 
Interestingly, randomization in loops 2 and 3 was disfavored in the folding-enriched 
library as we frequently recovered the parent GDPDwt sequence in these loops (~80% 
and ~40% parent sequence in randomly picked clones, respectively). All soluble clones 
isolated in the FACS experiments showed the parent sequence in loops 2 and 3, while 
containing other randomized loops. In addition, libraries that contained randomized loops 
2 and/or 3 also exhibited lower protease survival rates and lower GFP-fluorescence, 
which is further evidence that their randomization is detrimental to the stability of the 
(β/α)8 barrel. We suspect that the wild type loops observed in the final library arose 
during the step-wise library assembly. While initially present only at very low levels in 
the intermediate libraries, these variants were enriched during the folding selections. 
However, the ~10
12
 soluble members of the folding-enriched library have at least 3 
randomized loops and at least 13 randomized amino acids. For comparison, a recent 
study described the switch of one (β/α)8 scaffold enzyme to an unrelated (β/α)8 activity 
via a single loop insertion. [19] If a new enzymatic activity can be found with the 
exchange of a single loop as those results suggest, our library of soluble proteins with 
three and more randomized loops likely has an even greater potential to contain different 
enzymatic activities. In addition, some of the less soluble library members may also be 
exploitable by in vitro selection methods as, for example, the mRNA display has been 
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shown to help keep poorly soluble proteins in solution through the attachment of a large 
highly-soluble RNA molecule. However, the solubility of such proteins would 
subsequently need to be improved through directed evolution, in contrast to the ~10
12
 
already soluble library members. In summary, we demonstrated that those soluble clones 
have retained most of the overall structural features of the parent (β/α)8 fold despite the 
introduction of multiple randomized stretches of amino acids. To the best of our 
knowledge, this is the first report of a high quality library based on the (β/α)8 enzyme fold 
with such a high complexity.  
 Our work also allowed us to make several observations regarding the behavior of 
the GDPDwt (β/α)8 fold, the role of randomized loop positions and the impact of 
combining individual loop libraries. We observed that single, entirely randomized loop 
insertions into the GDPDwt resulted in libraries with 30-80% survival in the protease 
digestion folding selection. Interestingly, prior in vivo work demonstrated that single 
known loops inserted into an unrelated (β/α)8 barrel resulted in similar tolerances with 
regards to folding. [18] The authors suggested that it was the site of insertion and not the 
inserted sequence that had the greatest influence on the stability of the resulting protein 
chimera. The results we present here strongly support this notion and suggest that other 
(β/α)8 barrels may exhibit similar tolerances to single loop insertions, regardless of 
whether the loop sequence had been favored previously in nature or is entirely random. In 
fact, previous work suggests that random regions are beneficial in adapting known loops 
to the context of a new (β/α)8 barrel structure. [17] When we combined two libraries with 
different folding stabilities, the resulting library displayed a lower folding stability than 
the less stable input library, as evidenced in both the protease digestion and the GFP-
fusion assay for multiple libraries. We observed a general trend where the N-terminal half 
of the barrel appears more vital for folding stability than the C-terminal half. This finding 
was inferred from the low GFP fluorescence, the high protease digestion rates, and the 
sequencing results for libraries containing randomized N-terminal loops. Similar 
positional preferences were observed in previous experiments on another (β/α)8 scaffold. 
[18] Although we were initially concerned that the introduction of several randomized 
loops into the GDPDwt scaffold would drastically unfold the (β/α)8 fold, by all our 
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metrics, the data indicate that this scaffold is tolerant to multiple loop insertions, 
particularly in the C-terminal half of the barrel. In summary, our results support the 
hypothesis that the core of a hyperthermophile (β/α)8 barrel fold provides sufficient 
stability to offset the effects of destabilizing loops of the catalytic face, and render the 
(β/α)8 fold an attractive scaffold in enzyme engineering by loop insertion.  
 
2.5 Conclusion 
 The high quality and complexity of the libraries reported here are expected to 
provide an invaluable starting point for the engineering of novel enzymes and the 
understanding of the origins of enzymatic function in the (β/α)8 fold. By introducing 
randomized elements onto a stable scaffold in step-wise fashion and enriching for folded 
variants, we have increased the probability of finding novel enzymes with diverse 
activities. These initial, potentially low enzymatic activities will subsequently be evolved 
further under appropriate selection conditions to give rise to more efficient specialist 
enzymes. [40, 49, 50] Many (β/α)8 enzymes act on substrates with a phosphate group and 
some soluble variants of the folding-enriched library have retained the residues that 
compose the native phosphate binding site. This site can be used as a handle to improve 
substrate binding or to study the role of such handles in the evolution of enzymes. 
Furthermore, isolating novel activities from these libraries that are unrelated to the 
original GDPD function will help to elucidate whether the (β/α)8 barrel fold is 
predestined for certain activities, how it can be adapted to perform new functions, and 
what impact a library preselected for folding may have on isolation of enzymatic activity. 
Finally, an estimated 1% of our folding-enriched library contains sequences that are 
solubly expressed in E. coli while showing substantial diversity in the number and 
positioning of randomized loops. Our libraries are thus compatible with in vitro and in 
vivo evolution methods. Work is underway to interrogate the libraries for de novo 
enzymes using mRNA display and to study the (β/α)8 fold adaptability through bacterial 
selections.  
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2.6 Materials and methods 
 All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless 
otherwise stated. All restriction enzymes, T4 DNA ligase and Phusion High Fidelity 
DNA polymerase were purchased from New England Biolabs (Ipswich, MA). All PCR 
reactions were performed with Phusion High Fidelity DNA polymerase. If available, high 
fidelity versions of the restrictions enzymes were employed. Gel extraction, PCR clean 
up and DNA mini-prep kits were purchased from Qiagen (Valencia, CA). Sequencing 
reactions were performed either by ACGT, Inc. (Wheeling, IL) or University of 
Minnesota BioMedical Genomics Center (St. Paul, MN). 
 
2.6.1 Cloning and expression of GDPDwt and GDPDmut constructs:  
 GDPDwt gene, optimized for dual expression in rabbit reticulocyte and E. coli, 
was purchased from Genscript, USA. The construct was PCR amplified and cloned into 
pET28a vector (Novagen). GDPDmut was generated using standard mutagenesis 
protocols using pET28/GDPDwt as template. For protein expression, plasmids were 
transformed into BL21(DE3) Rosetta E. coli strains (Novagen) and grown on LB media 
in presence of kanamycin (34 mg/l) and chloramphenicol (34 mg/l). Overnight cultures 
were diluted 1:1,000 into fresh LB media and grown to OD600 = 1 prior to induction with 
IPTG (1 mM). Cells were grown an additional 4 hours at 37 °C prior to harvesting and 
storage at -20 °C. Frozen cell pellets were resuspended in lysis buffer (50 mM Tris-HCl 
pH 8.0, 50 mM NaCl) and lysed using an S-450D Digital Sonifier (Branson). Cell debris 
was removed by centrifugation and the His-tagged proteins were purified by affinity 
chromatography using Ni-NTA Superflow resin (Qiagen) under native conditions for 
GDPDwt and denaturing conditions for GDPDmut according to the manufacturer 
recommendation. Elution fractions containing GDPDmut were dialyzed to remove 
denaturants by first diluting 1:4 in dialysis buffer (50 mM Tris-HCl, 100 mM NaCl, pH 
7.5) then dialyzing overnight in 7 kDa MWCO Snake Skin Dialysis Tubing (Pierce) in 
dialysis buffer. The protein purification was evaluated by SDS-PAGE on precast 4-12% 
gradient gels (Invitrogen 
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2.6.2 Circular Dichroism (CD) spectroscopy:  
 All CD experiments were performed on a Jasco J-815 spectropolarimeter. For far-
UV experiments, ellipticity of 20 μM protein samples in 10 mM Tris-HCl pH 7.5, 20 mM 
NaCl was measured from 190 to 260 nm at 50 nm/min using a quartz cuvette with a 1 
mm path length. Each spectrum represents the average of 10 accumulations. For near-UV 
experiments, ellipticity was measured the same as far-UV except a quartz cuvette with a 
10 mm path length was used and wavelengths ranged from 260 to 350 nm. 
 
2.6.3 1-Anilinonaphthalene-8-sulfonic acid (ANS) fluorescence measurements: 
 ANS is an environmentally sensitive dye which exhibits increased fluorescence 
upon interaction with hydrophobic protein surfaces and has been previously used to 
indirectly report on protein tertiary structure. [51] Measurements were performed on 
either the SpectraMax M2 or M5 plate readers (Molecular Devices) in black flat-bottom 
96-well NUNC Maxisorp® plates. Samples containing protein (5 μM) and ANS (1 mM) 
in dialysis buffer (50 mM Tris-HCl, 100 mM NaCl, pH 7.5), were excited at 403 nm, 
monitoring emission at 430-600 nm in 1 nm intervals. Data was smoothed with 
Kaleidograph software. 
 
2.6.4 Size exclusion chromatography:  
 Ni-NTA purified protein samples were loaded onto a 10 mm x 300 mm column 
(Tricorn) packed with Superdex 75 resin (GE Healthcare) and analyzed on the AKTA 
FPLC system (GE Healthcare) in a buffer containing 50 mM Tris-HCl, 100 mM NaCl, 
pH 7.5. Column was calibrated using Amersham low molecular weight calibration kit 
(GE Healthcare). 
 
2.6.5 Library assembly:  
 All loop libraries were assembled via a three step process of PCR amplification, 
restriction digest and ligation (Figure S2.3). All PCR reactions employed a constant 
primer at the 5’ and 3’ termini and internal primers containing a restriction site (Tables 
S2.3 and S2.4). Loop randomization and insertion was carried out at the single or double 
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loop library level by amplifying two fragments of GDPDwt from the pET28/GDPDwt 
template and introducing the randomized NNS codons via one of the primers. Assembly 
of half libraries and final libraries was performed using internal primers that did not 
introduce any randomized nucleotides. Following PCR amplification, DNA was phenol-
chloroform extracted and ethanol-precipitated following standard molecular biology 
protocols. [52] DNA was digested with appropriate restriction enzyme (Table S2.4) and 
purified on 2% agarose gel. Purified digested fragments were ligated with T4 DNA ligase 
at 16 
o
C overnight. The ligation product was purified on 2% agarose gel and PCR 
amplified with external primers to generate ~10 copies of the full length template to be 
used for the next set of library construction. During the construction of folding-enriched 
library, the L1-2, L3-4, L5 and L6-7 libraries were subjected to a single round of mRNA 
display (below) to remove stop codons and frameshifts and then recombined to generate 
L1-4 and L5-7 libraries. These libraries were subjected to protease based selection 
(below) and then recombined to assemble the final folding-enriched library. During the 
control library assembly, half gene fragments of the L1-4 and L5-7 libraries were mRNA-
displayed to minimize artifacts related to folding. In the final assembly step for both the 
control and folding-enriched libraries, ~10
9
-10
10
 L1-4 and L5-7 DNA sequences were 
amplified on 20 ml scale to generate ~5x10
14
 starting sequences. Due to increased scale 
of the BsaI-HF digests and final ligation reaction, DNA purification was performed via 
4.5% native PAGE gel, extracted under UV-shadowing and electroeluted on S&S Elutrap 
(Schleicher & Schuell). 
 
2.6.6 mRNA display:  
 Creation of mRNA displayed fusions was performed similarly to previously 
published [43] but with the following alteration. RNA was produced from the DNA 
library with T7 RNA polymerase (5 nM DNA template, 200 mM HEPES, 35 mM MgCl2, 
2 mM spermidine, 5 mM dNTP (each), 0.1 mg/ml BSA, 40 mM DTT, 1 U/ml inorganic 
pyrophosphatase, 150 U/ml RNaseOUT (Invitrogen), pH 7.5) and incubated at 37 °C for 
3 hours. RNA was precipitated by LiCl (1/3 equivalent of 8M LiCl) at -20 °C for at least 
30 min. The RNA pellet was washed with ice cold 70% ethanol and dissolved in water. 
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RNA was photo crosslinked (3 μM RNA, 20 mM HEPES, 100 mM KCl, 1 mM 
Spermidine, 1 mM EDTA, 7.5 μM oligo, pH 7.5) with a Psoralen-puromycin oligo (5′-
X(tagccggtg)AAAAAAAAAAAAAAAZZACCP-3′ X = psoralen C6, lower case letters 
= 2′-OMe, Z = spacer 9, P = puromycin, stretch of A’s and ACC = DNA) under 365 nm 
light on ice for 20 min with an efficiency of approximately 50%. Crosslinked RNA was 
ethanol precipitated and dissolved in water. A 200 μl or 1 ml translation (200 nM 
crosslinked RNA, 40% nuclease treated rabbit reticulocyte lysate (Promega), 25 μM 
amino acid mix), 25 nM 
35
S-methionine with additional KCl and Mg(OAc)2 to a final 
concentration of 120 mM and 0.6 mM respectively) was incubated at 30 °C for 10 min 
followed by high-salt incubation (550 mM KCl, 50 mM MgCl2) for 5 min at RT. The 
translation mixture was diluted ten-fold into oligo(dT) binding buffer (20 mM Tris-HCl, 
10 mM EDTA, 1 M NaCl, 0.2% Triton X-100, pH 8) and incubated with oligo(dT) 
cellulose (GE Healthcare, 40 mg) with rotation for 15 minutes at 4 °C. The oligo(dT) 
cellulose was washed on a chromatography column (Bio-Rad) with more oligo(dT) 
binding buffer, oligo(dT) wash buffer (20 mM Tris-HCl, 0.3 M NaCl, pH 8) and eluted 
with elution buffer (2 mM Tris-HCl, pH 8). The eluent was spin filtered through a 0.45 
μm filter (Millipore) to remove any additional oligo(dT) cellulose and mixed with 10X 
phosphate buffered saline (PBS) with 0.1% Triton X-100. The mixture was added to 
Anti-Flag M2-Agarose Affinity Gel (25 μl, equilibrated according to the manufacturer’s 
instructions) and incubated with rotation for at least 1 h at 4 °C. Flag resin was washed 
on a chromatography column (Bio-Rad) with PBS w/ 0.01% Triton X-100 followed by 
Flag wash buffer (50 mM HEPES, 150 mM NaCl, 0.01% Triton X-100, pH 7.4) where 
the final wash was performed in batch in a microcentrifuge tube. Elution was performed 
by incubating Flag resin with Flag peptide (56 μM in Flag wash buffer) for 10 min at 
4 °C with rotation and filtered through a 0.45 μm filter (Millipore) to remove any 
additional Flag resin. Eluent was diluted with Flag elution buffer until mRNA displayed 
fusions reached 3x10
8
 fusions/μl followed by reverse transcription with Superscript II 
(1.5x10
8
 fusions/μl, 50 nM RT-primer (5’-TTTTTTTTTTTTTTTN 
CCAGATCCAGACATTCCCAT-3’), 50 mM Tris-HCl, 3 mM MgCl2, 10 mM 2-
mercaptoethanol, 0.5 mM dCTP, dGTP, TTP, 5 μM dATP, 100 U/ml RNaseOUT 
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(Invitrogen), 500 U/ml Superscript II (Invitrogen), pH 8.3). A 10 μl sample was removed 
to serve as a non-radiolabeled control prior to the addition of α-32P-dATP (Perkin 
Elmer,16 μM final concentration) to the reverse transcription. Both tubes were incubated 
at 42 °C for 30 min and the control was stored at -20 °C. The reverse transcription was 
treated with calf intestinal alkaline phosphatase (Amersham, 40 U/ml) at 37 °C for 10 
min. Reverse transcribed fusions were then dialyzed in a 20K MWCO Slide-A-Lyzer 
(Pierce) 3-4 times against dialysis buffer (50 mM Tris-HCl, 100 mM NaCl, pH 7.5) until 
all unincorporated 
32
P had been removed. 
 
2.6.7 In vitro folding selection by protease digestion:  
 The dialyzed fusions were subjected to our folding selection. Triton X-100 and 
sodium dodecyl sulfate were added to 0.1% and 0.05% (w/v) respectively. Fusions were 
incubated with Chymotrypsin (Princeton Separations, 6 μg/ml) at 30 °C for 5 min, the 
digest was stopped by the sequential addition of phenylmethylsulfonyl fluoride (2 mM) 
and KCl (final concentration of 5 mM) and incubated on ice for 10 minutes. The 
potassium dodecyl sulfate precipitate was removed via Ultrafree-MC 0.45 μm Spinfilter 
(Millipore) at 4 °C followed by addition of 3 volumes of Ni-NTA binding buffer (100 
mM Phosphate, 10 mM Tris-HCl, 250 mM NaCl, 6 M guanidinium hydrochloride 
(Amresco), 0.1% Triton X-100, pH 8). The mixture was added to 1 volume Ni-NTA 
agarose (Qiagen) pre-equilibrated to Ni-NTA binding buffer and incubated with rotation 
for at least 1 hour at 4 °C. The Ni-NTA agarose was washed on a chromatography 
column (Bio-Rad) with more Ni-NTA binding buffer followed by a gradient of increasing 
amounts of Ni-NTA native wash buffer (10 mM Tris-HCl, 250 mM NaCl, 0.01% Triton 
X-100, pH 8) followed by elution by Ni-NTA elution buffer (50 mM Tris-HCl, 50 mM 
NaCl, 500 mM imidazole, 0.01% Triton X-100, pH 8). The eluent was concentrated to a 
third its original volume using a SpeedVac concentrator, ethanol precipitated and 
dissolved in 10 mM Tris-HCl pH 8 by heating to 80 °C. cDNA was amplified by PCR 
with Phusion polymerase and primers to add a 5’-UTR (untranslated region). Yields from 
each purification step were determined via scintillation or Cerenkov counting on the 
Beckman LS6500 multipurpose scintillation counter. 
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2.6.7 GFP-based folding assay:  
 The GFP-based folding assay is based on the pER13a reporter plasmid previously 
employed to isolate protein variants with improved folding and contains an out of frame 
GFP. [46] A fraction of the library of interest (~10
8
-10
9
 sequences) was PCR amplified 
with Phusion polymerase and cloned into pER13a plasmid using NdeI and NotI 
restriction sites to generate N-terminal fusions to GFP. Libraries were ligated into the 
digested pER13a plasmid using T4 DNA ligase. Ligation reactions were purified via spin 
columns (PCR clean up kit, Qiagen) prior to electroporation into electrocompetent NEB 
5-alpha cells (New England Biolabs). Following 1 hour incubation at 37 
o
C, cells were 
plated and grown overnight on kanamycin containing agar plates. Approximately 10
4
-10
5
 
independent colonies were washed off the plates and their plasmids were isolated (mini-
prep kit, Qiagen). BL21(DE3) and BL21(DE3) Rosetta cells (Novagen) were used for 
GFP-fused expression of intermediate (Table S3.1) and final libraries (Table 3.3), 
respectively. Electrocompetent cells prepared using standard molecular biology protocols, 
[52] were transformed with ~10
8
 DNA sequences and grown overnight at 37 
o
C in LB 
media (50 ml) supplemented with kanamycin (75 mg/l ) and chloramphenicol (34 mg/l). 
Overnight culture was used to inoculate the same medium (10 ml) and cells were grown 
approximately to OD600 = 0.6, transferred to 30 
o
C for 30 min prior to addition of IPTG 
(0.5 mM). Growth was continued for 6 h at 30 °C. An aliquot of the cells (1.5 ml) was 
pelleted by centrifugation (Eppendorf 5415R, 3 min, 4,500 rpm, room temperature), 
washed with phosphate-buffered saline (PBS, 1 ml) and resuspended in PBS (500 μl). 
Flow cytometry experiments were performed at the University Flow Cytometry Resource 
(University of Minnesota, Twin-Cities). Samples were analyzed on FACSCalibur (BD 
Biosciences) using 488 nm excitation and monitoring emission by a 530/30 nm bandpass 
filter. FlowJo software package (TreeStar Inc) was used for data analysis. The population 
of cells transformed with the empty vector was gated out from all experiments before 
determining the GFP mode (most frequently found fluorescence value) for the remaining 
cells. Cell sorting experiments were performed on FACSAria (BD Biosciences). Sorting 
gates were defined on the side scatter vs. GFP fluorescence dot plots. The GDPDwt-like 
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population gate was set based on the cells transformed with GDPDwt-GFP construct 
while gates for low GFP and high GFP populations were set based on the cells 
transformed with the GFP-fused control library. Sorted cells were used to inoculate LB 
medium containing kanamycin and chloramphenicol and re-grown again under sorting 
conditions as above for Western blot analysis. An aliquot of the re-grown cells was 
removed prior to IPTG induction and plated on LB agar plates containing kanamycin and 
chloramphenicol. Individual clones picked at random from these plates were grown in 
liquid culture and analyzed by SDS-PAGE for soluble expression of library-GFP variants. 
Six clones from the high GFP population of the GFP-fused folding-enriched library (out 
of 20 soluble clones identified by SDS-PAGE) were subcloned into pET28a and 
expressed for further characterization, as above for the GDPD control constructs. 
 
2.6.8 Western blot analysis:  
 Cell pellets were lysed using BugBuster protein extraction reagent (Novagen) 
according to manufacturer’s recommendations. Insoluble fraction was pelleted and 
resuspended in the original volume of the BugBuster reagent. Samples were mixed with 
equal volume of 2X Laemmli sample buffer (BioRad), heated for 5 min at 95 
o
C and spun 
down. A fraction of all samples was removed, diluted 10-fold and run on 4-12% gradient 
gel (Invitrogen). Western blotting was performed according to standard protocols [52] 
using affinity-purified polyclonal rabbit anti-GFP primary antibody (Abcam, cat. no 290) 
at 1:5,000 dilution. Anti-rabbit secondary antibody labeled with the DyLight 800 infrared 
dye (Cell Signaling, cat. no 5151) was used at 1:20,000 dilution and visualized using the 
Li-Cor Odyssey infrared imaging system. Images were analyzed using Image J software 
package (NIH) to quantify intensities of anti-GFP stained bands.  
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2.7 Supplementary Information 
 
 
 
Figure S2.1 - Biophysical characterization of GDPDwt (black dotted line) and GDPDmut (black 
dashed line) proteins. A) Investigation of quaternary structure by size exclusion chromatography. 
Monomeric GDPDwt elutes at 11 ml while oligomeric GDPDmut elutes at 8 ml. B) Far-UV circular 
dichroism spectroscopy to study the secondary structure. GDPDwt exhibits characteristic alpha-helical 
peaks at 208 nm and 222 nm while GDPDmut has lost some secondary structure, as indicated by signal 
decrease in 222 nm. C) 1-Anilinonaphthalene-8-sulfonic acid (ANS) fluorescence measurements (tertiary 
structure). ANS fluorescence is known to increase upon interaction with exposed hydrophobic protein 
patches, suggesting increased presence of exposed hydrophobic patches in GDPDmut, associated with the 
loss of the native GDPDwt tertiary structure. Buffer is shown as solid light gray line. D) Near-UV circular 
dichroism spectroscopy reveals that GDPDmut has significantly less tertiary structure relative to GDPDwt. 
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Figure S2.2 - Folding selection by in vitro protease digestion. A) Schematic of the protease-digestion 
based selection by mRNA display. A mixture of folded and unfolded proteins that are covalently linked to 
their encoding mRNA/cDNA hybrid via puromycin (P) is subjected to chymotrypsin digest and then 
purified under denaturing conditions via Ni-NTA affinity chromatography. Only the cDNA of the well 
folded proteins is immobilized on the Ni-NTA resin, and amplified by PCR for downstream applications. In 
contrast, cleavage of unfolded proteins severs the link between His6-tag and cDNA, thereby preventing 
immobilization of the cDNA. B) Analysis of chymotrypsin digestion during initial optimization steps. 
mRNA-displayed GDPDwt and GDPDmut proteins were incubated with chymotrypsin for 10, 15 and 20 
min prior to analysis of crude digest reactions by SDS-PAGE. Undigested mRNA-protein fusions and 
fusions treated with proteinase K (to degrade proteins non-specifically) were used as controls for 0% and 
100% digestion, respectively. Under these conditions GDPDmut is preferentially digested by 
chymotrypsin. Final optimization steps included the additional use of detergents and an analysis of 
digestion based on comparison of His6-tag purified digested and undigested samples via scintillation 
counting.  
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Figure S2.3 - Step-wise strategy for the construction of libraries based on the (β/α)8 fold. Each box 
represents an individual library with randomized loop(s) (e.g. library L1-2). Libraries containing only a 
single randomized loop are not shown for clarity. The libraries were mRNA-displayed to remove stop 
codons or, in addition, were subjected to a folding selection by in vitro protease digestion (shown in yellow 
and blue, respectively). A) Construction of the folding-enriched library. Full length (β/α)8 barrel libraries 
were used in mRNA display and folding selection. B) Construction of the control library. (β/α)4 half-gene 
fragments of the barrel libraries were used in mRNA display to prevent the native (β/α)8 fold from biasing 
the randomized regions in the control library. 
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Figure S2.4 - Assessment of folding by GFP-fusion assay. Fluorescence histograms of E. coli 
BL21(DE3) cells expressing the GFP-fused control constructs and intermediate libraries. The empty vector 
population was gated out on the histograms of cells transformed with the GDPD constructs. None of the 
libraries shown here had been selected yet for folding. 
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Figure S2.5 - Analysis of library populations by fluorescence-activated cell sorting experiments 
(FACS). Side scatter versus GFP fluorescence dot plots are shown for A) GDPDwt-GFP, B) control library 
and C) folding-enriched library. In the top panel, the GDPDwt-like population of cells is framed with a 
thick black line. The low (L) and high (H) populations of library-GFP cells shown in the lower two panels 
were collected during the sorting experiment for further analysis. The number of cells in the medium (M) 
population was estimated (see Table S2.2).  
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Figure S2.6 - Comparison of the soluble and insoluble fractions of the FACS sorted library 
populations. A) SDS-PAGE gel Coomassie-stained. B) Western blot of SDS-PAGE gel using polyclonal 
anti-GFP antibody. Approximate molecular weights for library-GFP fusions (57 kD, black triangle) and for 
GFP alone (27 kD, white triangle). Equal amounts of soluble (s) and insoluble (i) fractions were loaded for 
each library. The soluble fraction of over-expressed GDPDwt-GFP fusion is shown as positive control. 
 
 
Table S2.1 - GFP-fused in vivo folding assessment of intermediate libraries. 
[a]
 
Species 
Mode of GFP 
fluorescence 
[b]
 
% of cells with GDPDwt GFP 
fluorescence 
[c]
 
GDPDmut 10.4 0.02 
L1-2 6.7 0.90 
L3-4 7.2 0.05 
L1-4 5.4 0.09 
L5 21.3 9.3 
L6-7 72.3 51.6 
L5-7 10 6.9 
GDPDwt 100 98.5 
[a] Constructs were transformed into E.coli BL21(DE3) strain. Stop-codon containing libraries that have 
not been subjected to mRNA display. Prior to analysis all data were gated to exclude cell populations that 
matched fluorescence and scatter profiles of cells transformed with empty plasmid.  
[b] Values normalized to the mode GFP fluorescence of GDPDwt-GFP.  
[c] Wild type cells were gated on the forward scatter versus GFP contour plot to include ~98% of all wild 
type cells. 
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Table S2.2 - Fraction of soluble, GDPDwt-like, library-GFP fusions in the FACS-sorted populations. 
 
% soluble GFP fusions 
of sorted cells of all cells 
Library population 
[a] [b]
 
% Non-empty 
cells 
[c]
 
By Western blot 
[d]
 By SDS-PAGE  
Control, low GFP 0.86% 0.24% <5% (0/18 clones) 0.002% 
Control, medium 
GFP 
0.23% 
[f]
 0.24%-5.76% 
[g]
 Not available 
0.001%-
0.013% 
Control high GFP 0.31% 5.76% <5% (0/19 clones) 0.018% 
Estimated % soluble proteins in control library 
0.020%-
0.033% 
[h]
 
 
Folding-enriched, 
low GFP 
3.18% 18.20% 29% (4/14 clones) 0.579% 
Folding-enriched, 
mid GFP 
1.68% 
[f]
 18.20%-26.70% 
[g]
 Not available 
0.306%-
0.449% 
Folding-enriched, 
high GFP 
0.54% 26.70% 
24.6% (20/81 
clones) 
0.144% 
Estimated % soluble proteins in folding-enriched library 
1.029%-
1.172% 
[h]
 
 
Enrichment of soluble proteins after folding selection [i] 35 to 50-fold 
[a] Library populations fell into the GDPDwt-like profile window defined by side scatter vs. GFP 
fluorescence dot plot of GDPDwt-GFP construct (Figure S2.5A).  
[b] Only the low and high GFP populations were sorted during the FACS experiment.  
[c] % Non-empty cells defined as the ratio (# of cells analyzed - # of cells with empty-vector) / (# of cells 
analyzed). A total of 1.4% of the control library and 5.4% of the folding-enriched library fell into the 
GDPDwt-like window used for sorting and analysis.  
[d] % Soluble GFP fusions of sorted cells calculated from Western blot analysis (Figure S2.6) using Image 
J to quantitate the intensities of all anti-GFP stained bands. Defined as the ratio (intensity of soluble GFP-
fusions) / Σ(intensity of all anti-GFP stained bands).  
[e] % Soluble GFP fusions of all cells calculated as (% non-empty cells x % soluble GFP fusions of sorted 
cells estimated from Wester blot) for the population of interest.  
[f] % Non-empty cells for the unsorted medium GFP population was calculated as the difference in % non-
empty cells populations (GDPDwt-like – low GFP – high GFP).  
[g] Values are lower and upper estimates based on % soluble GFP fusions of sorted cells in the low and 
high GFP populations.  
[h] Estimated % soluble proteins in a library calculated as Σ (% soluble GFP fusions of all cells) for low, 
medium and high GFP populations.  
[i] Fold improvement defined as the ratio (estimated % soluble proteins in the folding-enriched library)/ 
(estimated % soluble proteins in the control library). 
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Table S2.3 - List of primers used during library construction. 
Primer Sequence 
041B 
[a]
  
GCCTTCTAATACGACTCACTATAGGGACAATTACTATTTACAATTACAATGGGCAGCGA
TAAGATCCACC 
042 
[a]
 TTAATAGCCGGTGCCAGATCCAGACATTCC 
018 
TATGACCAAGCTTCCAGGGTGTTTTCCAGATACTTGGCGGAGTAACCSNNSNNGCCCAG
CACAATCAC 
019 CTGGAAAACACCCTGGAAG 
047 
AACAACAAGGTCTCAGGCGCTTTAAATCSNNSNNSNNSNNSNNGCTCACGACCACCTTG
CC 
048 AACAACAAGGTCTCGCGCCTGTTCGGTCTGGACG 
028 AACAACAAGGTCTCCCTCACGTTCSNNSNNSNNSNNGATTTCGATGTTGATGATCTTG 
029 
AACAACAAGGTCTCGTGAGGCCGCGGACGCAGTGCTGGAGATCAGCAAAAAGCGTAA
G 
022 
TGGAGGTCCTTGGTACCCTTGAATTTTTCATCCAGCAGGTCCAGATCSNNSNNSNNSNN
GGAGCTGAAAATCAGGTTCTTAC 
023 GATCTGGACCTGCTGGATG 
012 
AGTAGAGGTACCAAATACGGTTATNNSATCNNSNNSNNSNNSNNSTACGGTTCCATTGA
AAATTTCG 
015 CTTCGTCGATCAGATAACCG 
003 
AGTAAAGAGCTCAAAGGCCTGSNNSNNSNNSNNSNNSNNCACGTGCAGAGAGTACGGA
C 
017 AGGCCCTATCAGGCCTTTGAG 
013 
AGTAGATACGTATTTTGCGGTAGATTTCCGGATCSNNSNNSNNSNNSNNCACAAAAATC
ACGATGCC 
016 CTGAAAGAGCTGACCGATGG 
039 
TTAATAGCCGGTGCCAGATCCAGACATTCCCATTTTGTCATCGTCATCCTTATAGTCGG
AGCCACCGGTCTCACCCTTGAATTTTTCATCCAGC 
040B 
TTCTAATACGACTCACTATAGGGACAATTACTATTTACAATTACAATGCACCATCACCA
TCACCATGGTCTCAAGGGTACCAAATACGGTTAT 
035B 
GACTGAACTGATGCCTATATGCTTGTCCGTCCAGATTGGTCTCGTGTTTGAGAACGTGT
CCGATG 
036B AACTCAAGTATCGCTATGCCGGTCAATAACCGAGGTCTCAAACACTTCCTTCAGGGTGG 
049 
CTGCGTGGTAGCTCGTAGCACAGACTCAGCGGATACACACAGAGGTCTCAAAAATTCA
AGGGTACCAAATACGG 
050 
GCACTCCGCTTAGATAGATAGCCAGAAGACAGACAAGGTCTCATTTTTCATCCAGCAG
GTCCAG 
037B 
AAGTAGCATAGAGTGTCGCTCTGGATGTCAAGGTCTCAAAAGGAGCGTCCGTACTCTCT
G 
038B 
ATGATAGCAGATGGACTTAGATTTCCGGTCAGGTGCCGAGGTCTCCCTTTTCCACGCGC
TCCACG 
GDPDx_001 
[b]
 TCTGTAAACCATGGATGGGCAGCGATAAGATCCAC 
GDPDx_002 
[b]
 CTGTGCGCTCGAGTTAATAGCCGGTGCCAGATCC 
GDPDx_003 
[c]
 GAAGGAGATATACATATGGGCAGCGATAAGATC 
GDPDx_004 
[c]
 GGAGCCAGCGCGGCCGCCATAGCCGGTGCCAGATCCAG 
GDPDmut_Fw 
[d]
 GAAGCCGGCGCGAATCGTGAGGAGCTGGATGTG 
GDPDmut_Rev 
[d]
 CACATCCAGCTCCTCACGATTCGCGCCGGCTTC 
030 
[e]
 
TTCTAATACGACTCACTATAGGGACAATTACTATTTACAATTACAATGGGCAGCGATAA
GATCGTGATTGTGCTGGGCCATCGCGG 
 [a] Primers used as standard primers to amplify any full length GDPD-based template during the library 
construction.  
[b] Primers used to amplify template DNA for insertion into the pET28a plasmid for protein expression.  
[c] Primers used to amplify template DNA for insertion into the pER13 plasmid for the GFP-fusion assay.  
[d] Primers used to generate pET28/GDPDmut from the pET28/GDPDwt template.  
[e] Primers 030 and 042 were used to generate GDPDmut(-His6) from the pET28/GDPDmut template.  
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Table S2.4 Fragments used in library assembly. 
[a,b]
 
 5'-Fragment 3'-Fragment  
Library 
[d]
 
Name Template FW REV Name Template FW REV 
Restriction 
enzyme 
used 
[c]
 
L1 L1_A 
pET28/ 
GDPDwt 
041B 018 L1_B 
pET28/ 
GDPDwt 
019 042 HindIII 
L2 L2_A 
pET28/ 
GDPDwt 
041B 047 L2_B 
pET28/ 
GDPDwt 
048 042 BsaI 
L3 L3_A 
pET28/ 
GDPDwt 
041B 028 L3_B 
pET28/ 
GDPDwt 
029 042 BsaI 
L3(-
His6) 
L3_A(-
His6) 
pET28/ 
GDPDwt 
030 028 L3_B 
pET28/ 
GDPDwt 
029 042 BsaI 
L4 L4_A 
pET28/ 
GDPDwt 
041B 022 L4_B 
pET28/ 
GDPDwt 
023 042 KpnI 
L5 L5_A 
pET28/ 
GDPDwt 
041B 015 L5_B 
pET28/ 
GDPDwt 
012 042 KpnI 
L6 L6_A 
pET28/ 
GDPDwt 
041B 003 L6_B 
pET28/ 
GDPDwt 
017 042 SacI 
L7 L7_A 
pET28/ 
GDPDwt 
041B 013 L7_B 
pET28/ 
GDPDwt 
016 042 SnaBI 
L1-2 
[e]
 
L1-
2_A 
L1 041B 047 L2_B 
pET28/ 
GDPDwt 
048 042 BsaI 
L3-4 
[e]
 
L3-
4_A 
pET28/ 
GDPDwt 
041B 028 
L3-
4_B 
L4 029 042 BsaI 
L6-7 
[e]
 
L6-
7_A 
L6 041B 034 
L6-
7_B 
L7 033 042 BsaI 
L1-4 
[f]
 
C-L1-
4_A 
L1-2 041B 036B 
C-L1-
4_B 
L3-4 035B 042 BsaI 
L5-7 
[g]
 
C-L5-
7_A 
L5 041B 038B 
C-L5-
7_B 
L6-7 037B 042 BsaI 
L1-4 
(m) 
F-L1-
4_A 
L1-2 (m) 041B 036B 
F-L1-
4_B 
L3-4 (m) 035B 042 BsaI 
L5-7 
(m) 
F-L5-
7_A 
L5 (m) 041B 038B 
F-L5-
7_B 
L6-7 (m) 037B 042 BsaI 
Control 
library 
C-
frag_A 
L1-4 frag 
(m) 
041B 050 
C-
frag_B 
L5-7 frag 
(m) 
049 042 BsaI 
Folding-
enriched 
library 
F-
frag_A 
L1-4 
(m&p) 
041B 050 
F-
frag_B 
L5-7 
(m&p) 
049 042 BsaI 
[a] Individual libraries were generated by amplifying the 5'- and 3'-fragments of the library using the 
specified template, and FW /REV primer pair.  
[b] Libraries denoted with (m) have been subjected to mRNA display; libraries denoted with (p) have been 
subjected to in vitro folding selection by protease digestion.  
[c] 5'- and 3'-fragments were digested with the indicated restriction enzyme (RE), gel-purified and ligated 
to produce the individual libraries. The BsaI restriction site, which is absent in the parent GDPDwt 
scaffold, was introduced into the 5-‘ and 3’ fragments by PCR amplification and was removed again during 
the gel purification of digested fragments.  
[d] Individual libraries were gel purified after the ligation reaction. A fraction of the purified library was 
used as a template for the successive steps in library assembly.  
[e] Libraries were subjected to mRNA display during folding-enriched library construction and then PCR 
amplified with 041B/042 primer pair to restore T7 promoter sequence lost during the transcription process.  
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[f] Library was used as template with 041B/039 primer pair to generate the control library fragment (L1-4 
frag) subjected to mRNA display.  
[g] Library was used as template with 040B/042 primer pair to generate the control library fragment (L5-7 
frag) subjected to mRNA display. 
 
2.7.1 DNA sequence of the GDPDwt scaffold used as template for library assembly 
GCCTTCTAATACGACTCACTATAGGGACAATTACTATTTACAATTACAATGGGCAGCGAT 
AAGATCCACCATCACCATCACCATGTGATTGTGCTGGGCCATCGCGGTTACTCCGCCAAG 
TATCTGGAAAACACCCTGGAAGCTTTCATGAAAGCGATCGAAGCCGGCGCGAATGGTGTG 
GAGCTGGATGTGCGCCTGTCTAAAGACGGCAAGGTGGTCGTGAGCCATGATGAAGATTTA 
AAGCGCCTGTTCGGTCTGGACGTCAAAATCCGTGACGCCACCGTGTCTGAACTGAAAGAG 
CTGACCGATGGCAAAATTACCACCCTGAAGGAAGTGTTTGAGAACGTGTCCGATGACAAG 
ATCATCAACATCGAAATCAAGGAACGTGAGGCCGCGGACGCAGTGCTGGAGATCAGCAAA 
AAGCGTAAGAACCTGATTTTCAGCTCCTTTGATCTGGACCTGCTGGATGAAAAATTCAAG 
GGTACCAAATACGGTTATCTGATCGACGAAGAGAACTACGGTTCCATTGAAAATTTCGTG 
GAGCGCGTGGAAAAGGAGCGTCCGTACTCTCTGCACGTGCCCTATCAGGCCTTTGAGCTC 
GAATATGCGGTGGAGGTGCTGCGCTCCTTCCGTAAAAAGGGCATCGTGATTTTTGTGTGG 
ACCCTGAATGATCCGGAAATCTACCGCAAAATACGTAGAGAGATCGATGGTGTGATTACC 
GACGAAGTGGAGCTGTTTGTGAAACTGCGTGGCGGCAGCGGTGGCTCCGACTATAAGGAT 
GACGATGACAAAATGGGAATGTCTGGATCTGGCACCGGCTATTAA 
 
Color code: 
T7 transcription promoter / TMV translation enhancer 
Thio6/His6 
GDPDwt 
(GGS)2 spacer  
FLAG tag 
Puromycin-crosslinking region 
 
 
Primers 041B and 042 were used as standard primers to amplify any full length GDPD-based template 
during the library construction. Primers GDPDx_001 and GDPDx_002 were used to amplify template 
DNA for insertion into the pET28a plasmid for protein expression. Primers GDPDx_003 and GDPDx_004 
were used to amplify template DNA for insertion into the pER13 plasmid for the GFP-fusion assay. 
Primers GDPDmut_Fw and GDPDmut_Rev were used to generate pET28/GDPDmut from the 
pET28/GDPDwt template. Primers 030 and 042 were used to generate GDPDmut(-His6) from the 
pET28/GDPDmut template. 
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2.7.2 Sequence alignment of the six soluble F(s) clones characterized in this chapter 
(Figure 2.4).  
Alignment was performed using Clustal Omega server, Clustal O(1.1.0) 
Loop residues randomized during library construction are highlighted in green. 
* = column contains identical amino acid 
: = column contains different but highly conserved amino acids 
 
GDPDwt      MGSDKIHHHHHHVIVLGHRGYSAKYLENTLEAFMKAIEAGANGVELDVRLSKDGKVVVSHDEDLKRLFG 
F(s)1       MGSDKIHHHHHHVIVLGSRGYSAKYLENTLEAFMKAIEAGANGVELDVRLSKDGKVVVSHDEDLKRLFG 
F(s)2       MGSDKIHHHHHHVIVLGHRGYSAKYLENTLEAFMKAIEAGANGVELDVRLSKDGKVVVSHDEDLKRLFG 
F(s)3       MGSDKIHHHHHHVIVLGRLGYSAKYLENTLEAFMRAIEAGANGVELDVRLSKDGKVVVSHDEDLKRLFG 
F(s)4       MGSDKIHHHHHHVIVLGNGGYSAKYLENTLEAFMKAIEAGANGVELDVRLSKDGKVVVSHDEDLKRLFG 
F(s)5       MGSDKIHHHHHHVIVLGRVGYSAKYLENTLEAFMKAIEAGANGVELDVRLSKDGKVVVSHDEDLKRLFG 
F(s)6       MGSDKIHHHHHHVIVLGRLGYSAKYLENTLEAFMKAIEAGANGVELDVRLSKDGKVVVSHDEDLKRLFG 
            *****************  ***************:********************************** 
 
GDPDwt      LDVKIRDATVSELKELTDGKITTLKEVFENVSDDKIINIEIKEREAADAVLEISKKRKNLIFSSFDLDL 
F(s)1       LDVKIRDATVSELKELTDGKITTLKEVFENVSDDKTINIEIKEREAADAVLEISKKRKNLIFSSFDLDL 
F(s)2       LDVKIRDATVSELKELTDGKITTLKEVFENVSDDKIINIEIKEREAADAVLEISKKRKNLIFSSFDLDL 
F(s)3       LDVKIRDATVSELKELTDGKITTLKEVFENVSDDKIINIEIKEREAADAVLEISKKRKNLIFSSFDLDL 
F(s)4       LDVKIRDATVSELKELTDGKITTLKEVFENVSDDKIINIEIKEREAADAVLEISKKRKNLIFSSFDLDL 
F(s)5       LDVKIRDATVSELKELTDGKITTLKEVFENVSDDKIINIEIKEREAADAVLEISKKRKNLIFSSFDLDL 
F(s)6       LDVKIRDATVSELKELTDGKITTLKEVFENVSDDKIINIEIKEREAADAVLEISKKRKNLIFSSFDLDL 
            *********************************** ********************************* 
 
GDPDwt      LDEKFKGTKYGYLIDE-ENYGSIENFVERVEKERPYSLHVP----YQAFELEYAVEVLRSFRKKGIVIF 
F(s)1       LDEKFKGTKYGYLIDE-ENYGSIENFVERVEKERPYSLHVTPTLLSQAFELEYAVEVLRSFRKKGIVIF 
F(s)2       LDEKFKGTKYGYKISLWASYGSIENFVERVEKERPYSLHVSSTKDAQAFELEYAVEVLRSFRKKGIVIF 
F(s)3       LDEKFKGTKYGYKIGRGGGYGSIENFVERVEKERPYSLHVYSGSPLQAFELEYAVEVLRSFRKKGIVIF 
F(s)4       LDEKFKGTKYGYIISLKDTYGSIENFVERVEKERPYSLHVQRASFKQAFELEYAVEVLRSLRKKGIVIF 
F(s)5       LDEKFKGTKYGYGIAEGLVYGSIENFVERVEKERPYSLHVELEFMIQAFELEYAVEVLRSFRKKGIVIF 
F(s)6       LDEKFKGTKYGYLIDE-ENYGSIENFVERVEKERPYSLHVAVGRVLQAFELEYAVEVLRSFRKKGIVIF 
            ************ *     *********************      **************:******** 
 
GDPDwt      VWT-LNDPEIYRKIRREIDGVITDEVELFVKLRGGSGGSDYKDDDDKMGMSGSGTGY 
F(s)1       VKNNVCDPEIYRKIRREIDGVITDEVELFVKLRGGSGGSDYKDDDDKMGMSGSGTGY 
F(s)2       VPCLRCDPEIYRKIRREIDGVITDEVELFVKLRGGSGGSDYKDDDDKMGMSGSGTGY 
F(s)3       VASSTHDPEIYRKIRREIDGVITDEVELFVKLRGGSGGSDYKDDDDKMGMSGSGTGY 
F(s)4       VAPDLPDPEIYRKIRREIDGVITDEVELFVKLRGGSGGSDYKDDDDKMGMSGSGTGY 
F(s)5       VRADMSDPEIYRKIRREIDGVITDEVELFVKLRGGSGGSDYKDDDDKMGMSGSGTGY 
F(s)6       VTSVTRDPEIYRKIRREIDGVITDEVELFVKLRGGSGGSDYKDDDDKMGMSGSGTGY 
            *     ***************************************************
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Chapter 3:  
Thermostable artificial enzyme isolated by in vitro selection 
 
 The following is a reprint of the manuscript: Morelli, A., Haugner III, J. C., and 
Seelig, B. (2014) Thermostable artificial enzyme isolated by in vitro selection. PLOS 
ONE. The article is currently in minor revisions at this open access journal. Seelig 
designed the high-temperature substrate and performed the selection. I expressed the 
artificial ligases and characterized their activity. Morelli performed all circular dichroism 
measurements. 
 
3.1 Overview 
 Artificial enzymes hold the potential to catalyze valuable reactions not observed 
in nature. One approach to build artificial enzymes introduces mutations into an existing 
protein scaffold to enable a new catalytic activity. This process commonly results in a 
simultaneous reduction of protein stability as an undesired side effect. While protein 
stability can be increased through techniques like directed evolution, care needs to be 
taken that added stability, conversely, does not sacrifice the desired activity of the 
enzyme. Ideally, enzymatic activity and protein stability are engineered simultaneously to 
ensure that stable enzymes with the desired catalytic properties are isolated. Here, we 
present the use of the in vitro selection technique mRNA display to isolate enzymes with 
improved stability and activity in a single step. Starting with a library of artificial RNA 
ligase enzymes that were previously isolated at ambient temperature and are therefore 
mostly mesophilic, we selected for thermostable active enzyme variants by performing 
the selection step at 65 °C. The most efficient enzyme, ligase 10C, is not only active at 65 
°C, but is also an order of magnitude more active at room temperature compared to 
related enzymes previously isolated at ambient temperature. Concurrently, the melting 
temperature of ligase 10C increased by 35 degrees compared to these related enzymes. 
While low stability and solubility of the previously selected enzymes prevented a 
structural characterization, the improved properties of the heat-stable ligase 10C finally 
allowed us to solve the three-dimensional structure by NMR. This artificial enzyme 
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adopted an entirely novel fold that has not been seen in nature, which was published 
elsewhere. These results highlight the versatility of the in vitro selection technique 
mRNA display as a powerful method for the isolation of thermostable novel enzymes. 
 
3.2 Introduction 
 Protein stability is often a limiting factor for the application, engineering and 
structural studies of proteins. Low protein stability can result in aggregation, 
susceptibility to protease degradation and poor yields in the expression of soluble protein, 
thereby complicating the study and use of these proteins. For commercial applications, 
proteins commonly need to be particularly stable to increase their tolerance to process 
conditions like high temperatures or organic solvents [1]. Furthermore, proteins with low 
stability are less tolerant to mutations thereby limiting further engineering because even 
slightly destabilizing mutations can lead to unfolding. This can create situations where 
mutations that would improve enzyme activity in a protein engineering project appear 
ineffective because the enzyme was not stable enough to remain folded [2]. Conversely, 
improved thermal stability correlates with mutational robustness and evolvability [3]. 
 Methods to increase the thermodynamic stability of proteins include rational 
design, consensus-based design, directed evolution, and commonly some combination of 
these approaches [4]. Rational design introduces mutations predicted to enable additional 
stabilizing interactions [5]. However, this approach requires extensive structural 
knowledge, substantial computing power and is technically challenging, which still limits 
the accessibility of this method. Consensus based-design utilizes phylogenetic 
information to determine which amino acids are preferred at certain positions [5]. This 
method can also be used to reconstruct thermostable ancestral proteins or, be combined 
with structural knowledge, which likely further improves the prediction of stabilizing 
mutations. However, these approaches are dependent on the quality of the constructed 
phylogenetic tree, which is non-trivial to accurately assemble. Directed evolution is a 
combinatorial approach that introduces mutations at random and then screens for desired 
properties such as improved activity or stability [6, 7]. High throughput screens are often 
performed in vivo, utilizing colorimetric [8] or fluorescent [9] reporters to measure levels 
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of soluble expression as readout for stability or in vitro using protease resistance and 
phage display [10, 11]. Proteins can also be assayed directly for thermostability and 
activity from lysates or extracts, but these methods have a relatively low throughput [4, 
12]. As mutations are introduced randomly, the chance of success increases with the 
number of mutants sampled. This favors high throughput methods which can sample 
millions to trillions of mutants [13, 14]. These individual methods aimed to generate 
more stable protein variants are frequently combined for best results [15]. 
 We previously reported the in vitro selection of de novo RNA ligase enzymes that 
catalyze a reaction not observed in nature [16]. These artificial enzymes ligate RNA with 
a 5'-triphosphate to the 3'-hydroxyl of second RNA forming a native 5'-3' linkage and 
releasing pyrophosphate. These artificial ligases are zinc dependent metalloenzymes of 
about 10 kDa. Several enzymes resulting from this in vitro selection experiment were 
analyzed in more detail. All examined enzymes were soluble when expressed as fusion 
proteins with maltose-binding protein (MBP), but most enzymes were poorly soluble 
when expressed on their own. NMR HSQC spectroscopy of the most soluble clone, ligase 
#6, revealed that a significant portion of the protein was well-folded, yet the overall 
resolution of the data was insufficient to solve the three-dimensional structure [16]. To 
overcome this issue, we again utilized in vitro selection. We modified the conditions of 
our original procedure and continued the selection to isolate ligase variants with 
improved stability in order to facilitate structural and mechanistic studies of these 
artificial enzymes. Here, we describe in detail the in vitro selection of RNA ligases with 
increased stability, including ligase 10C. For this directed evolution experiment we 
utilized the mRNA display technology, an in vitro display method, which covalently links 
each protein to its encoding mRNA [17, 18]. Using this technology, up to 10
13
 unique 
proteins can be sampled in a single experiment, which is orders of magnitude more than 
most other selection strategies [13]. To isolate enzymes with increased thermodynamic 
stability, we modified parts of the selection procedure and performed the ligation step at 
65 °C. For the selection reported here, we used the output library from our previous 
selection at room temperature [16] as starting material. We hypothesized that enzymes, 
which are active at elevated temperature, will have a more stable protein fold that in turn 
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will facilitate structural characterization. We also hoped that the increased structural 
stability would correspond to increased solubility and expression in vivo. After several 
rounds of selection, representative ligase clones were sequenced and tested for soluble 
expression in E. coli. The soluble and most active ligase 10C was characterized further 
and its activity and stability was compared to two closely related sequences from the 
previous selection at room temperature. The experiments revealed that ligase 10C is both 
more stable and more active than either of these ligases. The structure of ligase 10C and 
an application for this enzyme have been described elsewhere [19, 20]. This is the first 
report of an mRNA display selection at high temperature. These results demonstrate the 
efficacy of mRNA display for isolating thermostable enzymes as stability and activity are 
selected simultaneously in a high throughput experiment.  
 
3.3 Results 
3.3.1 Setup of Selection Procedure 
 Sequence analysis of the artificial RNA ligase enzymes that resulted from the 
final round of the previous in vitro selection performed at 23 °C [16] revealed substantial 
sequence diversity. The DNA encoding those diverse ligases was used as the starting 
library for the selection at 65 °C described in this paper without introducing further 
sequence diversity. The RNA ligation reaction catalyzed by the previously selected 
enzymes is dependent on a complementary splint oligonucleotide that base-pairs to the 
two substrate RNAs [16] (Figure 3.1). During the selection at 23 °C, this splint base-
paired to eight nucleotides of each substrate (Figure 3.1B). In order to ensure stable base-
pairing during a splinted ligation at elevated temperatures, a longer splint was chosen to 
extend the region complementary to each substrate to twenty nucleotides (Figure 3.1C). 
The 40-nucleotide-long splint resulted in a melting temperature of 76 °C and 69 °C with 
the PPP-substrate and the HO-substrate, respectively (Figure S3.1).  
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Figure 3.1 - In vitro selection of artificial ligase enzymes with increased stability. (A) Schematic of the 
isolation of ligase enzymes. The DNA library encodes the library of proteins that resulted from the original 
selection of ligase enzymes at 23 °C [16, 21]. The DNA is transcribed into RNA, modified with puromycin 
at the 3'-end and translated in vitro yielding a library of mRNA-displayed proteins [21]. Reverse 
transcription with a primer containing one RNA substrate shown in red results in a complex of protein, 
mRNA, cDNA and substrate. This complex is incubated at 65 °C with the second RNA substrate (red) and 
the complementary splint as highlighted in the orange box. The cDNA of ligases active at this temperature 
is immobilized on streptavidin beads and amplified for subsequent rounds of selection, or identified by 
cloning and sequencing. (B) Detailed view of ligation reaction substrates in complex with the mRNA-
displayed protein. The two strands of RNA in red, the 5'-triphosphate RNA (PPP-substrate) and 3'-hydroxyl 
RNA (HO-substrate), are joined in a template-dependent ligation reaction. The PPP-substrate is part of the 
reverse transcription primer. The photocleavable site (PC) is used to release the cDNA that encodes active 
enzymes from streptavidin immobilization by irradiation at 365 nm. The splint acts as template of the 
ligation and base pairs with 8 nucleotides of each RNA substrate during the previously published selection 
at 23 °C [16, 21], and with (C) 20 nucleotides of each substrate during the current selection at 65 °C. HEG4 
represents the linker of four hexaethylene glycol units (red wavy line). 
 
 To enable the selection of active enzymes, the PPP-substrate was linked to the 
mRNA-displayed proteins via the reverse transcription (RT) primer that initiates the 
cDNA synthesis (Figure 3.1A). This linkage resulted in a high local concentration of 
substrate in the vicinity of each protein. In order to reduce this local concentration and 
thereby favor the selection of enzymes with an increased substrate affinity, we 
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lengthened the RT primer by an additional eighteen non-complementary nucleotides and 
four flexible hexaethylene glycol linker units (HEG4, Figure 3.1C). The hexaethylene 
glycol linker simply acted as a long unstructured tether to increase the average distance 
between protein and substrate. The use of the longer RT primer in combination with the 
splint of 40 nucleotides (nt) in length (Figure 3.1C) resulted in a ligase activity of about 
50% compared to a ligation using the shorter RT primer and the 16 nt splint (Figure 
3.1B).  
 We then evaluated the ligase activity of the starting library at increasing 
temperatures in order to determine a temperature at which the majority of the library 
members are inactive. Using the 40 nt splint and the HEG4-RT primer, at 65 °C no 
ligation was detectable (< 10%), whereas at 60 °C the ligation activity was about half of 
the activity measured at 23°C. Therefore, we decided to carry out the selection for higher 
stability at 65 °C. 
 During the previous selection for ligases, 57% of the isolated enzymes had 
acquired a second FLAG binding sequence (DYKXXD) in addition to the FLAG binding 
sequence that was part of the N-terminal constant region. This was likely a result of a 
selection bias caused by two FLAG affinity purification steps per round of selection. In 
order to counteract this FLAG purification bias, we changed the selection protocol to 
using the E-tag affinity purification instead. Therefore, we replaced the FLAG tag coding 
sequence in the N-terminal constant region of the library with an E-tag sequence by PCR. 
The ligation activity was unaffected by the change of tags.  
 
3.3.2 In Vitro Selection at 65 °C 
 To enrich for RNA ligase enzyme with increased thermostability, we performed a 
total of six rounds of selection and amplification (Figure 3.1A). After reverse 
transcription, the mRNA-displayed proteins were incubated with the HO-substrate-65 and 
the RNA splint for 60 min and/or 5 min. The percentage of cDNA that was immobilized 
on streptavidin beads after each round of selection is shown in Figure 3.2. In the case of 
the 60 minute incubation, the percentage of immobilized cDNA increased steadily over 
the course of the selection, from 0.61% after round 1 to 6.6% after round 6. In order to 
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increase the selection pressure by favoring enzymes with faster ligation rates, in round 4, 
we incubated a second aliquot of the mRNA-displayed proteins for only 5 min yielding 
0.66% immobilized cDNA. This cDNA was used as input for following round, but no 
increase in the amount of immobilized cDNA after 5 min incubation was observed in 
round 5 (amount decreased to 0.41%). Therefore, we performed the sixth and final round 
of selection, again with 60 min incubation. The resulting DNA was cloned and sequenced 
for further analysis. 
 
 
Figure 3.2 - Progress of selection for ligases at 65 °C. The fraction of 
32
P-labelled cDNA that bound to 
streptavidin agarose after each round of selection is shown. The reaction time was either 60 min or 5 min as 
indicated by black or gray bars, respectively.  
 
3.3.3 Sequence Analysis and Expression of Selected Ligases 
 The sequence alignment of 32 clones from the sixth round of selection at 65 °C 
revealed two protein families (Figure S3.2). One representative clone from each family 
was cloned and expressed in E. coli to examine soluble expression (Figure S3.3). While 
both clones expressed well, ligase 10C was highly soluble whereas ligase 10H was 
largely insoluble. Furthermore, native Ni-NTA affinity purification of ligase 10H yielded 
no soluble protein (data not shown) and, therefore, ligase 10H was not characterized 
further.  
 The sequence of ligase 10C shares similarities to ligases #6 and #7 from the 
original selection with #7 being more similar (Figure 3.3). All three ligases are almost 
identical in sequence in the formerly randomized region 2, and all three share the deletion 
of 17 amino acids following region 1. Ligases 10C and #7 also share the sequence in 
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region 1, but 10C contains a second deletion of 13 amino acids near the C-terminus. This 
C-terminal deletion is also found in other clones from the selection at 23 °C [16], but 
these proteins were poorly soluble when expressed without an maltose-binding protein 
fusion and therefore unsuited for a direct comparison. 
 
 
Figure 3.3 - Sequence alignment of the library used as input for original ligase selection (on top) [40] 
with ligases #6, #7 [16] and 10C that were selected at 23 °C and at 65 °C, respectively [41, 42]. The 
amino acids in regions 1 and 2 of the original library were randomized prior to the selection at 23 °C and 
are shown as “x”. Dashes symbolize amino acids that are identical to the starting library. A period 
highlighted in gray represents a deletion. The underlined N-terminal amino acids of the library and ligase 
10C represent a Flag epitope tag and an E epitope tag, respectively.  
 
3.3.4 Activity of Ligase Enzymes 
 To compare the enzymatic activity of ligase 10C to ligases #6 and #7, we assayed 
the three enzymes at 23 °C and 65 °C (Figure 3.4). Ligase 10C was the only enzyme 
active at 65 °C. In comparison, ligases #6 and #7 were active at room temperature as 
expected, but had no measurable activity at 65 °C. In addition to its activity at 65 °C, 
ligase 10C was also active at room temperature. To compare the activity of the three 
enzymes more accurately, we measured the kobs for each ligase at 23 °C. At a 
subsaturating substrate concentration of 10 μM, ligase 10C had a kobs of 0.165 ± 0.015 h
-1
 
while ligases #6 and #7 had kobs of 0.0174 ± 0.0066 h
-1
 and kobs of 0.0207 ± 0.0045 h
-1
, 
respectively (Table S3.1). This represents an 8 to 10-fold increased activity of ligase 10C 
compared to ligases #6 and #7 even at 23 °C. While the main goal of the selection was to 
isolate an enzyme with greater thermostability, as an added benefit, the most stable 
enzyme also featured an improved catalytic rate at room temperature.  
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Figure 3.4 Activity of ligase enzymes assayed at different temperatures. Ligases #6 and #7 had been 
selected previously at 23 °C [16, 21] and ligase 10C was selected at 65 °C. In this assay, the 
32
P-labeled 
PPP-substrate-65, HO-substrate-65 and 40 nt splint were incubated with the individual enzymes for 16 h 
and activity monitored by gel-shift. 
 
3.3.5 Characterization of Thermal Stability by Circular Dichroism (CD) 
 In order to assess if the unique enzymatic activity of ligase 10C at 65 ºC was 
correlated to increased structural stability, we measured thermal denaturation curves of 
all three ligases by circular dichroism. In preparation of the thermal unfolding 
experiment, we measured the CD spectra of the three enzymes (Figure S3.4). All three 
spectra exhibited two minima of negative ellipticity at 205 nm and between 220 and 225 
nm, respectively. While those minima suggested α-helical secondary structural content 
[23], the 205 nm minimum was substantially more negative than the second minimum, 
which differs from purely alpha helical proteins that have similar absolute values for both 
minima. Nevertheless, we used the strong negative ellipticity of all three ligases at 222 
nm to monitor thermal unfolding of the proteins over a temperature range from 5 to 91 
ºC. We found all three enzymes to give the characteristic single sigmoidal transition 
corresponding to a two-state unfolding reaction (Figure 3.5). As determined from the 
curves, the enzymes showed very different melting temperatures. Ligase 10C had the 
highest melting temperature (Tm = 72 ºC), which was 35 degrees higher than the Tm of 
ligase #6 (37 ºC), and 24 degrees higher than the Tm of ligase #7 (48 ºC). The high 
melting temperature of 72 ºC for ligase 10C was in agreement with its retained enzymatic 
activity at 65 ºC as the enzyme has not undergone unfolding yet. In contrast, ligases #6 
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and #7 were fully denatured at 65 ºC, and, therefore, their complete lack of enzymatic 
activity at 65 ºC could be explained by their unfolding. 
 
 
Figure 3.5 - Thermal unfolding curves of ligases #6, #7 and 10C. Thermal unfolding was monitored by 
circular dichroism at 222 nm. For each measurement 10 accumulations were acquired. 
 
3.4 Discussion 
 We isolated a thermostable artificial RNA ligase enzyme by in vitro selection at 
65 °C of a library of artificial ligases that were originally generated at 23 °C. The isolated 
ligase 10C was more thermostable and more active than the two most closely sequence-
related ligases #6 and #7 identified during the selection at 23 °C. Ligase 10C has a 
melting temperature (TM) of 72 °C corresponding to a stability increase of 24 degrees 
compare to #7, and 35 degrees compared to ligase #6. Previously reported TM 
improvements through protein engineering are commonly between 2 to 15 degrees [5]. 
The TM increase by 35 degrees reported here favorably compares with those rare 
examples of ‘record-setting stabilizations’ [4, 24-26]. While the ligases #6 and #7 have 
no measurable enzymatic activity at 65 °C, ligase 10C ligates RNA at 65 °C with an 
activity that is similar to its activity at 23 °C. Furthermore, the activity of ligase 10C at 23 
°C is about an order of magnitude higher than the activity of the ligases #6 and #7 at the 
same temperature.  
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 The improved thermostability of ligase 10C is likely due to improved 
intermolecular contacts within the protein compared to the mesophilic ligases. However, 
it isn’t clear from an examination of the primary sequences how the changes to 10C 
promote this stabilization. To examine this further, we mapped the differences between 
ligase #7 and 10C onto the previously solved structure of 10C (Figure 3.6). 10C and #7 
were compared as they are very similar yet have large differences in thermostability. All 
differences between these two ligases are found in or near the structured region 
responsible for zinc coordination. In 10C there are two residues at the C-terminus, Ile68 
and His69, which we previously established [19] make long range contacts with several 
residues at the N-terminus: Lys17, His18, Ala27 and Glu28. Notably, His18 is one of the 
zinc coordinating residues in 10C and mutating this position to Ala results in an insoluble 
protein [19]. In ligase #7, the residue corresponding to Ile68 is mutated to Methionine. In 
addition, between the residues corresponding to Ile68 and His69 in 10C, ligase #7 
contains an additional 13 amino acids, which might displace His69 and its contacts to the 
N-terminus. Presumably these mutations can compromise these long range contacts and 
decrease the stability of #7 at high temperature. 10C also contains two additional 
mutations (S54 and D65) which may influence protein stability, but it’s not immediately 
obvious how crucial they are to the overall improvement. 
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Figure 3.6 - Solved structure of ligase 10C highlighting differences between 10C and #7. We mapped 
the differences between ligase #7 and 10C onto the previously published structure of 10C [19] omitting the 
flexible termini. Mutations are shown in red, residues potentially perturbed by the mutations are shown in 
blue and long range NOEs are shown by dashed black lines. 
 
 Of the two ligase families we isolated in our heat-stabilization selection, the 
family corresponding to 10H was not solubly expressed in E. coli. During the mesophile 
selection, we noted that of the seven ligases characterized, only #6 and #7 were soluble 
without being expressed as a MBP fusion. While ligase 10C is closely related to #6 and 
#7, ligase 10H is most similar to ligase #1 which also did not express solubly. Isolating 
clones like 10H and #1 might perhaps be expected as soluble expression in E.coli was 
never directly selected for in our experiments because mRNA display uses an in vitro 
eukaryotic translation system. Additionally, the fused RNA is suspected to increase 
protein solubility which might contribute to this result. Generally this is a favorable 
property of mRNA display because it can be used to characterize poorly soluble proteins. 
It’s possible that ligase 10H could have been solubilized through MBP fusion like ligase 
#1, but that would have complicated structural studies. Ultimately our selection was 
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successful because we isolated a soluble, thermostable enzyme which we had not been 
able to identify previously in our library pool. 
 The structure of the artificial enzyme, RNA ligase 10C, does not match with any 
known protein folds. Considering the TM of 72 °C for this protein, it is particularly 
surprising to discover the lack of secondary structural motifs combined with highly 
dynamic regions. While it is increasingly appreciated that catalytic activity of enzymes 
can require conformational flexibility [27-29], thermal stability is usually associated with 
tight packing and rigidity. Generally, thermophilic enzymes possess well packed 
hydrophobic cores [30], few exposed surface loops [31] and additional stabilizing 
interactions such as salt bridges [32] and a high number of hydrogen bonds [33]. These 
features lead to an increased rigidity that, while favoring stability at higher temperature, 
often appears to decrease activity at lower temperature. This observation has been 
interpreted to mean that stability, dynamics and catalysis are a tradeoff, but this common 
notion has recently been called into question [34]. The structure of the ligase 10C [19] 
combines a high flexibility and the absence of a packed hydrophobic core with 
thermostability, and is equally active at 65 °C and at ambient temperature. The structure 
of this de novo enzyme challenges the common view of how enzymes are supposed to 
appear -a view that is biased by proteins amenable to crystallization. The high degree of 
disorder and flexibility present in 10C, might be a feature that favors its evolvability. For 
example, the presence of disordered regions and a loosely packed structures found in 
viral proteins, structural characteristic very similar to 10C, may allow for increased 
evolvability because each mutation, due to a lower amino acid interconnectivity, would 
lead to a slower loss in stability, compared to the more packed structures of thermophilic 
enzymes [35]. Similarly, ligase 10C might also be highly evolvable because of its flexible 
structure and disordered regions. Yet, this artificial enzyme was generated de novo and, 
unlike biological proteins, has not been shaped by billions of years of evolution. As its 
structure and function has just come into existence, ligase 10C can be considered a model 
protein for primordial enzymes. For these reasons, properties of this enzyme like its 
evolutionary potential will be interesting to study, yet comparisons to natural proteins 
might be challenging. 
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 The starting library for this selection at elevated temperature was a mixture of 
protein variants that was final the output of the previously described selection for 
artificial ligases at 23 °C [16]. No further genetic diversity had been introduced. 
Sequencing of the starting library showed a diverse mixture of unrelated sequences and 
sequence families. Ligase 10C had not been observed during the sequencing of 49 
individual clones and was only sufficiently enriched and detected after the subsequent 
selection at 65 °C. It is conceivable that future mutagenesis and directed evolution of 
ligase 10C using the same selection strategy will further improve thermal stability and 
activity. These studies will help us understand the evolutionary potential of this artificial 
enzyme and also yield improved catalysts for a variety of applications [20]. 
 
3.5 Conclusions 
 The discovery of this thermostable enzyme and its unusual structure emphasizes 
the value of directed evolution approaches that do not require a detailed understanding of 
protein structure-function relationships, but instead randomly sample sequence space for 
functional proteins. In contrast, it would have been impossible to construct this particular 
artificial enzyme by rational design despite recent advances in rational protein 
engineering. In the current project, we employed the in vitro selection technique mRNA 
display [17, 18]. This method uses product formation as the sole selection criterion and is 
independent of the mechanism of the catalyzed reaction. The technique has several 
advantages over other selection strategies [36]. The mRNA display technology enables to 
search through large libraries of up to 10
13
 protein variants. This feature is beneficial 
because the chance of finding a desired activity increases with the number of variants 
interrogated. Previous reports on mRNA display include the improvement of folding and 
stability of proteins by selecting for resistance to protease degradation [37], or by 
selecting in the presence of increasing amounts of the denaturant guanidine hydrochloride 
[38, 39]. Interestingly, in parallel to our successful selection for RNA ligases at elevated 
temperature, we also attempted a similar selection in presence of guanidine 
hydrochloride, but no enrichment was observed even after six rounds (data not shown). 
Nevertheless, to our knowledge the work presented here is the first description of an 
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mRNA display selection at elevated temperatures yielding thermostable proteins. The in 
vitro format of mRNA display should facilitate other selections at a variety of pH, 
temperatures, ionic strength, or in the presence of co-solvents, inhibitors or other 
chemicals. Such experiments will help to study the coevolution of protein stability and 
activity, and also has the potential to produce proteins that are more stable in industrial or 
biomedical applications.  
 
3.6 Materials and Methods 
3.6.1 Preparation of Oligonucleotides 
 32
P-labeled PPP-substrate-23 used in original selection at 23 °C (5'-PPP–
GGAGACUCUUU) and PPP-substrate-65 for selection at 65 °C (5'-PPP–
GGAGAUUCACUAGCUGGUUU) were prepared through T7 transcription as reported 
previously [16, 21]. The HO-substrate-23 (5'–CUAACGUUCGC), HO-substrate-65 (5'-
UCACACUGUCUAACGUUCGC) and HO-substrate-65-Bio (5'-(PC)-
UCACACUGUCUAACGUUCGC, (PC) represents PC biotin phosphoramidite from 
Glen Research) were purchased from Dharmacon and prepared according to the 
manufacturer’s protocol. The DNA splint (5'–GAGTCTCCGCGAACGT) 
complementary to the substrates-23 and RNA splint (5'- 
AAACCAGCUAGUGAAUCUCCGCGAACGUUAGACAGUGUGA) complementary 
to the substrates-65 were purchased from Integrated DNA Technologies The reverse 
transcription primer (HEG4-RT) was produced by ligating the PPP-substrate-65 to 
BS75P-HEG4 in the presence of BS76 as template using T4 DNA ligase [22] and purified 
by denaturing PAGE. All oligonucleotides were dissolved in ultra-pure water and 
concentrations determined by UV absorbance. 
 
3.6.2 Selection of RNA Ligases at 65 °C 
 The mRNA display selection was performed as previously published [16], with 
the following exceptions. Primers BS99 and BS24RXR2 were used to amplify the DNA 
by PCR. Primer BS99 replaces the N-terminal FLAG affinity tag that was used in the 
previous selection at room temperature [16] with the E-tag. Accordingly, both FLAG 
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affinity purification steps in the previous protocol were substituted by E-tag affinity 
purifications. For the first E-tag purification, the mRNA-displayed proteins eluted from 
the oligo(dT)cellulose were mixed with binding buffer (same as Flag binding buffer [16]) 
and then incubated for 30 min at 4 °C with rotation with 25 µL Anti-E affinity gel (from 
Anti E-tag affinity column, GE healthcare Biosciences; prewashed with E clean buffer 
(100 mM glycine, pH 3.0, 0.05% Tween-20) and binding buffer). The Anti-E tag affinity 
gel was then washed with binding buffer and eluted with binding buffer containing two 
equivalents of E-peptide (Bachem, Osteocalcin (7-19, human); one equivalent of E-
peptide saturates the antigen sites of the antibody resin) for 3 min at 4 °C. The second E-
tag purification was performed in a similar fashion using 50 µL Anti-E affinity gel and 6 
equivalents of E-peptide to elute. The elution from the second E-tag affinity purification 
was incubated with the HO-substrate-65-Bio and the RNA splint in presence of 2 mM 
MgCl2 and 100 µM ZnCl2 for 1 hour at 65 °C in selection rounds 1, 2, 3 and 5. In round 
4, the sample was divided into two aliquots, one of which was incubated for 1 h, and the 
other aliquot was incubated for 5 min. The reaction was quenched and purified on 
streptavidin beads as described previously [16], and the photocleaved DNA was 
amplified by PCR and used as input for the following round. For round 5, the 
photocleaved DNA from round 4 was used that resulted from the 5 min incubation.  
 
3.6.3 Expression & Purification of RNA Ligases 
 RNA ligases were expressed and purified as previously described [19]. 
 
3.6.4 Screening for Ligase Activity by Gel-Shift Assay 
 5 μM 32P-labeled PPP-substrate-65, 6 μM RNA splint, 7 μM HO-substrate-65, 20 
mM HEPES pH 7.5, 100 mM NaCl, 100 μM ZnCl2 and 1.7 μM enzyme (purified by Ni-
NTA affinity chromatography [19]) were combined and incubated for 16 hours at 23 °C 
and 65 °C. Reactions were stopped by the addition of EDTA to a final concentration of 
10 mM. Immediately following, the RNA was denatured for 40 min at 65 °C in 7.5% 
formaldehyde, 58% formamide and 11.6 mM MOPS pH 7.0. Samples were separated by 
20% denaturing PAGE gel containing 2% formaldehyde. The gel was analyzed using GE 
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Healthcare (Amersham Bioscience) Phosphorimager and ImageQuant software 
(Amersham Bioscience). The amount of radiation in both the substrate and product bands 
was measured and % ligated was determined by dividing the intensity of the product band 
by the sum of the product and substrate bands. 
 
3.6.5 Determination of Observed Rate Constants (kobs) 
 5 μM enzyme (purified by Ni-NTA affinity and size exclusion chromatography 
[19]) was incubated with 10 μM 32P-labeled PPP-substrate-23, 15 μM DNA splint, 20 μM 
HO-substrate-23 and ligation was monitored up to 2 hours at 23 °C. Reactions were 
quenched with two volumes of 20 mM EDTA in 8 M urea after 0, 15, 30, 60 and 120 
minutes, heated to 95 °C for 4 min and separated by 20% denaturing PAGE gel. The gel 
was analyzed using GE Healthcare Phosphorimager and ImageQuant software 
(Amersham Bioscience). The rate constant (kobs) was determined by taking the slope of 
the linear fit of % ligated over time and correcting for enzyme concentration by 
multiplying by the ratio of PPP-substrate to enzyme (10 uM : 5 uM or 2) giving a value in 
per hour (h
-1
).  The reported values are an average of 3 independent replicates ± the 
standard deviation.  Total conversion was < 10% for all cases. 
  
3.6.6 Circular Dichroism and Thermal Denaturation 
 Ligase enzymes (purified by Ni-NTA affinity and size exclusion chromatography 
[19]) were concentrated to 50 μM and dialyzed against CD buffer (150 mM NaCl, 2 mM 
HEPES, 0.5 mM 2-mercaptoethanol, 100 μM ZnCl2). Circular dichroism spectra and 
thermal denaturation curves were recorded on a JASCO J-815 spectropolarimeter at 30 
μM or 50 μM protein, respectively. The following parameters were used for both 
measurements: 1.5 nm band width, 2 seconds response time, standard sensitivity, 10 
accumulations. The ellipticity at 222 nm was monitored to determine thermal 
denaturation curves over a temperature range from 5 to 91 °C with a ramp rate of 1 
°C/min and a temperature pitch of 2 °C. 
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3.7 Supporting Information 
 
Table S3.1 - Data for determining kobs. 
Replicate Ligase 10C Ligase 6 Ligase 7 
Slope 
[a]
 R2 Slope R2 Slope R2 
1 0.0894 h
-1
 0.973 0.0124 h
-1
 0.910 0.0128 h
-1
 0.989 
2 0.0828 h
-1
 0.982 0.00768 h
-1
 0.951 0.00984 h
-1
 0.993 
3 0.0750 h
-1
 0.981 0.00599 h
-1
 0.834 0.00840 h
-1
 0.991 
[a] Only the first 4 timepoints were used with ligase 10C as the final point had begun to plateau and would 
have skewed the analysis.  All 5 timepoints were used for ligases 6 and 7. 
 
 
 
 
Figure S3.1 - Thermal denaturation of substrate and splint oligonucleotides used in the selection and 
activity assays at 65 °C. The first derivative of the melting curve for the 40 nt splint in the presence of 
both PPP-substrate-65 and HO-substrate-65 RNA oligonucleotides is presented. The concentration of each 
oligonucleotide was 0.5 µM in a buffer containing 70 mM KCl, 100 µM ZnCl2, 5 mM 2-mercaptoethanol 
and 20 mM HEPES at pH 7.5.  
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Figure S3.2 - Clones identified from round 6 of the in vitro selection at 65 ºC. Two protein families (A, 
B) were identified and a representative clone from each family was chosen for further characterization (10C 
and 10H, shown in red). 
 
Figure S3.3 - Protein expression in E. coli of representative ligases selected at 65 °C. A Coomassie-
stained SDS-PAGE gel shows samples of whole cells pre- and post-induction and the insoluble and soluble 
fractions after cell lysis and centrifugation. Red boxes in the lane “Soluble fraction” indicate the presence 
or absence of soluble ligases 10C and 10H, respectively. 
Chapter 3 
 89 
 
 
 
Figure S3.4 - Circular dichroism spectra of ligases #6, #7 and 10C at 25 °C. 
 
3.7.1 Sequences of ligases selected at 65 °C 
 
10C  
MGAPVPYPDPLEPRGGKHICAICGNNAEDYKHTDMDLTYTDRDYKNCESYHKCSDLCQYCRYQKDLAIHHQ
HHHGGSMGMSGSGTGY 
 
10H 
MGAPVPYPDPLEPRGGKHICAICGDILDDDYDYKQTDSREGRQGFFKRTLRKDLTYSCRDYKYRESYHKCS
DLCQSCRYQKALAIHHQHHHGGSMGMSGSGTGY 
 
 
Sequences of ligases selected previously at 23 °C for comparison  
#6 
MDYKDDDDKDGKHICAICGDTVTNTDYKTPDLTSTCRDYKNRESYHKCSDLCQYCRYQKALAMGTKREAAQ
EEVGSHHQHHHGGSMGMSGSGTGY 
 
#7 
MDYKDDDDKGGRHICAICGNNAEDYKHTDMDLTYTDRDYKNCESYHKCQDLCQYCRYQKALAMGIKREAVQ
EEVGSHHQHHHGGSMGMSGSGTGY 
 
 
3.7.2 Oligonucleotide sequences 
 
BS75P-HEG4 
5'-P-TGTACGATTCGATGACGA-HEG4-TTTTTTTTTTTTTTTCCCAGATCCAGACATTC 
(“P” represents the 5'-phosphate group, “HEG4” represents four hexaethylene glycol units (Spacer18 from 
Glen Research) 
 
BS76 
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5'-TCGTCATCGAATCGTACA AAACCAGCTAGTGAATC 
 
BS99 
5'-TCTAATACGACTCACTATAGGGACAATTACTATTTACAATTACAATGGGAGCACCAGTCCCTTACCCT
GATCCGCTGGAACCGCGTGGCGGAAAGCACATCTGC 
 
BS24RXR2 
5'-TTAATAGCCGGTGCCAGATCCAGACATTCCCATAGAACCGCCATGATGATG 
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Chapter 4:  
Structure and dynamics of a primordial catalytic fold generated by in 
vitro evolution 
 The following is a reprint of the article: Chao, F.-A., Morelli, A., Haugner III, J. 
C., Churchfield, L., Hagmann, L. N., Shi, L., Masterson, L. R., Sarangi, R., Veglia, G., 
and Seelig, B. (2013) Structure and dynamics of a primordial catalytic fold generated by 
in vitro evolution. Nat. Chem. Biol. 9, 81-83. The article is reprinted here with permission 
from Macmillan Publishers Ltd. Chao solved the structure of the ligase by NMR with 
help from Masterson and Shi. Churchfield and I prepared ligase samples for NMR and 
characterized mutants by activity and CD. Morelli characterized the zinc binding and 
available Cys residues. Sarangi characterized the zinc coordination by EXAFS. 
 
Hyperlink to original publication 
http://www.nature.com/nchembio/journal/v9/n2/full/nchembio.1138.html 
 
4.1 Overview 
 Engineering functional protein scaffolds capable of carrying out chemical 
catalysis is a major challenge in enzyme design. Starting from a non-catalytic protein 
scaffold, we recently generated a novel RNA ligase by in vitro directed evolution. This 
artificial enzyme lost its original fold and adopted an entirely novel structure with 
dramatically enhanced conformational dynamics, demonstrating that a primordial fold 
with suitable flexibility is sufficient to carry out enzymatic function. 
 
4.2 Introduction 
The known structures of naturally occurring proteins can be assigned to an 
apparently finite number of different fold families [1, 2]. Starting from an existing fold, 
divergent evolution through a combination of gene duplication and mutations is a 
common path for proteins to acquire new functions while retaining their original fold [3, 
4]. However, the origin of those biological folds remains subject to debate [5, 6]. Only a 
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few examples have been described in which new function acquisition is accompanied by 
a simultaneous change in the protein fold. Those examples have largely been generated 
by rational design or involve protein binders [7-13]. 
Recently, we created artificial RNA ligase enzymes by in vitro evolution [14, 15]. 
These enzymes catalyze the joining of a 5'-triphosphorylated RNA to the 3'-hydroxyl 
group of a second RNA, a reaction for which no natural enzyme catalysts have been 
found. We began with a non-catalytic small protein domain consisting of two zinc finger 
motifs from the DNA binding domain of human retinoid-X-receptor (hRXRα) [16] 
(Figure 4.1). Two adjacent loops of this protein were randomized to generate a 
combinatorial library of mutants as input for the selection and evolution process [17]. 
Although zinc fingers are common structural motifs, they are not known to take part in 
catalysis in natural proteins. In contrast, we isolated from the zinc finger library active 
enzymes that exhibit rate accelerations of more than two-million-fold [14]. 
 
4.3 Results 
Sequence analysis of the artificial enzyme showed that several amino acids 
essential to maintaining zinc finger structure integrity were mutated or deleted, 
suggesting that the original scaffold may have been abandoned during the process of 
mutagenesis and evolution. The original hRXRα scaffold consisted of two loop-helix 
domains, each containing a zinc ion tetrahedrally coordinated by four cysteines [16]. 
However, during evolution of the ligase enzyme, only half of the zinc-coordinating 
cysteines had been conserved. In the starting scaffold, two helices were packed 
perpendicularly to form the globular fold and build the hydrophobic core and an 
additional helix was located at the C-terminus (Figure 4.1b). In the ligase enzyme, seven 
residues of the former DNA recognition helix and ten residues of the C-terminal helix 
were deleted from the original hRXRα scaffold.  
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Figure 4.1 - Changes in primary sequence and three-dimensional structure upon directed evolution 
of the hRXRα scaffold to the ligase enzyme 10C. (a) Comparison of the primary sequences of 
hRXRα[16] (residues 132-208) and the artificially evolved ligase (residues 17-68). The two zinc finger 
regions are highlighted with purple and green brackets. The red letters denote residues that are not 
conserved between the two sequences. (b) Three-dimensional structure of hRXRα[16] and NMR ensemble 
of ligase 10C (for clarity, flexible termini are not shown). Although both proteins contain two zinc fingers, 
the overall structures are substantially different. Only two zinc-coordinating cysteines of each zinc finger in 
hRXRα are still coordinating zinc in ligase 10C (highlighted in yellow, see also Figure 5.1A) while all 
other ligands differ in the two structures. In contrast to hRXRα, zinc finger Zn-II in ligase 10C comprises 
residues of both N- and C-terminal sequence, imposing a cyclic structure to the enzyme. Residues involved 
in zinc coordination are labeled and shown in blue. Note that the new ligase lost both helical domains of the 
DNA binding domain (grey in left structure), replacing the recognition helix with a long unstructured loop 
(grey in right structure).  
 
NMR structural analyses of the ligase 10C, chosen for its superior solubility and 
thermostability, revealed that the evolved ligase lost the original zinc finger scaffold, 
adopting an entirely novel structure (Figure 4.1b). This new three-dimensional structure 
still contained two zinc sites that constitute the folding core of the protein, however, the 
two Zn
2+
 ions were coordinated by several new ligands with a different register. The 
deletion of two N-terminal cysteines during directed evolution resulted in the 
concomitant rearrangement of the local geometry of the zinc-binding loop. Additionally, 
the short stretch of anti-parallel β-sheet within the first zinc finger (Zn-I) was also 
deleted. The C-terminal loop-helix domains and the recognition helix of hRXRα 
Chapter 4 
 94 
responsible for binding to the DNA groove [18] were lost completely; the latter was 
replaced by an unstructured loop of twenty amino acids connecting the two new zinc 
fingers. The zinc fingers made up the most structured region, as demonstrated by the 
presence of short- and long-range nuclear Overhauser Effect (NOE) contacts. Moreover, 
several long-range NOEs indicated that the two metal-binding loops are in close 
proximity, while most of the protein presented only short range NOE contacts (Figure 
S4.1 and Table S4.1). The conformational ensemble resulting from simulated annealing 
calculations showed two well-defined regions (residues 17-35 and 49-69) with root-
mean-square-deviation from the average of less than 1 Å, while the large loop 
encompassing residues 36-48 was completely unstructured (RMSD greater than 6 Å). 
The three-dimensional structure of the enzyme was compounded by residual dipolar 
coupling measurements, which also helped to better define the local geometry around the 
zinc binding sites (Figures S4.2 and S4.3).  
The two metal centers were responsible for the overall fold of the ligase. In the 
absence of Zn
2+
, the NMR fingerprint spectrum of the enzyme displayed broad and 
mostly unresolved resonances, typical of a molten globule. Titration of Zn
2+
 to the metal-
free protein first saturated the C-terminal Zn
2+
 binding site (Zn-II) and induced a 
substantial structural rearrangement with sharper and more dispersed resonances (Figures 
S4.4 and S4.5). The transition between the unfolded and folded states of the ligase 
involved multiple intermediate species. For selected resonances, we could discern the 
presence of two distinct states in slow exchange in the NMR time scale. Complete 
saturation with Zn
2+
 funneled the enzyme into a more defined structure, with the 
complete resolution of fingerprint resonances showing only one population of peaks. 
Elemental analysis by inductively coupled plasma mass spectrometry revealed 2.74 ± 
0.01 equivalents (± s.d.) of bound zinc per ligase molecule. We were able to fit the 
thermocalorimetry data using models with two or more Zn
2+
 binding sites, however, the 
fit does not improve significantly with n>2 (Figure S4.6 and Table S4.2). Assigning two 
sites in accordance with the NMR titration data leads to one binding site Zn-II with 
higher affinity (Kd ~ 3μM), and a second binding site Zn-I with lower affinity for Zn2+ 
(Kd ~ 93 μM). These values were further supported by the zinc concentration dependence 
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of the enzyme activity, showing a steep drop in activity at concentrations below 100 µM 
Zn
2+
 (Figure S4.7). Notably, the ligase affinity for Zn
2+
 was substantially lower than 
those reported for natural zinc-containing proteins which commonly have dissociations 
constants of 10
-8
-10
-13
 M [19]. Structure calculations were carried out in the absence of 
explicit Zn
2+
 ions to avoid conformational search bias and converged toward a structural 
ensemble with two distinct Zn
2+
 binding sites: the tetracoordinated N-terminal site (Zn-I) 
with weaker binding affinity, and the hexacoordinated C-terminal loop (Zn-II) with 
higher binding affinity (Figure S4.2 and S4.3). EXAFS data corroborated these results, 
showing that both Zn sites coordinated with two S(Cys) ligands with a Zn-S distance of 
2.3 Å, and at least one site had four Zn-N/O ligands while the other site had two to four. 
These atom ligands can be either protein based or water molecules (Figure S4.8). 
The directed evolution process that yielded the artificial enzyme was based only 
on product formation without structural constraints [14]. As a result, the ligase enzyme 
evolved into a new structure with substantially increased conformational dynamics 
compared to the original DNA-binding scaffold [20]. In fact, ligase 10C showed an 
overall increase in structural plasticity and malleability. While the two zinc fingers 
exhibited heteronuclear NOEs similar to the original scaffold, the region where the two 
helical domains were deleted displayed much higher flexibility, with heteronuclear NOEs 
below 0.5. These data indicate augmentation of conformational dynamics in the 
picosecond to nanosecond time scale supported by longitudinal (T1) and transverse (T2) 
nuclear spin-relaxation measurements as well as hydrogen/deuterium exchange data 
(Figures 4.2a, S4.9 and S4.10a). 
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Figure 4.2 - Conformational dynamics of the ligase enzyme 10C. (a) Mapping of the heteronuclear 
NOEs (proxy for fast dynamics on a picosecond-nanosecond time scale) on ligase 10C. Residues involved 
in zinc coordination are labeled. (b) Mapping of the exchange rates (Rex) obtained from relaxation 
dispersion measurements as a proxy for slow dynamics (microsecond-millisecond time scale). The color 
gradient and thickness of the backbone indicate that the ligase fast dynamics is located mostly in the 
unstructured loop, while the slow dynamics is located mostly in the region N-terminal to the Zn-II site 
(residues 46-53) and is potentially correlated to catalytic activity.  
 
A distinct signature of the hRXRα structure is slow (microsecond-millisecond) 
conformational dynamics[20] (Figure S4.10b), which may be correlated with the 
protein’s ability to optimize protein-DNA interactions. The in vitro evolution of hRXRα 
into the RNA ligase redistributed those conformational dynamics, particularly in the 
region N-terminal to the Zn
2+
 binding site Zn-II (residues 46-53, Figure 4.2b).  
To probe the substrate binding surface, we carried out an NMR titration with a 
pseudo-substrate that lacked the 2'-hydroxyl group, preventing enzyme turnover (Figure 
S4.11). Chemical shift perturbation mapping of the ligase structure (Figures 4.3a and 
S4.12) indicated that one of the highly perturbed regions in the substrate bound form 
(residues 46-53) corresponds to high values of chemical exchange (slow conformational 
dynamics) in the substrate-free form (Figure 4.2b). Notably, most alanine mutations in 
this region decreased or completely obliterated the enzyme’s activity (Figures 4.3b and 
5.3c). Specifically, mutations E48A, Y50A and H51A abolished enzymatic activity, 
whereas C47A and C53A caused a 97% reduction in ligase function. These residues’ high 
conservation among evolved ligase variants further demonstrated their importance 
(Figure 4.3d). The combined results suggest that this protein region (residues 46-53) is 
important for substrate recognition and binding and may contain the active site of the 
enzyme. Four of those five mutation-sensitive residues (C47, E48, H51, C53) are good 
Chapter 4 
 97 
potential metal ligands. Many natural enzymes, such as polymerases, that catalyze 
chemical reactions similar to the specific RNA ligation described here use a mechanism 
involving catalytic divalent metal ion cofactors, which are coordinated jointly by the 
nucleic acid substrates and active site residues of the enzyme [21]. One may speculate 
that upon forming the enzyme-substrate complex some of the mutation-sensitive residues 
in ligase 10C are involved in binding additional Zn
2+
 ions that facilitate catalysis, but are 
not bound by the protein alone. However, additional experiments studying the enzyme in 
complex with substrate are needed to elucidate the catalytic mechanism of our artificial 
enzyme. 
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Figure 4.3 - Substrate binding surface of ligase 10C probed by NMR and alanine scanning. (a) 
Mapping of NMRchemical shift perturbations (intensity changes, ΔI) for ligase 10C shows regions affected 
by formation of the complex with RNAsubstrate. The most perturbed regions are indicated by thicker lines 
and darker colors. Zinc-coordinating residues are labeled. (b) Activity assay of ligase 10C and alanine 
mutants by gel shift. Ligation activity is normalized to the activity of ligase 10C and represents the mean 
value from two independent experiments. Residues with activity below detection limit are shown in blue. 
(c) Sequence conservation analysis of region 45-54 for ligase enzymes generated by directed evolution 
[14]. The sequences were analyzed using the web based application WebLogo (V 2.8.2) from a dataset of 
49 enzyme sequences. Residues E48, Y50, and H51 (blue) which completely lost activity during alanine 
scanning (see above) were conserved among all sequences. The two residues with 97% reduced activity of 
their alanine mutant were either conserved (C53) or had one alternative amino acid (C47). None of the 
other residues in this region were conserved. 
 
4.4 Discussion 
The increased flexibility of the new ligase structure relative to the parent hRXRα 
could potentially originate from their different functional roles. hRXRα is a DNA binder 
and has been proposed to work through an induced-fit mechanism [16]. In contrast, the 
RNA ligase has evolved to function as a catalyst. This role requires additional flexibility 
to optimize interactions with a target molecule and carry out chemical catalysis using 
transient interactions that occur in excited conformational states rather than through a 
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stable, low energy complex [22-24]. This argument is supported by an independent 
directed evolution experiment in which the same hRXRα library yielded proteins that 
bind ATP and maintain the original, non-catalytic DNA binding scaffold, but have no 
catalytic function [17]. In contrast, the evolution of the ligase enzyme resulted in a 
different structure and increased dynamics.  
Compared to natural enzymes which evolved over billions of years, the 
laboratory-evolved ligase enzyme contained substantially fewer secondary structure 
elements such as α-helices and β-strands, and instead exhibited increased flexibility. The 
complete reorganization of the starting scaffold during in vitro evolution may have led to 
the loss of these structural elements. This novel structure has not been subjected to 
extensive selection pressure which shaped contemporary enzymes during their natural 
evolution and can therefore be considered an early or primordial catalytic fold. Further 
evolution of this enzyme in vitro or inside a cell will explore if incremental mutations 
lead to structural and dynamic properties more similar to natural enzymes. While 
flexibility has been suggested to increase the probability of developing new functions [5], 
it also reduces overall protein stability; a trade-off which enzymes must balance during 
evolution. 
 
4.5 Conclusions 
This report describes the first new protein structure emerging simultaneously with 
a novel enzymatic function. This ligase evolved in the absence of selection pressure to 
maintain the protein’s original function (DNA binding). Would proteins evolving in 
nature also more readily adopt new folds and functions if they were freed from 
maintaining their original function? While the search for such examples in nature is still 
ongoing, the simplified environment of in vitro evolution enables us to generate 
precedents and study basic principles of complex natural evolution. Finally, in vitro 
directed evolution has the potential to produce novel biocatalysts for a wide range of 
applications. The unique structure of the artificial ligase enzyme demonstrates that this 
approach can successfully generate novel enzymes without being limited to known 
biological folds [25]. 
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4.6 Materials and Methods 
 All chemical compounds used in this study were purchased from Sigma-Aldrich 
unless noted otherwise and were of Molecular Biology Grade, and certified for the 
absence of ribonucleases when used for ligation reactions.  
 
4.6.1 Sequence of RNA ligase 10C. 
MGAPVPYPDPLEPRGGKHICAICGNNAEDYKHTDMDLTYTDRDYKNCESYHKC
SDLCQYCRYQKDLAIHHQHHHGGSMGMSGSGTGY 
 All ligase protein preparations consisted of the sequence above except for point 
mutations in the case of ligase mutants. Note that the sequence HHQHHH functions 
similarly to a 6xHis-tag.  
 
4.6.2 Expression and purification of 
15
N-labeled ligase protein for NMR studies. 
 Ligase samples were expressed in E. coli BL21-DE3 Rosetta strain cells 
(Novagen). Cells were grown in LB with 36 μg/mL kanamycin overnight at 37˚C. This 
culture was then used to inoculate 1 L of LB medium containing 36 μg/mL kanamycin. 
The cultures were grown to an OD600 of 0.6-0.8 at 37˚C, spun down, and resuspended in 
M9 minimal medium (50 mM Na2PHO4, 22 mM KH2PHO4, 8.5 mM NaCl, 2 mM 
MgSO4, 1 mg/L thiamine, 1 mg/L biotin, 60 μM ZnSO4, 10 g/L dextrose, 1 g/L 
15
NH4Cl, 
and 36 μg/mL kanamycin, pH = 7.3). Cultures were shaken for 1 h at 37˚C, induced with 
1 mM IPTG, and shaken overnight at room temperature before being spun down and 
stored at -20˚C.  
 Frozen cell pellets were resuspended in lysis buffer (20 mM HEPES, 400 mM 
NaCl, 100 μM ZnCl2, 100 mg/L Triton X-100, 5 mM β-mercaptoethanol, pH = 7.4) and 
lysed using a S-450D Digital Sonifier (Branson). Cell debris was removed by 
centrifugation and the His-tagged ligase protein was purified by affinity chromatography 
using Ni-NTA Superflow resin (QIAGEN). The protein was eluted with acidic elution 
buffer (20 mM NaOAc, 400 mM NaCl, 0.1 mM ZnCl2, 100 mg/L Triton X-100, 5 mM β-
mercaptoethanol, pH = 4.5) into 1 M HEPES at pH = 7.5, and immediately mixed to 
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adjust the pH. Protein purification was evaluated by SDS-PAGE on Ready Gel precast 
gels (Bio-Rad). Elution fractions containing ligase protein were concentrated under high 
pressure in a stirred-cell concentrator unit with a 5,000 MWCO Ultracel Ultrafiltration 
cellulose membrane (Millipore) and dialyzed into FPLC buffer (20 mM HEPES, 150 mM 
NaCl, 0.1 mM ZnCl2, and 0.5 mM β-mercaptoethanol, pH = 7.5). 
 Monomer ligase protein was isolated by size-exclusion chromatography using the 
AKTA FPLC system (GE Healthcare) equipped with a 10 mm x 300 mm column 
(Tricorn) and Superdex 75 resin (GE Healthcare). The separation was carried out in 
FPLC buffer. Fractions containing monomer protein were pooled and concentrated using 
10,000 MWCO Ultra-4 Centrifugal Filter units (Millipore). Purity was assessed by SDS 
PAGE gel (Figure S4.13). 
 
4.6.3 Expression and purification of 
15
N/
13
C-labeled ligase samples for NMR studies. 
 Ligase samples were expressed in E. coli BL21-DE3 Rosetta strain cells 
(Novagen). Cells were grown in LB with 36 μg/mL kanamycin overnight at 37˚C, spun 
down, and resuspended in M9 minimal medium (contents as described above, except with 
2 g/L 
13
C-dextrose). The resuspended cells were used to inoculate 100 mL of M9 
minimal medium and were grown to an OD600 of 0.6 at 37˚C, at which time the culture 
was used to inoculate 900 mL of M9 minimal medium. The 1 L culture was grown to an 
OD600 of 1.0 at 37˚C, induced with 1 mM IPTG, and shaken overnight at 37˚C before 
being spun down and stored at -20˚C. The 15N/13C-labeled protein was purified in the 
same manner as the 
15
N-labeled protein samples. 
 
4.6.4 Expression of selectively labeled ligase protein for NMR studies. 
 Ligase samples were expressed in E. coli BL21-DE3 Rosetta strain cells 
(Novagen). Cells were grown in LB with 36 μg/mL kanamycin overnight at 37˚C, spun 
down, and used to inoculate 1 L of selectively labeled M9 medium (40 mM Na2PHO4, 22 
mM KH2PHO4, 8.5 mM NaCl, 1 mM MgSO4, 50 μM CaCl2, essential vitamins and 
minerals, and 36 μg/mL kanamycin, pH 7.0). To the medium was also added 250 mg of a 
single 
15
N-labeled amino acid (Cys, Leu, Lys or Tyr), 600 mg of the remaining 19 
Chapter 4 
 102 
unlabeled amino acids and, except for labeling 
15
N Cys, one of the following additional 
amino acid supplements: 900 mg Gln, Asn and Arg when labeling 
15
N Lys; 900 mg Val, 
and Ile when labeling
 15
N Leu; and 900 mg Phe, Trp, Ala, Ser, Gly, and Cys when 
labeling
 15
N Tyr. Cultures were grown to an OD600 of 1.0 at 37˚C, induced with 1 mM 
IPTG, and shaken for 6 h at 37˚C before being spun down and stored at -20˚C. 
Selectively labeled protein was purified in the same manner as the 
15
N-labeled protein 
samples. 
 
4.6.5 Generation of ligase mutants. 
 Ligase mutants were obtained by site-directed mutagenesis (QuikChange 
Lightning, Agilent). Plasmid DNA was purified using the QIAprep Spin Miniprep kit 
(QIAGEN). The ligase mutants were verified by DNA sequencing. The primer sequences 
used to generate the indicated mutations in the ligase were designed in accordance with 
the QuikChange Primer Design tool (Agilent) and were as follows:  
K45A F: 5'-CTACACCGATCGAGACTACGCGAATTGTGAGAGCTACC 
K45A R: 5'-GGTAGCTCTCACAATTCGCGTAGTCTCGATCGGTGTAG 
N46A F: 5'-CCGATCGAGACTACAAGGCTTGTGAGAGCTACCATAAGTG 
N46A R: 5'-CACTTATGGTAGCTCTCACAAGCCTTGTAGTCTCGATCGG 
C47A F: 5'-CCGATCGAGACTACAAGAATGCTGAGAGCTACCATAA 
C47A R: 5'-TTATGGTAGCTCTCAGCATTCTTGTAGTCTCGATCGG 
E48A F: 5'-GACTACAAGAATTGTGCGAGCTACCATAAGTGCTCGG 
E48A R: 5'-CCGAGCACTTATGGTAGCTCGCACAATTCTTGTAGTC 
S49A F: 5'-AGACTACAAGAATTGTGAGGCCTACCATAAGTGCTCGGAC 
S49A R: 5'-GTCCGAGCACTTATGGTAGGCCTCACAATTCTTGTAGTCT 
Y50A F: 5'-CTACAAGAATTGTGAGAGCGCCCATAAGTGCTCGGACTTGTG 
Y50A R: 5'-CACAAGTCCGAGCACTTATGGGCGCTCTCACAATTCTTGTAG 
H51A F: 5'-CTACAAGAATTGTGAGAGCTACGCTAAGTGCTCGGACTTGTG 
H51A R: 5'-CACAAGTCCGAGCACTTAGCGTAGCTCTCACAATTCTTGTAG 
K52A F: 5'-ACAAGAATTGTGAGAGCTACCATGCGTGCTCGGACTTGTGC 
K52A R: 5'-GCACAAGTCCGAGCACGCATGGTAGCTCTCACAATTCTTGT 
C53A F: 5'-GTGAGAGCTACCATAAGGCCTCGGACTTGTGCCAGT 
C53A R: 5'-ACTGGCACAAGTCCGAGGCCTTATGGTAGCTCTCAC 
S54A F: 5'-GTGAGAGCTACCATAAGTGCGCGGACTTGTG 
S54A R: 5'-CACAAGTCCGCGCACTTATGGTAGCTCTCAC 
 
4.6.6 Expression and purification of ligase mutants.  
 Ligase mutants were expressed in E. coli BL21-DE3 Rosetta cells (Novagen). 
Cells were cultured in 1 L of LB medium with 36 μg/mL kanamycin to an OD600 of 0.8-
1.0 at 37˚C. Cultures induced with 1 mM IPTG and shaken for 6 h at 37˚C before being 
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spun down and stored at -20˚C. Ligase mutant proteins were purified by Ni-NTA affinity 
chromatography in the same manner as described for the 
15
N-labeled protein samples. 
 
4.6.7 Analysis of metal content by ICP-MS. 
 Ligase 10C was purified as described for the 
15
N-labeled protein samples and then 
dialyzed three times against buffer (100 mM NaCl, 10 mM β-mercaptoethanol, 20 mM 
TrisHCl at pH 7.5; pre-treated with Chelex 100 beads (Bio-Rad) for 2 h and filtered) at a 
ratio of 1/1,000. The metal content of 14 μM protein was measured by ICP MS (Thermo 
Scientific XSERIES 2 ICP-MS w/ ESI PC3 Peltier cooled spray chamber, Department of 
Earth Sciences at the University of Minnesota). 
 
4.6.8 Ligase activity assay for zinc dependence. 
 Ligase 10C was purified as reported previously [14]. Zinc was removed from 
ligase 10C by treatment with ion exchange resin (Chelex 100, Bio-Rad). 5 μM Ligase 
10C was incubated with 20 μM HO-substrate, 10 μM 32P-labeled PPP-substrate/splint, 20 
mM HEPES (pH 7.5), 150 mM NaCl, 500 μM β-mercaptoethanol, and the indicated 
concentrations of ZnCl2 for 6 h at room temperature. The ligation reactions were 
quenched with 20 mM EDTA/8 M urea, heated to 95°C for 4 min, and separated by 
denaturing PAGE gel. The gel was analyzed using a GE Healthcare (Amersham 
Bioscience) Phosphorimager and ImageQuant software (Amersham Bioscience). 
 
4.6.9 Ligase activity assay of 10C and alanine mutants. 
 5 μM Ligase 10C (or alanine mutant) was incubated for 6 h at room temperature 
in the presence of 20 μM HO-substrate, 10 μM 32P-labeled PPP-substrate/splint, 24 mM 
HEPES (pH 7.5), 130 mM NaCl, 100 μM β-mercaptoethanol, and 120 μM ZnCl2. The 
ligation reactions were quenched with 20 mM EDTA and 8 M urea, heated to 95°C for 4 
min, and separated by denaturing PAGE gel. The gel was analyzed using a GE 
Healthcare (Amersham Bioscience) Phosphorimager and ImageQuant software 
(Amersham Bioscience). 
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4.6.10 Resonance assignment. 
 All NMR spectra were acquired at 298 K on a Bruker spectrometer equipped with 
cryoprobe at 700 MHz and Varian spectrometer at 600 MHz. The samples were in buffer 
of 150 mM NaCl, 20 mM HEPES, 10 mM β-mercaptoethanol, and pH 7.5. Moreover, all 
protein samples were saturated with ZnCl2 by observing changes in HSQC spectra prior 
to other NMR experiments. Triple resonance spectra such as CBCA(CO)NH, HNCACB 
[26-28] were used to assign peaks on 
15
N-HSQC. All resonances in these two 3D spectra 
and 
15
N-HSQC were picked and fed into the PISTACHIO program (National Magnetic 
Resonance Facility in Madison, WI, USA) [29] to obtain preliminary assignments. Final 
complete assignments were done by manual checks and searches. Carbonyl groups and 
others side-chain carbons were assigned by HNCO and C(CO)NH-TOCSY[30]; side-
chain protons were assigned by 
15
N-NOESY-HSQC, 
15
N-TOCSY-HSQC, and 
HC(CO)NH-TOCSY experiments [30] with 150 ms mixing time, 60 ms mixing time, and 
12 ms mixing time, respectively. 
 
4.6.11 Distance restraints. 
 All proton distance restraints were determined from the cross-peak intensities in 
the NOESY spectra by calibration with HN(i)Hα(i-1) distances located at the C-terminal 
region [31], whose helix propensity was shown by chemical shift index and 
3
JHNHα 
coupling values [31, 32]. The cross peaks from HN(i)Hα(i-1) distances in that region 
were categorized as medium NOEs, so the intensities of other cross peaks smaller than 
this intensity range were defined as weak NOEs and those larger than this range belonged 
to strong NOEs. The upper bounds of distance restraints of strong, medium, and weak 
NOEs were given as 2.9, 3.5, and 5 Å respectively, and lower bounds were set to 1.8 Å in 
all cases. Starting from unambiguously assigned NOEs at the beginning of calculation, 
mis-calibrated NOEs were adjusted and then ambiguously assigned NOEs were gradually 
added into the restraint table during iterative calculation. 
 
4.6.12 Torsion angle restraints. 
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 Backbone Phi angle restraints were acquired from the HNHA experiment, and the 
quantitative 
3
JHNHα coupling values were calculated from the intensity ratios of cross 
peaks to diagonal peaks and corrected by 3.7% to account for relaxation [33]. The 
correction is proportional to the rotational correlation time of the protein (3 ns), which 
was measured from 1-dimensional TRACT experiment[34]. The Phi angle of residue i 
with J-coupling larger than 8.5 Hz was restrained from -160° to -80°, and that with J-
coupling smaller than 6 Hz was restrained from -90° to -40°. Moreover, the Psi angle 
restraints were derived from the 
15
N-NOESY data. If the intensity ratio of the HN(i)Hα(i) 
cross peak to the HN(i)Hα(i-1) peak is smaller than one, the Psi(i-1) is restrained from 
20° to 220°; otherwise, the Psi(i-1) is restrained from 80° to -140° [35, 36]. 
 
4.6.13 RDC measurement. 
 The stability of several alignment media for ligase 10C was tested. 5% neutral and 
negative-charged acrylamide gel was first attempted, but only weak residual dipolar 
couplings (absolute values < 5 Hz) were obtained. Additionally, the samples precipitated 
in both DMPC/D7PC and DMPC/D6PC bicelle preparations. We also tested the liquid 
crystalline medium formed by CPCl (cetylpyridinium chloride) and 1-hexanol, but had 
poor results in terms of sample stability. The sample was finally aligned in the other 
liquid crystalline medium made by the mixture of C12E5 (5% alkyl-poly(ethylene 
glycol)) and 1-hexanol (r=0.85)[37]. The residual dipolar couplings of amide groups were 
obtained by measuring the splitting difference between a decoupling HSQC peak and a 
TROSY peak in isotropic solution and anisotropic medium.  
 
4.6.14 Structure calculations. 
 Simulating annealing protocols were performed in the XPLOR package [38]. An 
extended structure was first generated and the initial temperature was set at 3,500 K, then 
the temperature was cooled down to 0 K with 15,000 steps. The structure with the lowest 
energy was used for refinement with the initial temperature of 5,000 K and 30,000 steps. 
The resulting structure was further refined with RDC data after optimization of the 
parameters Da and Rh. The angle restraints of the zinc coordination geometry were based 
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on ideal geometries derived from X-ray data [39, 40], which are in quantitative 
agreement with the EXAFS experiments. Distances derived from EXAFS have 
previously been used as restraints in NMR refinement [41, 42]. Here, we report a 
structural ensemble of 20 conformers. The PROCHECK statistics show that 76.4% of 
residues are in most favored regions and 21.1% of residues are in allowed regions. 
 
4.6.15 Zn K-edge EXAFS. 
 Ligase 10C protein was fully saturated with excess Zn
2+
 and then dialyzed to 
remove excess Zn
2+
. The final protein sample was 1.39 mM in 15 mM Tris, pH = 7.5 and 
112.5 mM NaCl. 20% v/v) glycerol was added to the protein samples in order to form a 
glass required for the EXAFS experiments. The Zn K-edge X-ray absorption spectra of 
ligase 10C were measured at the Stanford Synchrotron Radiation Lightsource (SSRL) on 
the 16 pole, 2 T wiggler beamline 9-3 under standard ring conditions of 3 GeV and ~200 
mA ring current. A Si(220) double-crystal monochromator was used for energy selection. 
Other optical components used for the experiments were a cylindrical Rh-coated bent 
focusing mirror. Spectra were collected in the fully tuned configuration of the 
monochromator. The solution samples were immediately frozen after preparation and 
stored under liquid N2 until measurement. During data collection, the samples were 
maintained at a constant temperature of ~6 K using an Oxford Instruments CF 1208 
liquid helium cryostat. Data were measured to k= 16 Å
-1
 by using a Canberra Ge 100-
element monolith detector. Internal energy calibration was accomplished by simultaneous 
measurement of the absorption of a Zn-foil placed between two ionization chambers 
situated after the sample. The first inflection point of the foil spectrum was fixed at 
9,660.7 eV. Data presented here are a 15 scan average. The data were processed by fitting 
a second-order polynomial to the pre-edge region and subtracting this from the entire 
spectrum as background. A five-region spline of orders 2, 3, 3, 3 and 3 was used to model 
the smoothly decaying post-edge region. The data were normalized by subtracting the 
cubic spline and assigning the edge jump to 1.0 at 9,680 eV using the Pyspline program 
[43]. Theoretical EXAFS signals χ(k) were calculated by using FEFF (Macintosh version 
8.4) [44-46]. Initial model was based on the Zn(Cys)2(His)2 active site in a zinc finger 
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protein (1MEY)[47]. Based on the preliminary fits, the models were modified to 
accommodate a six-coordinate active site (4 Zn-N/O and 2 Zn-S(Cys)). 
 The theoretical models were fit to the data using EXAFSPAK [48]. The structural 
parameters varied during the fitting process were the bond distance (R) and the bond 
variance σ2, related to the Debye-Waller factor resulting from thermal motion, and static 
disorder of the absorbing and scattering atoms. The non-structural parameter E0 (the 
energy at which k=0) was also allowed to vary but was restricted to a common value for 
every component in a given fit. Coordination numbers were systematically varied in the 
course of the fit but were fixed within a given fit. 
4.6.16 Accession codes  
 Protein Data Bank: the accession code for ligase 10C is 2LZE. Biological 
Magnetic Resonance Data Bank: the accession number for ligase 10C is 18749. 
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4.7 Supplementary Information 
 
Table S4.1 - Summary of NMR structural statistics of 20 conformers. The RMSD of the structural 
ensemble is calculated within well-structured regions (residues 17-35 and 49-69).  
 Protein 
NMR distance and dihedral constraints  
Distance constraints  
    Total NOE 354 
    Intra-residue    106 
    Inter-residue 248 
      Sequential (|i – j| = 1) 162 
      Medium-range (|i – j| < 4) 34 
      Long-range (|i – j| > 5) 52 
      Intermolecular 0 
    Hydrogen bonds 0 
Total dihedral angle restraints 34 
     15 
     19 
Total RDCs 
    Q (%) 
 
26 
14.6 
Structure statistics  
Violations (mean and s.d.)  
    Distance constraints (Å)     0.1 (0.01) 
    Dihedral angle constraints (º) 1.3 (0.4) 
    Max. distance constraint violation (Å) 0.8 (0.4) 
    Max. dihedral angle violation (º)     5.7 (1.6) 
Deviations from idealized geometry  
    Bond lengths (Å)     0.008 
    Bond angles (º) 1.0 
    Impropers (º) 0.5 
Average pairwise r.m.s. deviation** (Å)      
    Heavy      1.4 
    Backbone   0.8 
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Table S4.2 Thermodynamic parameters for Zn
2+ 
binding determined by Isothermal Titration 
Calorimetry. After completely removing the Zn
2+
 from the protein with Chelex 100 chelating ion 
exchange resin (BioRad), 5 μM ligase enzyme was slowly titrated with 400 μM ZnCl2 solution, and the heat 
release was monitored using a MicroCal VP-ITC instrument (GE Healthcare). All samples contained at 150 
mM NaCl, 20 mM HEPES, 10 mM β-mercaptoethanol, and pH 7.5, and the data were fitted with a 
sequential two-site binding model. The values represent the average of three measurements. 
 Average value Standard deviation 
Kd1 (μM) 3.0
 
0.6
 
ΔH1 (kcal/mole) 122.9
 
14.8
 
ΔS1 (cal/mole/°) 437.7 49.7 
Kd2 (μM) 92.8
 
8.9
 
ΔH2 (kcal/mole) -123.7
 
13.3
 
ΔS2 (cal/mole/°) -396.3 45.0 
 
 
Table S4.3 - EXAFS least squares fitting results for ligase 10C. 
Coordination/Path R(Å) 
[a] σ2(Å2)[b] E0 (eV) F
 [c]
 
4 Zn-N 2.00 (0.005) 731 
-12.3 0.18 
2 Zn-S 2.30 (0.003) 453 
6 Zn-C
 
3.00 (0.015) 1,077 
12 Zn-C-N
 
3.09 (0.034) 1,077 
[d] 
6 Zn-C
 
4.16 (0.012) 169 
6 Zn-C-N 4.19 (0.013) 169 
[d]
 
6 Zn-C-N
 
4.30 (0.014) 169
 [d]
 
[a] The estimated standard deviations for the distances were calculated by EXAFSPAK and are given in 
parentheses (see also Figure S5.8 caption).  
[b] The σ2 values are multiplied by 105.  
[c] Error is given by Σ[(χobsd – χcalcd)
2
 k
6]/Σ[(χobsd)
2
k
6
].  
[d] The σ2 value for the Zn-C (single scattering) and Zn-C-N (multiple scattering) paths were linked to be 
the same value. 
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Figure S4.1 - Summary of the NOEs observed from NOESY spectra. (a) Horizontal bars show the 
presence of NOE signals between residues. Bar thickness corresponds to the NOE intensity. (b) Long-range 
NOEs observed in ligase 10C. 
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Figure S4.2 - Convergence of the structural ensemble of 20 conformers. (a) Average backbone RMSD 
of the conformational ensemble. (b) Correlation between experimental RDC values and average back-
calculated RDC values from the ensemble. 
 
 
 
 
 
Figure S4.3 - The structural ensembles are calculated before and after incorporating Zn
2+ 
ions into 
the coordinates. (a) Ensemble of 20 lowest energy conformers (residues 17-69) selected from 100 
structures. The NOEs, torsion angles, and RDC values were included in these calculations. Note that the 
two Zn
2+
 ions and coordination were not included. (b) Ensemble of 20 lowest energy conformers (residues 
17-69) obtained including Zn
2+
 ions and coordination. The two Zn
2+
 ions are shown as blue spheres. The 
side chains involved in the coordination are displayed in red (H18, E28(OD2), C57, C60, D65(OD1), and 
C20, C23, D34(OD1)) and, additionally, both zinc binding sites each contain a single water ligand (not 
shown) resulting in a hexacoordinated and tetracoordinated sites, respectively. The backbone RMSD 
between the well-structured regions (residues 17-35 and 49-69) of the ensembles with Zn
2+
 and without 
Zn
2+
 is 0.52 Å. 
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Figure S4.4 - Zn
2+
 titration into 
15
N-labeled ligase 10C monitored by NMR. A selected region of HSQC 
spectra recorded during Zn
2+
 titration is shown. Residues of partially Zn
2+
-saturated sample displayed slow 
exchange on the NMR time scale between forms bound to one or two Zn
2+
.  
 
 
Figure S4.5 - HSQC spectra recorded upon Zn
2+
 titration. Molar ratios of ligase 10C to zinc were: 1) 
10C:Zn=1:0, 2) 10C:Zn=1:1, 3) 10C:Zn=1:2, 4) 10C:Zn=1:3, 5) 10C:Zn=1:4, 6) 10C:Zn=1:6. 
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Figure S4.6 - Zn
2+
 titration into the ligase enzyme monitored by ITC. Samples contained 5 μM ligase 
10C, 150 mM NaCl, 20 mM HEPES, 10 mM β-mercaptoethanol, pH 7.5 and were measured by Isothermal 
Titration Calorimetry using a MicroCal VP-ITC instrument (GE Healthcare). (a) The graph represents the 
raw data for the blank titration (buffer without ligase). (b) The graph represents raw data for the Zn
2+
 
titration of ligase 10C. (c) The figure shows the heat release of the Zn
2+ 
titration of ligase 10C after 
subtracting the blank titration. The data is fit to a model of two binding sites. The data can be fitted to 
models with two or more Zn
2+ 
binding sites, however, the fit does not improve significantly with n>2. The 
Zn
2+ 
titration was carried out in triplicate and the errors are summarized in the Table S4.2.  
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Figure S4.7 - Zn
2+
 dependence of ligase activity. The maximum activity was observed at 145 µM Zn
2+
. 
Towards lower Zn
2+
 concentrations the activity sharply drops, matching the expected behavior predicted 
from the dissociation constants measured by Thermocalorimetry. Towards higher Zn
2+ 
concentrations, the 
activity also decreases but more slowly. One possible explanation is that Zn
2+
 at high concentrations might 
also bind to additional sites with lower affinity thereby reducing the activity. Error bars represent one 
standard deviation. Ligation activity for samples at 0.1, 1, 5 and 10,000 μM ZnCl2 was below the detection 
limit of 1%. 
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Figure S4.8 - Analysis of zinc coordination by EXAFS spectroscopy (Extended X-ray Absorption 
Fine Structure). (a) The k
3
 weighted Zn K-edge EXAFS (inset) and their corresponding non-phase shift 
corrected Fourier transforms for ligase 10C are presented. The experimental data are shown as black lines 
and the fit as red lines. The best-fit parameters are given in Table S5.3. While a coordination with four 
ligands is most commonly observed for zinc ions, a coordination geometry including six ligands has been 
observed in natural proteins numerous times[39, 49]. The first shell coordination number was varied from 
four-coordinate to six-coordinate. In each case the number of Zn-S and Zn-N/O components was 
systematically varied to obtain the best F value. These fits show that the data are most consistent with a six-
coordinate site with 2 Zn-S and 4 Zn-N/O components. A 1:1 occupation of the two sites modeled from 
NMR analysis would have resulted in best-fit with 3 Zn-N/O and 2 Zn-S coordination. However, the 
process of dialysis (removal of excess Zn is necessary for EXAFS experiments) may lead to stripping of 
some Zn from the weakly bound N-terminal site. This leads to an increase in the number of six-coordinate 
sites over four-coordinate sites in the protein and results in a best-fit first shell with more than 3 Zn-N/O 
paths.  
 The EXAFS data are dominated by first shell Zn-N/O and Zn-S, while second and third shells are 
significantly weaker. The second and third shells were fit with single (Zn-C) and multiple-scattering (Zn-C-
N) theoretical paths generated using a representative Zn-N(His) model. These weak features are due to a 
combination of single and multiple scattering from the amino acid ligands. The multiple scattering features 
are different from characteristic Zn-N(His)n[50] or ZnS(Cys)n[51] systems due to interference between 
second shell components of Cys and His ligands. Note that standard deviations in bond distances obtained 
from EXAFSPAK assume the use of raw, low-noise data. Although the data quality presented here are 
quite high, it is important to note that in the presence of several single and multiple scattering paths, the 
choice of a specific path to represent an average of multiple paths will also affect the standard deviations. 
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Typically second shell paths have errors of the order 0.05 to 0.1 Å. Furthermore these standard deviations 
do not reflect the fact EXAFS analysis typically underestimates bond distances (relative to 
crystallography). The protein samples used for EXAFS analysis were extensively dialyzed and had no 
extraneous source of sulfur, precluding non-protein based Zn-S ligation. 
 A visual inspection of the FEFF fit presented here shows that the first peak (corresponding to Zn-
N/O paths) in the Fourier Transform is a slightly poorer fit relative to the second peak (corresponding to 
Zn-S paths). In an attempt to improve the fits and to differentiate between 3 Zn-N/O and 4 Zn-N/O fits, 
split first shell fits were performed. Significant statistical improvement was not observed. 
             (b) The Rsq values (Σ[(χobsd – χcalcd)
2
 k
6]/Σ[(χobsd)
2
k
6
]) for four- to six- coordinate first shell fits are 
presented as a function of increasing number of Zn-S ligands with concomitant decrease in the number of 
Zn-N/O ligands. ( ) four-coordinate, ( ) five-coordinate. ( ) six-coordinate. The Rsq of the four-
coordinate fit is significantly worse than that of the five- or six- coordinate fits. Note that although the best 
Rsq value is obtained with 4 Zn –N/O and 2 Zn-S ligands, the five coordinate fits with either 3 Zn-N/O and 
2 Zn-S or 2 Zn-N/O and 3 Zn-S ligands also have reasonably low Rsq values. For the 2 Zn-N/O and 3 Zn-S 
fit to be correct, the two Zn sites need to have 2 Zn-S and 4 Zn-S ligands, respectively. Such a structure is 
ruled out by NMR data, which show that the sites do not have more than two S-based ligands. Since the 
first shell coordination number error can be up to 20%, it is difficult to differentiate between the 4 Zn-O/N 
and 3 Zn/O fits with a high level of statistical confidence. Note that both the 4 Zn-N/O and 3 Zn-N/O fits 
indicate that the high Zn-affinity site is six-coordinate. Six-coordinate Zn sites account for at least 11% of 
all Zn sites in biology based on NMR and crystallography studies[49]. EXAFS studies with cysteine 
ligands are typically limited to four- and five-coordinate sites[52]. Studies have been performed on six-
coordinate sites, but typically with all light atom ligands[53]. In general, a comparison of total EXAFS 
intensity can give an insight into the coordination number but the presence of two different first shell 
ligands (N/O and S) modulates the EXAFS data strongly, making an accurate comparison of EXAFS data 
between two systems with different coordination numbers difficult[52]. In such a situation, the error in first 
shell coordination number determination can be greater than 20%. Since the EXAFS data are best fit with 
between 3 and 4 light atom ligands, the higher error indicates that the second site can be between tetra- and 
septa-coordinate. Since, a seven coordinate site has no biological precedence, the second site is between 
tetra- and hexa-coordinate. 
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Figure S4.9 - Structure and conformational dynamics probed by NMR experiments. (a) Chemical 
shift indexes (ΔCα-ΔCβ), steady-state NOE, longitudinal relaxation rates (R1), transverse relaxation rates 
(R2), and R1/R2 ratios as determined by NMR spectroscopy (unassigned residues are marked with an "X"). 
The errors are estimated by the signal-to-noise (H-X NOE), standard deviations of the fitting (R1, R2, and 
R1/R2), or duplicate experiments (ΔR2). The two zinc fingers are highlighted with dashed red lines. (b) The 
decrease of peak intensities due to H/D exchange was mapped onto one NMR conformer (residues 17-69 
are displayed). The intensity of the peaks was normalized to a reference HSQC spectrum of the ligase 10C 
in 10% D2O. The sample was lyophilized and dissolved in the same volume of 80% D2O. After 6 minutes, 
the HSQC spectrum was acquired and compared with the initial spectrum to monitor solvent exposed 
amide groups. The solid red line in the diagram represents the average intensity retention plus 2σ.   
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Figure S4.10 - Mapping of the conformational dynamics of the DNA binding domain (hRXRα) [16]. 
(a) Heteronuclear NOEs (proxy for fast dynamics on a picosecond-nanosecond time scale) on the structure 
of hRXRα[16]. (b) Exchange rates (Rex) obtained from relaxation dispersion measurements as a proxy for 
slow dynamics (microsecond-millisecond time scale). The color gradient and the thickness of the backbone 
indicate the intensity of the motions.  
 
 
 
 
Figure S4.11 - Chemical structure of inactive ligation substrate. Substitution of the 2'-hydroxyl group 
of the terminal nucleotide in the HO-substrate with a 2'-deoxy modification (red box) results in inactivation 
of the ligation reaction. Ligation of active substrates occurs between a 5'-triphosphorylated RNA (PPP-
substrate) and the 3'-hydroxyl group of the second RNA (HO-substrate) while both RNAs are base-paired 
to a complementary oligonucleotide (splint). The dashed arrow symbolizes the proposed bond formation.  
Chapter 4 
 119 
 
 
Figure S4.12 - Titration of RNA substrate into ligase 10C monitored by NMR spectroscopy. (a) The 
ligase enzyme (300 μM) was titrated with the inactive RNA ligand in 150 mM NaCl, 20 mM HEPES, 10 
mM β-mercaptoethanol, and pH 7.5. The HSQC spectra during the titration showed no significant changes 
in chemical shifts. (b) Slices of a selected peak (H51) in HSQC spectra during ligand titration showed 
significant line-broadening. 
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Figure S4.13 - Purity and identity of purified ligase 10C. SDS-PAGE gel (NuPAGE 4-12% Bis-Tris gel, 
Invitrogen) Coomassie stained of ligase 10C purified by nickel affinity chromatography and size exclusion 
chromatography and 10-250 kDa ladder P7703S (New England Biolabs) used as a marker. The identity of 
ligase 10C was confirmed by MALDI mass spectrometry yielding a characteristic [M+H]
+
 signal at m/z = 
9,648 ± 1.4 (± s.d. from five independent measurements), which is consistent with the expected mass of the 
ligase 10C without the N-terminal methionine (MW = 9,648.7 Da). The purity of labeled constructs and all 
mutants matched that of the purified ligase 10C shown here. 
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Chapter 5:  
Universal labeling of 5'-triphosphate RNAs by artificial RNA ligase 
enzyme with broad substrate specificity. 
 
 The following is a reprint of the article: Haugner III, J. C., and Seelig, B. (2013) 
Universal labeling of 5'-triphosphate RNAs by artificial RNA ligase enzyme with broad 
substrate specificity. Chem. Commun. 49, 7322-24. The article is reproduced by 
permission of The Royal Society of Chemistry. Seelig and I designed all experiments and 
interpretated data. I performed all experiments. 
 
Hyperlink to original publication 
http://pubs.rsc.org/en/content/articlelanding/2013/cc/c3cc44454f#!divAbstract 
 
5.1 Overview 
 An artificial RNA ligase specific to RNA with a 5′-triphosphate (PPP-RNA) 
exhibits broad sequence specificity on model substrates and secondary siRNAs with 
direct applications in the identification of PPP-RNAs through sequencing. 
 
5.2 Introduction 
 The development of novel enzymes to manipulate nucleic acids has been a driving 
force in pioneering methods for molecular biology, genomics and transcriptomics. One 
such type of enzymes are ligases, which join together two strands of nucleic acids by 
forming a phosphodiester bond with a 3′-5′ linkage. Many known natural ligases couple 
the phosphodiester bond formation with ATP hydrolysis through a series of group 
transfers. [1, 2] Ligases have been used extensively in the analysis of large mixtures of 
RNA to add adapters of known sequence to the RNAs [3, 4], thus enabling reverse 
transcription, PCR amplification and ultimately their identification by microarray 
analysis or sequencing. [5] As all known natural ligase enzymes require a 5′-
monophosphate terminus (P-RNA) for the ligation reaction to occur, RNA mixtures are 
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typically enzymatically modified to uniformly introduce the 5′-monophosphate in 
preparation for ligation and sequencing. This can prove problematic for interpreting 
subsequent RNA sequencing data as classes of RNA characterized by a different 5′-
phosphorylation can no longer be easily distinguished in sequencing data. Identifying 
primary transcripts, also called immature RNA, can be particularly difficult because they 
have a 5′-triphosphate (PPP-RNA) and cannot be selectively purified from other classes 
of RNAs. While the triphosphate of eukaryotic mRNA is eventually capped, other classes 
of RNA retain the 5′-triphosphate as one of their only identifying features. This includes 
prokaryote mRNA, some viral mRNAs in eukaryotes, [6] transcripts from mitochondria 
[7] and chloroplasts, [8] and secondary siRNAs. [9, 10] To identify these RNAs from cell 
isolates, methods exist which enrich for PPP-RNAs prior to sequencing, but they 
commonly identify false positives and require laborious independent verification with a 
complementary method. [11] Therefore, an alternative, simplified method for identifying 
PPP-RNAs with improved accuracy would be highly desirable.  
 The splinted, 5′-triphosphate-dependent ligation of two RNA strands has 
repeatedly been used as a model reaction to generate novel catalysts. Both artificial 
ribozymes [12-14] and deoxyribozymes [15, 16] have been generated that catalyze this 
reaction. However, these catalytic nucleic acids often have strict sequence requirements 
near the ligation site, limiting the choice of PPP-RNA sequences that can be ligated. 
Furthermore, these nucleic acid enzymes act as both catalyst and complementary splint, 
which requires a new catalyst to be designed and synthesized specifically for each new 
substrate sequence. Previously, we reported the de novo selection and evolution of 
triphosphate dependent artificial RNA ligases. [17, 18] These protein enzymes ligate a 5′-
triphosphate RNA substrate to the 3′-hydroxyl of a second RNA exclusively forming a 3′-
5′ linkage while both substrates are aligned by a complementary oligonucleotide splint 
(Figure 5.1). The artificial ligases are zinc-dependent metalloproteins of ~10 kDa and 
were derived from the two zinc finger protein hRXRα. [17] We solved the structure of 
RNA ligase 10C, a highly active variant, revealing a novel protein fold with highly 
unusual structural features. [19]  
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Figure 5.1 - Artificial RNA ligase catalyzing the formation of a 3′-5′-phosphodiester bond between a 
5′-triphosphate RNA (red) and 3′-hydroxyl RNA (blue) substrate. The proposed mechanism of the 
reaction is shown. A complementary splint DNA oligonucleotide (black) anneals to the RNA and is 
necessary for ligation. 
 To determine if this enzyme could be used for the general identification of PPP-
RNAs, we investigated the sequence specificity of ligase 10C. This artificial enzyme had 
been generated to ligate a single substrate pair, but had never been challenged to evolve 
an ability to ligate alternative RNA sequences. To determine the sequence specificity of 
10C, we varied the nucleotides adjacent to the ligation site. We also tested a substrate 
pair of entirely unrelated sequence to assess the impact of large scale changes in 
sequence. Finally, to extend 10C for practical applications, we investigated whether this 
ligase can perform selective ligation in a mixture of secondary siRNAs. These 
experiments demonstrate RNA ligase 10C exhibits broad sequence specificity and 
therefore should be a valuable tool for the whole-cell isolation and identification of PPP-
RNA. 
 
5.3 Results 
 RNA ligase 10C was assayed for the ligation of chemically synthesized RNA 
oligonucleotides to PPP-RNA substrates synthesized and 
32
P-labeled by in vitro 
transcription. Assay conditions were chosen to mimic conditions used in commercial 
RNA isolation and sequencing kits. [20, 21] Under these conditions, 10C was able to 
ligate the original substrates used during its evolution as well as an unrelated sequence, 
even though the nucleotides flanking the ligation site were completely different (Figure 
5.2). Ligation rates were similar for these two substrates with the kobs of 0.45 ± 0.01 h
-1
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for the original substrates and 0.24 ± 0.01 h
-1
 for the substrate pair with unrelated 
sequence. We expanded upon these experiments by testing different nucleotides at the 3′-
hydroxyl and 5′-triphosphate sides of the ligation site independently (Table S5.1). As we 
were limited to the transcription by T7 RNA polymerase, we only created PPP-RNA 
substrates beginning with a G or A. [22] For all substrates tested, the kobs were similar 
within a 10-fold range (Figure S5.1). By comparison, the most commonly used natural 
enzyme T4 DNA ligase has been shown to have an approximately 3-fold difference in kcat 
in the ligation of nicked DNA depending on the sequence surrounding the ligation site. 
[23] If the ligation using 10C is allowed to proceed overnight as is commonly done with 
commercial ligases, the differences in yield for different substrates are reduced to < 3-
fold. Although the ligase 10C was originally selected to ligate only one specific pair of 
substrate sequences, the enzyme does not require any specific nucleotide sequence near 
the ligation site.  
Figure 5.2 - Ligation of two pairs of RNA substrates by artificial ligase 10C. The arrow represents the 
site of ligation. The data were fit to first-order kinetics Y = Yf (1-e
-kt
) where Yf = final yield and k = kobs. 
The solid lines show the progress of the reaction with the substrates that were originally used to generate 
ligase 10C (5′ CUAACGUUCGC↓GGAGACUCUUU). Dashed lines indicate the ligation of a second 
substrate pair of unrelated sequence (5′ GCAUGUCAGCA↓AGGCCUAUCAA) that has the same GC 
content. Data are the mean of 3 replicates ± SD.  
 
 The ligation rate of ligase 10C is comparable to previously reported 
deoxyribozymes [15] which catalyze the same reaction under similar reaction conditions, 
but is lower than the typical rate observed for natural ligase protein enzymes. [24] 
Nevertheless, the current activity of 10C is sufficient for immediate applications, and 
Chapter 5 
 125 
engineering efforts to improve the catalytic efficiency of 10C are underway. In contrast to 
previously generated nucleic acid enzymes, [12-15] ligase 10C can ligate all different 
RNA sequences without the need to tailor-make a modified catalyst for each substrate 
because the complementary splint is not part of, or attached to, the catalyst.  
 To directly demonstrate the utility of 10C, we tested the ligase with two 
secondary short interfering RNAs (siRNAs). siRNAs are involved in the regulation of 
gene expression through the RNAi pathway. Secondary siRNAs are a unique class of 
siRNA that were identified in C. elegans and have a 5′-triphosphate as they are 
synthesized by an RNA-dependent RNA polymerase to amplify the RNAi response. [9, 
10, 25] We chose two previously published siRNAs (S2, S3 in Figure 5.3a) [9] which we 
transcribed with T7 polymerase. Those siRNAs lack secondary structure that could 
interfere in base pairing to the complementary DNA splint. We also included the original 
PPP-RNA substrate (S1) used to evolve ligase 10C as it shares a similar 5′-sequence with 
the secondary siRNAs. As expected, ligase 10C was capable of ligating 5′-
triphosphorylated versions of all three substrates to an adapter sequence 8 nucleotides in 
length. While the 8 nt adapter was chosen to facilitate separation of RNAs in the gel, 
longer adapters of constant sequence can be used to enable subsequent RNA sequencing. 
Substrates of the same sequence but with a 5′-monophosphate instead of the 5′-
triphosphate were not ligated (Figure 5.3b).  
 We then combined the three 5′-triphosphorylated substrates in a single reaction 
and tested if individual splints could specifically promote the ligation of their 
complementary substrates in a mixture of similar sequences. No cross-reactivity between 
splints was detected, despite sequence identity of the substrates in three of the four 
nucleotides adjacent to the ligation site (Figure 5.3b). The discrimination between 
substrates with a complementary splint and those with imperfect complementarity is 
>100-fold, using the limit of detection of the assay as a conservative estimate. Calculated 
melting temperatures (Tm) of the splint/substrate combinations indicate that only the 
matching sequence pairs will hybridize at the temperature and ionic strength of the 
ligation mixture (Table S5.2). By using splints with relatively short overhangs (e.g. 8 
base pairs), the hybridization stringency increases dramatically as even single 
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mismatches can reduce the Tm by more than 10 °C. Therefore, the ligation of sequencing 
adapters to biologically relevant RNAs by ligase 10C can be controlled through the use of 
a splint which specifically base pairs to the desired PPP-RNA substrate.  
 
Figure 5.3 - Application of the artificial RNA ligase enzyme to selectively ligate secondary siRNA. (a) 
Alignment of the original ligation substrate (S1) and secondary siRNA substrates (S2) and (S3). Sequence 
similarities are highlighted in yellow. For each of the three substrates, a matching complementary splint 
oligodeoxynucleotide (black) was used to ligate them to a 3′-hydroxy-substrate “adapter”. The adapter is 
identical in all three cases (blue). The first eight nucleotides of each substrate base-pair to its respective 
splint and are capitalized. (b) Denaturing PAGE gel depicting ligation experiments with substrates S1 to S3 
to form products P1 to P3, demonstrating the necessity of a triphosphate (PPP) at the 5′-terminus (lanes 3, 
7, 11). No ligation is observed for substrates with a 5′-monophosphate (P) (lanes 2, 6, 10). Lanes 4, 8 and 
12 show the selective ligation of a single substrate in a mixture of substrates with highly similar sequences, 
which is dependent on the presence of the correct complementary splint. The substrate bands are marked by 
empty triangles and the product bands by filled triangles. 
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5.4 Discussion 
 The artificial RNA ligase enzyme 10C has a potential application in the 
sequencing of PPP-RNAs (Figure S5.2). Deep RNA sequencing (RNA-seq) is replacing 
traditional microarray technology for large scale RNA analysis in part because of its 
increased dynamic range and lower detection limit. RNA-seq has been used to 
characterize specific RNA subpopulations, including those which are of low cellular 
abundance. [5] One of the primary challenges in the analysis of specific RNA classes is 
the minimization of false positive results due to sample contamination with other classes 
of RNA or cleavage products. [5] For PPP-RNAs, ligase 10C offers a simple and direct 
route for the ligation of adapters without false positives as the triphosphate provides the 
energy needed to drive bond formation. We envision that, in addition to sequencing 
specific sequences, total PPP-RNA could be analyzed by using oligonucleotide splints 
with a short degenerate sequence overhang. This would allow for ligation of any RNA 
sequence and has been used previously for RNA-seq in a similar fashion. [20]  
  
5.5 Conclusions 
 In summary, these results highlight the value of the artificial RNA ligase 10C for 
the direct isolation and identification of virtually any PPP-RNA. Efforts are underway to 
utilize ligase 10C in RNA sequencing efforts to evaluate the efficacy of 10C to identify a 
broad range of PPP-RNAs from biological samples. Finally, this exemplary application 
of the artificial RNA ligase highlights the potential of in vitro selection and evolution 
methods for the creation of useful artificial biocatalysts. [26, 27] 
 
5.6 Materials and Methods 
 All chemicals were purchased from Sigma-Aldrich unless otherwise stated. 
 
5.6.1 Expression & Purification of RNA Ligase 10C:  
 RNA Ligase 10C was expressed and purified as previously published. [19]  
 
5.6.2 Preparation of Oligonucleotides:  
Chapter 5 
 128 
 The α-32P-labeled PPP-RNA substrates were prepared by in vitro transcription 
using T7 RNA polymerase as previously published. [19] The inactive α-32P-labeled P-
RNA substrates were prepared by treating PPP-RNA with 5′ RNA Polyphosphatase from 
Epicentre followed by phenol/chloroform extraction or PAGE gel purification to remove 
the Polyphosphatase. The RNA-OH substrates were purchased from Dharmacon and 
prepared according to the manufacturer’s protocol. DNA splints were purchased from 
Integrated DNA Technologies. All oligonucleotides were dissolved in ultra-pure water 
and concentrations determined by UV absorbance. 
 
5.6.3 Ligation Assay:   
 1 μM PPP-RNA, 3 μM RNA-OH and 6 μM DNA splint (Table S5.1) were 
combined in a buffer containing 20 mM HEPES pH 7.5, 100 mM NaCl, 100 μM ZnCl2. 
The oligonucleotides were annealed by heating the solution to 60 °C for 3 minutes and 
allowing it to cool at room temperature for 10 min. A stock of 50 μM RNA Ligase 10C in 
buffer containing 20 mM HEPES pH 7.5, 150 mM NaCl, 100 μM ZnCl2 and 0.5 mM β-
mercaptoethanol was added to the oligonucleotide mix to a final concentration of 10 μM 
enzyme. The ligation reactions were incubated at room temperature for the indicated 
times, and quenched with two volumes of 20 mM EDTA in 8 M urea, heated to 95 °C for 
4 min and separated by 20% denaturing PAGE gel. The gel was analyzed using GE 
Healthcare Phosphorimager and ImageQuant software (Amersham Bioscience). 
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5.7 Supporting Information 
 
 
Figure S5.1 - Probing the sequence specificity of RNA ligase 10C with various substrate 
combinations. The PPP-RNA substrates and the RNA-OH substrates are shown in red and blue, 
respectively. The data are the mean of 3 replicates ± SD and were fit to first-order kinetics Y=Yf(1-e
-kt
) with 
Yf=final yield and k=kobs. The arrow represents the site of ligation and the complementary splint required 
for the reaction is omitted for clarity. (a) Single nucleotide changes next to the ligation site. The C↓G 
substrates are the original two sequences that were used in the selection and evolution of RNA ligase 10C. 
Rates of ligation (kobs) ranged from 0.12 ± 0.01 h
-1
 for U↓G to 0.85 ±0.05 h-1 for A↓G. While not all 
theoretically possible substrate nucleotide combinations were tested, the combination U↓A is likely to have 
the lowest reaction rate. This rate can be estimated by multiplying the kobs (U↓G) by the fraction of kobs 
(C↓A) / kobs (C↓G) which yields an approximate value of 0.085 h
-1
, assuming that the reaction rate 
contributions from nucleotides on both sides of the ligation site are independent. (b) Change of whole 
sequence of ligation substrates. Progress of ligation is shown for combinations of the original substrate 
sequences used during the selection and evolution of ligase 10C (solid gray line) and substrate sequences 
that are completely unrelated, but have the same length and GC content (dashed lines). For detailed 
sequence information see Table S5.1. 
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Figure S5.2 - General method for the modification of RNA samples necessary for next generation 
sequencing. RNA is typically not sequenced directly, but first converted to DNA through reverse 
transcription. Adapters add the needed terminal constant regions that facilitate the annealing of primers and 
reveal the orientation of the original RNA sequence. The artificial RNA ligase enzyme can be used during 
the “Ligate adapters” step to ligate the adapter to those “Isolated RNA” molecules that have a 5′-
triphosphate group utilizing degenerate splints (dashed box). Ligase 10C can also ligate the second adapter 
to the 3′-terminus of the “Isolated RNA” if an adapter with a 5′-triphosphate is used.  
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Table S5.1 - Oligonucleotide substrate combinations used in the sequence specificity and application 
experiments. 
Substrate combinations RNA-OH PPP-RNA 
[a]
 DNA Splint 
Variation at ligation site 
[b]
     
     [c]
 5′–CUAACGUUCGC 5′–GGAGACUCUUU 5′–GAGTCTCCGCGAACGT 
 5′–CUAACGUUCGC 5′–AGAGACUCUUU 5′–GAGTCTCTGCGAACGT 
 
5′–CUAACGUUCGA 5′–GGAGACUCUUU 5′–GAGTCTCCTCGAACGT 
 5′–CUAACGUUCGG 5′–GGAGACUCUUU 5′–GAGTCTCCCCGAACGT 
 5′–CUAACGUUCGU 5′–GGAGACUCUUU 5′–GAGTCTCCACGAACGT 
Variation of whole sequence     
        c
 5′–CUAACGUUCGC 5′–GGAGACUCUUU 5′–GAGTCTCCGCGAACGT 
 5′–GCAUGUCAGCA 5′–AGGCCUAUCAA 5′-ATAGGCCTTGCTGACA 
 5′–CUAACGUUCGC 5′–AGGCCUAUCAA 5′–ATAGGCCTGCGAACGT 
 5′–GCAUGUCAGCA 5′–GGAGACUCUUU 5′–GAGTCTCCTGCTGACA 
Secondary siRNA    
         
5′-ACGUUCGA 5′–GGAGACUCUUU 5′-GAGTCTCCTCGAACGT 
       
5′-ACGUUCGA 
5′-
GCAGAAACUGGAACC
CAGGU 
5′-GTTTCTGCTCGAACGT 
       
5′-ACGUUCGA 
5′-
GGAACCCAGGUGUUG
GUCUUUG 
5′-TGGGTTCCTCGAACGT 
 
 [a] All oligonucleotides in this column carry a 5′-terminal triphosphate, which is not shown here to 
simplify the table.  
[b] Nucleotides that were varied are underlined and shown in bold.  
[c] This combination of substrate sequences is identical to the original substrates used in the selection and 
evolution of the RNA ligase enzymes. 
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Table S5.2 - Melting temperatures (Tm) calculated for the hybridization of each PPP-RNA substrate 
with each of the three different splints used in the application experiment. The Tm values for fully 
complementary PPP-RNA/splint combinations are close to room temperature or above (shown in bold). All 
combinations that would result in mismatches yielded calculated Tm values that were substantially below 
room temperature (shown in parentheses and italics). In practical terms, this means that the fully 
complementary combinations are stable under the reaction conditions used in the application experiment, 
whereas the mismatched combinations are unlikely to hybridize. 
PPP-RNA Tm (by Pasteur 
[a]
) Tm (by Stratagene 
[b]
) 
 Splint-1 Splint-2 Splint-3 Splint-1 Splint-2 Splint-3 
Original (S1) 30.1 °C - - 22.8 °C (-19.9 °C) (-27.3 °C) 
siRNA (S2) - 18.3 °C - (-14.8 °C) 17.6 °C (-63.0 °C) 
siRNA (S3) - - 30.2 °C (-27.3 °C) (-57.4 °C) 22.8 °C 
[a] Tm values were calculated using the Melting 4.1f calculator hosted by Mobyle@Pasteur 
(http://mobyle.pasteur.fr/cgi-bin/portal.py?#forms::melting) with adjustments made for the RNA/DNA 
duplex, [Na+] and [oligonucleotide].  
[b]Tm values were calculated using Stratagene’s QuikChange® Primer Design Program (Tm = 81.5 + 
0.41(%GC) - (675/N) - % mismatch, where N = total number of bases. 
https://www.genomics.agilent.com/CollectionSubpage.aspx?PageType=Tool&SubPageType=ToolQCPD&
PageID=15) Note that this calculator assumes a DNA/DNA duplex. The calculator was used because no 
suitable RNA/DNA calculator was available that considers mismatches. While the real Tm values for 
RNA/DNA duplexes are higher than those calculated for the respective DNA/DNA duplexes, the general 
trend between different sequences is expected to be similar. 
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Chapter 6:  
Development of the application of artificial ligase 10C for the next 
generation sequencing of 5'-triphosphate RNA  
 
 The following is a collection of unpublished experiments to develop the 
application of the artificial RNA ligase for the sequencing of PPP-RNAs from a complex 
mixture. I performed all experiments unless otherwise stated. 
 
6.1 Overview 
 In the previous chapters we described an RNA ligase that was specific for RNA 
substrates with a 5ꞌ-triphosphate (PPP-RNA). The enzyme was made through in vitro 
evolution and catalyzes the splinted ligation of RNA with a 5ꞌ-triphosphate to a second 
RNA forming a native 5ꞌ-3ꞌ linkage and releasing pyrophosphate. In this chapter, we 
describe the use of this ligase for the profiling of PPP-RNA though RNA sequencing. 
Using degenerate splints, our ligase adds constant adaptor sequences to both termini of 
PPP-RNA allowing them to be reverse transcribed and PCR amplified. We optimized the 
ligation conditions to increase yields as well as identified numerous inhibitors to avoid. 
Finally we have adapted our protocol to be compatible with the Illumina TruSeq
TM
 
platform for RNA sequencing.  
 
6.2 Introduction 
 Unprimed RNA synthesis produces RNA with a 5ꞌ-triphosphate (PPP-RNA). 
While the 5ꞌ end can be cleaved during the maturation of ribosomal RNAs or capped in 
the case of eukaryotic mRNA, several types of RNA maintain the 5ꞌ-triphosphate as their 
key distinguishing feature. Notable examples of PPP-RNA include mRNA in 
prokaryotes, secondary siRNAs in C. elegans, [1, 2] mRNA synthesized in the 
mitochondria [3] or chloroplast [4] and some viral mRNAs. [5] Currently, research on 
PPP-RNAs is hampered as these RNAs cannot be selectively purified from the RNA 
mixture and the distinguishing triphosphate is not visible after sequencing. In order to 
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identify PPP-RNAs a few protocols have been developed to enrich PPP-RNA within a 
sequencing sample, but all of these methods are susceptible to the identification of false 
positives. [6] 
 Current protocols to sequence and identify PPP-RNA rely on a specific 
phosphatase such as Tobacco Acid Phosphatase [7] or RNA 5ꞌ polyphosphatase that 
converts triphosphate to monophosphate. [6] The 5ꞌ-tagRACE method utilizes two 
separate adapters, the first acts as a decoy while the second one is used for sequencing. 
First, the short decoy adapter is ligated to all RNA in the sample with a 5ꞌ-
monophosphate (P-RNA) removing them from the pool. Subsequently, the RNA sample 
is treated with a phosphatase to convert the 5ꞌ-triphosphate to a monophosphate followed 
by ligation of the sequencing adaptor. [7] An alternative RACE method utilizes 
Terminator 5ꞌ-phosphate-dependent exonuclease to degrade all 5’-monophosphate RNA 
prior to the phosphatase treatment. [6] Both protocols ultimately rely on a standard RNA 
ligase, which can only act on P-RNA substrates, to join the sequencing adaptors to the 
originally 5’-triphosphorylated RNA after first eliminating all endogenous P-RNAs from 
the sample. While these protocols certainly enrich PPP-RNAs in the sample, some P-
RNA sequences will inevitably pass through the procedure resulting in false positive 
results. 
 Our lab has developed artificial RNA ligases that are dependent on a 5ꞌ-
triphosphate for activity. [8] One particular variant called “Ligase 10C” was shown to 
have broad sequence specificity and has potential for the large scale identification of 
PPP-RNAs from complex mixtures. [9] Unlike natural ligases which use a cofactor such 
as ATP, 10C uses the chemical energy of the triphosphate with pyrophosphate as the 
leaving group to join two strands of RNA together in a mechanism that closely resembles 
an RNA polymerase. [10] Because of this energetic requirement, ligation of sequencing 
adaptors by ligase 10C should be highly selective for PPP-RNA over P-RNA. In this 
chapter, we describe our efforts to adapt RNA ligase 10C for the sequencing of isolated 
PPP-RNAs. We propose a process with a single ligation step where ligase 10C adds 
sequencing adaptors to both ends of PPP-RNA prior to reverse transcription and PCR 
amplification (Figure 6.1). While the exact adaptors used can easily be varied based on 
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the application or sequencing platform, we chose to base our adaptors on the Illumina 
TruSeq
TM
 platform for RNA identification as it is the most prominent platforms used in 
RNA biology today. Our first step was to optimize the ligation conditions and to identify 
compounds that might be present in the RNA sample that could inhibit the ligation. We 
also sought to measure and if necessary, reduce the RNase activity of the ligase 
preparation to improve the detection sensitivity especially for low abundance RNAs. 
Finally, we applied our sequencing protocol to an idealized substrate to verify the 
efficacy of the process.  We are currently collaborating with several research groups that 
are interested in different classes of PPP-RNA to test our kit with original RNA samples 
isolated from cells. 
 
Figure 6.1 General scheme for the addition of sequencing adaptors specifically to of PPP-RNA using 
the artificial RNA ligase 10C. Ligase 10C ligates both adaptors in a single step although the 3ꞌ adaptor 
could be added by other means. 
 
6.3 Results 
 To optimize ligation yields, we varied ligation conditions one variable at a time to 
determine the range of conditions where ligase 10C had >90% of maximum activity 
(Table 6.1). Ligase 10C is a 10 kDa metalloprotein that binds two zinc ions. [10] The 
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enzyme is dependent on zinc for structure and activity so zinc needs to be supplemented 
in the reaction buffer. When measured, ligase 10C has an apparent optimal concentration 
of 250 μM ZnCl2 which was significantly different from the optimum of a related enzyme 
(ligase #4, 100 μM ZnCl2) characterized in a previous publication. [10] However, when 
we initially determined the zinc concentration for maximal ligation activity of ligase 10C, 
we did so in the presence of 2 mM β-mercaptoethanol (βME) compared to ~0.2 mM used 
with ligase #4. βME is a reducing agent commonly used in protein biochemistry to 
maintain cysteines in their reduced state and had been included in the storage buffer of 
ligase 10C to improve the stability of the zinc-binding enzyme. But we found that the 
reducing agent was competing with ligase 10C for binding of zinc. When βME 
concentrations were reduced 20-fold, the zinc concentration for maximal activity was 
found to be approximately 120 μM (Figure S6.1). [8] 
 
Table 6.1 - Optimum ligation conditions 
Variable > 90% activity Optimum
[a]
 
pH 6.8-7.6 7.3 
[NaCl] 80-150 mM 120 mM 
[ZnCl2] 90-230 μM 143 ± 4.4 μM 
βME[b] < 100 μM - 
[a]  pH value is the average of two experiments, [NaCl] is a single experiment and [ZnCl2] is the average of 
three experiments 
[b] βME or β-mercaptoethanol was initially considered a vital component of the storage buffer but further 
investigation revealed it acted as an inhibitor 
 
 As part of the optimization process, we also screened and identified inhibitors of 
ligase 10C (Table 6.2). Several inhibitors we identified act by competing with ligase 10C 
for zinc binding such as EDTA, Bis-Tris buffer and the reducing agents (βME, DTT & 
TCEP). While reducing agents and Bis-Tris buffer are not typically thought of as 
chelators of divalent cations, their ability to bind some metals has been previously 
reported. [11, 12] Ligase 10C also appears to be inhibited by magnesium (IC50 = 1 mM) 
which is noteworthy because natural enzymes that catalyze similar reactions are 
dependent on magnesium for activity. Ligase 10C is also inhibited by pyrophosphate, 
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which is one of the products of the ligation reaction. While pyrophosphate also has the 
potential to inhibit 10C by competing with the enzyme for zinc binding, its primary mode 
of inhibition is likely through a direct interaction with the enzyme itself. There are two 
lines of evidence that support this conclusion. First, the IC50 value is substantially lower 
than the IC50 of EDTA, although zinc has a higher affinity for EDTA (Kd = 10
-16
) than for 
pyrophosphate (Ksp = 10
-8
). Second, when the zinc concentration was increased by ~4-
fold in the ligation mixture, the IC50 value for pyrophosphate was essentially unchanged 
(Figure S6.2). Theoretically this implies that ligation yields might be increased by the 
addition of a pyrophosphatase to breakdown pyrophosphate, but in practice the final 
concentration of pyrophosphate is typically less than the IC50 value. One unexpected 
inhibitor identified in our experiments was glycogen which is a commonly used as a co-
precipitant for nucleic acids to minimize losses during ethanol precipitation. While the 
mechanism of this inhibition is unclear, omitting glycogen from precipitations is a simple 
precaution and RNA recoveries for this application without glycogen are regularly > 90% 
showing that it is unnecessary in sample preparation. 
 
Table 6.2 - Summary of known inhibitors of ligase 10C 
Compound IC50
[a]
 Proposed 
mechanism
[b]
 
Pyrophosphate 10 μM product inhibition  
βME 2 mM zinc binding  
DTT < 5 mM zinc binding 
TCEP 2 mM zinc binding 
Glycogen 10 μg/mL n.d. 
Bis-Tris Buffer < 10 mM zinc binding 
Mg
2+
 1 mM n.d. 
EDTA 50 μM zinc binding 
SUPERase In
TM[c]
 100 U/mL n.d. 
[a] IC50 is the concentration of a compound which inhibits the activity of the enzyme by 50%. 
[b] Proposed mechanism by which the compound might inhibit the enzyme. 
[c] Only one concentration of SUPERase In™ was tested which happened to inhibit the enzyme by 50%. 
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 In all ligation experiments no significant substrate or product degradation was 
observed with ligase 10C purified as previously described. [9-10] However, in these 
experiments we used a relatively high concentration of RNA (low micromolar) and short 
substrates (less than 25 nt). These parameters are different from a typical RNA sample 
that was isolated from a cell and used for RNA sequencing. Therefore, we needed to 
assess the RNase susceptibility under more realistic conditions.  To better assess RNase 
activity we incubated samples of ligase 10C with nanomolar concentrations of a long 
(802 nt) RNA substrate. Under these conditions we could now clearly detect RNase 
activity in our ligase samples. To reduce the RNase activity, we first supplemented the 
mixture with the RNase inhibitor SUPERase In. However, even with SUPERase In 
present, substantial amounts of RNase activity was observed. Moreover while the 
concentration of SUPERase In wasn’t sufficient to inhibit RNase activity, it decreased 
ligase activity by 50%. (Data not shown) Other commercial RNase inhibitors such as 
RNaseOUT and RNAsin were briefly considered, but they are both dependent on DTT, 
an identified inhibitor, and therefore cannot be used with ligase 10C. The solution instead 
came from an additional, orthogonal round of purification. Originally, the ligase protein 
was purified by Ni-NTA and size exclusion chromatography. Adding a third ion 
exchange purification reduced the RNase activity dramatically. (Figure 6.2) 
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Figure 6.2 - Reducing RNase activity of the ligase 10C preparation by removing RNase 
contaminations in a 3 step purification process. A 
32
P labeled RNA substrate was incubated with 
samples of ligase 10C for the times indicated and analyzed by PAGE to visualize RNase activity. Using the 
2 step purification protocol, the RNA was completely degraded after 18 hours.  Using the 3 step protocol 
there is no detectable amounts of degradation after 18 hours. 
 
 In our proposed scheme for sequencing PPP-RNA (Figure 6.1), the first step after 
the isolation of RNA is to ligate sequencing adaptors to each end of the sample RNA 
using ligase 10C. The 5ꞌ adaptor is a chemically synthesized RNA oligo while the 3ꞌ 
adaptor was made using in vitro transcription so that it would contain a 5ꞌ-triphosphate. 
Both adaptors ligate with similar efficiencies to 21 nt PPP-RNA model substrate both 
individually and in combination (Figure 6.3). The 21 nt substrate was chosen to mimic 
the size of fragmented mRNA from bacteria and secondary siRNAs from C. elegans 
which are two proposed applications for this method.  
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Figure 6.3 - Ligation of sequencing adaptors to a 21 nt model substrate. Urea PAGE of the 
32
P labeled 
PPP-RNA substrate incubated with ligase 10C in the presence and absence of the sequencing adaptors and 
their corresponding complementary splints. Without any adaptors or splints present, the PPP-RNA will 
undergo a small amount of self-ligation. In the presence of adaptors and complementary splints, the desired 
product dominates. Ligation of the 3ꞌ adaptor to the 21 nt substrate consistently produces a double band on 
the gel for an unknown reason. Fully ligated product is observed only in the presence of both adaptors. 
 
 To demonstrate that only PPP-RNA can be amplified during PCR after ligation, 
we tested the protocol with an equivalent P-RNA substrate to ensure it couldn’t be 
amplified (Figure 6.4). The PPP-RNA sample with all necessary adapters, splints and 
ligase yields the expected single band at approximately 140 bp. This band was excised 
from the gel and sequenced which confirmed that it contained the 21 nt PPP-RNA 
substrate ligated to the sequencing adapters. For the 5’-monophosphate substrate RNA 
(absence of a 5ꞌ-triphosphate), no fully ligated band was detected after the PCR although 
there are other lower bands present in the sample. If the total number of cycles is reduced 
from 25 to 10 as would be done in the sequencing experiment, only the fully ligated PPP-
RNA and not the P-RNA sample produces any bands (data not shown). To investigate the 
identity of these additional bands, several ligation components were omitted one at a time 
in the case of the P-RNA substrate, while the 3ꞌ adaptor and splint were present in all 
lanes. A band at approximately 120 bp appears to be ligated adaptor dimer as it forms 
only when the 5ꞌ adaptor and ligase are present. The adaptor dimer band is also more 
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intense when the 5’ splint is omitted as expected. The lower band correlates with the 
addition of the 5ꞌ splint and forms both in the presence and absence of ligase which 
implies it is not a ligated product. In summary, these data show that ligase 10C 
selectively ligates sequencing adapters to PPP-RNA. 
 
 
Figure 6.4 - PCR amplification after the adaptor ligation procedure performed on PPP-RNA vs. P-
RNA substrates. Ligations were performed as indicated above with the 3ꞌ adaptor and splint present in all 
cases prior to reverse transcription, 25 cycles of PCR amplification and analysis by agarose gel. Fully 
ligated product was only observed with the PPP-RNA substrate as expected. In the absence of PPP-RNA, 
additional minor bands were observed that correspond to a ligated adaptor dimer as well as an unknown 
band associated with the 5ꞌ splint. 
 
 In order to test or artificial ligase 10C for sequencing applications with actual 
RNA samples isolated from different kinds of cells, we initiated several collaborations 
with RNA biologists that are interested in different classes of PPP-RNA. 
 
6.4 Discussion 
 While we present a single method for the sequencing of RNA with ligase 10C, 
this is not the only available path for sequencing PPP-RNA with ligase 10C. In particular, 
only the 5ꞌ adaptor needs to be ligated by 10C for the method to work. The 3ꞌ adaptor can 
be introduced by 10C as shown here or by any other means desired. For example, the 3ꞌ 
adaptor could be added through a separate ligation step or it could be introduced through 
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a reverse transcription primer, avoiding the second ligation step entirely. Our experiments 
showed that a byproduct of our current scheme is the potential formation of adaptor 
dimers during the ligation step albeit at a low rate. This could be eliminated entirely 
through the alternate method if desired by the end user. Another alternate method for 
conducting this sequencing protocol would be to use a modified 5ꞌ adaptor labeled with 
biotin or click chemistry linkers to remove non-ligated RNAs from the sample mixture 
prior to reverse transcription and PCR. While the non-ligated RNAs should be eliminated 
through a lack of enrichment during the PCR step, this step could be made even more 
stringent through the additional purification. 
 Currently, ligase 10C is dependent on a complementary splint to ligate two RNA 
strands. This can provide remarkable selectivity for isolating a single desired sequence 
out of a mixture, but it can be difficult to ligate RNA which forms stable secondary 
structures near the ligation site. Ligase 10C is a thermostable enzyme with a melting 
temperature of 72°C so presumably the ligation could be performed at high temperature 
to decrease or eliminate secondary structure, but it is not possible to perform such a 
ligation with the degenerate splints necessary to capture all PPP-RNAs in a sample. 
Therefore a non-splinted 5ꞌ-triphosphate dependent thermostable ligase could be very 
useful for improving coverage of sequences in the RNA pool that might otherwise be 
difficult to detect because it forms secondary structure at lower temperature. 
  
6.5 Conclusions 
 The research presented here demonstrates the capability of the artificial RNA 
ligase 10C to be used in the sequencing of PPP-RNA. Ligase 10C was well characterized 
to help avoid potential pitfalls in RNA sample preparation. While the ligase appeared to 
be incompatible with commercial RNase inhibitors, the triple-purified enzyme showed no 
RNase activity under realistic sequencing application conditions. RNA ligations for 
RNA-sequencing in commercial kits are also performed without RNase inhibitors as both 
the RNA sample and ligase are expected to be RNase free. If desired, ligase 10C can be 
readily inactivated through the addition of zinc chelators. Our collaborations have shown 
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that our kit can isolate PPP-RNAs isolated from cells, but further work is needed to 
increase the robustness of the protocol. 
  
6.6 Materials & Methods 
All chemicals were purchased from Sigma-Aldrich unless otherwise stated. 
 
6.6.1 Expression & Purification of RNA Ligase 10C 
 RNA ligase 10C was expressed and purified as previously published. [10] For the 
RNA degradation experiments the protocol was modified as follows. Ni-NTA and size 
exclusion (Superdex G75) purified protein samples were loaded onto a MonoQ 5/50 GL 
column (GE Healthcare) and analyzed on the AKTA FPLC system (GE Healthcare). 
Buffer A: 20 mM Tris-HCl pH 8, 250 μM β-mercaptoethanol (βME) and 50 μM ZnCl2, 
Buffer B: 20 mM Tris-HCl pH 8, 1 M NaCl, 250 μM βME and 50 μM ZnCl2. Ligase 10C 
was bound to the column in 100% buffer A, then eluted by a gradient of 0-30% buffer B 
over 10 column volumes. Elution fractions were pooled and dialyzed against 2 changes of 
2 L ligase storage buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 500 μM βME, 100 μM 
ZnCl2). 
 
6.6.2 Preparation of Oligonucleotides 
 The α-32P-labeled PPP-RNA substrates were prepared by in vitro transcription 
using T7 RNA polymerase as previously published. [10] Non radioactive PPP-RNA 
substrates and 3ꞌ RNA adaptors were prepared in the same way as the 32P-labeled 
counterparts but without the use of α-32P-UTP and with equal concentrations of non-
radioactive NTP in the transcription. Non radioactive P-RNA substrates and 5ꞌ RNA 
adaptors were purchased from Dharmacon and prepared according to the manufacturer’s 
protocol. DNA splints were purchased from Integrated DNA Technologies. All 
oligonucleotides were dissolved in ultra-pure water and concentrations determined by UV 
absorbance prior to use in the ligation assays. See Table S6.1 for the sequences of all 
oligonucleotides used. 
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6.6.3 Ligation Assay 
 For the optimization of ligation conditions and identification of inhibitors 10 μM 
PPP-RNA, 20 μM RNA-OH and 30 μM DNA splint were combined in a buffer 
containing 20 mM HEPES pH 7.5, 100 mM NaCl, 100 μM ZnCl2. A stock of 25 μM 
RNA ligase 10C in buffer containing 20 mM HEPES pH 7.5, 150 mM NaCl, 100 μM 
ZnCl2 and 0.5 mM βME was added to the oligonucleotide mix to a final concentration of 
5 μM enzyme and ligation proceeded at room temperature. Potential inhibitors were 
added prior to the addition of ligase at the indicated concentrations. 
 For the ligation of sequencing adaptors 500 nM PPP-RNA, 600 nM RNA 
adaptors and 1.2 μM DNA splints were combined in a buffer containing 20 mM HEPES 
pH 7.5, 100 mM NaCl, 100 μM ZnCl2. A stock of 50 μM RNA ligase 10C in buffer 
containing 20 mM HEPES pH 7.5, 150 mM NaCl, 100 μM ZnCl2 and 0.5 mM β-
mercaptoethanol was added to the oligonucleotide mix to a final concentration of 10 μM 
enzyme and the ligation proceeded at 16°C. 
 The ligation reactions were quenched with two volumes of 20 mM EDTA in 8 M 
urea, heated to 95 °C for 4 min and separated by 20% denaturing PAGE gel. The gel was 
analyzed using GE Healthcare Phosphorimager and ImageQuant software (Amersham 
Bioscience). 
 
6.6.4 Measurement of RNase activity 
 The α-32P-labeled 802 nt RNA substrate was prepared by in vitro transcription 
using T7 RNA polymerase as previously published. [10] To test for RNase activity in 
preparations of the ligase enzyme, 50 nM substrate was combined with 10 μM ligase 10C 
in RNA ligation buffer and incubated at room temperature until stopped by the addition 
two volumes of 20 mM EDTA in 8 M urea. Samples were heated to 95 °C for 4 min and 
separated by 20% denaturing PAGE gel. The gel was analyzed using GE Healthcare 
Phosphorimager and ImageQuant software (Amersham Bioscience). 
 Sequence of 802 nt RNA substrate: 
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5ꞌ - GGGACAAUUA CUAUUUACAA UUACAAUGGG CAGCGAUAAG AUCCACCAUC ACCAUCACCA  
UGUGAUUGUG CUGGGCCAUC GCGGUUACUC CGCCAAGUAU CUGGAAAACA CCCUGGAAGC  
UUUCAUGAAA GCGAUCGAAG CCGGCGCGAA UCGUGAGGAG CUGGAUGUGC GCCUGUCUAA  
AGACGGCAAG GUGGUCGUGA GCCAUGAUGA AGAUUUAAAG CGCCUGUUCG GUCUGGACGU  
CAAAAUCCGU GACGCCACCG UGUCUGAACU GAAAGAGCUG ACCGAUGGCA AAAUUACCAC  
CCUGAAGGAA GUGUUUGAGA ACGUGUCCGA UGACAAGAUC AUCAACAUCG AAAUCAAGGA  
ACGUGAGGCC GCGGACGCAG UGCUGGAGAU CAGCAAAAAG CGUAAGAACC UGAUUUUCAG  
CUCCUUUGAU CUGGACCUGC UGGAUGAAAA AUUCAAGGGU ACCAAAUACG GUUAUCUGAU  
CGACGAAGAG AACUACGGUU CCAUUGAAAA UUUCGUGGAG CGCGUGGAAA AGGAGCGUCC  
GUACUCUCUG CACGUGCCCU AUCAGGCCUU UGAGCUCGAA UAUGCGGUGG AGGUGCUGCG  
CUCCUUCCGU AAAAAGGGCA UCGUGAUUUU UGUGUGGACC CUGAAUGAUC CGGAAAUCUA  
CCGCAAAAUA CGUAGAGAGA UCGAUGGUGU GAUUACCGAC GAAGUGGAGC UGUUUGUGAA  
ACUGCGUGGC GGCAGCGGUG GCUCCGACUA UAAGGAUGAC GAUGACAAAA UGGGAAUGUC  
UGGAUCUGGC ACCGGCUAUU AA 
 
6.6.5 Reverse Transcription and PCR amplification of ligated PPP-RNA 
 Sequencing adaptors were ligated to PPP-RNA as described in section 6.6.3 in a 
10 μl reaction volume. Reaction was halted by adding 0.5 μl of 4 mM EDTA, 6 μl of 
reaction mixture were removed and mixed with 1 μl of 7 μM reverse transcription primer. 
The mixture was heated to 70°C for 2 min then placed on ice. Sample was reverse 
transcribed through the addition of 2 μl 5x 1st strand synthesis buffer (Invitrogen), 0.5 μl 
of 12.5 mM dNTP (NEB), 1 μl of 100 mM DTT (Invitrogen), 1 μl RNaseOUT 
(Invitrogen) and 1 μl Superscript II (Invitrogen) followed by incubating at 50°C for 1 
hour. PCR was conducted by adding 22.5 μl ultrapure water, 10 μl 5x phusion buffer 
(NEB), 2 μl of 12.5 μM primer (forward and reverse), 1 μl of 12.5 mM dNTP (NEB) and 
0.5 μl Phusion polymerase (NEB). The PCR program was as follows: the sample was 
heated to 98°C for 30 seconds, 5 to 30 cycles of 98°C for 10 seconds, 60°C for 30 
seconds and 72°C for 15 seconds, with a final extension step of 72°C for 2 min. 5 μl 
samples of the PCR mix were analyzed by 2% agarose gel containing ethidium bromide. 
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6.7 Supplementary Materials 
 
 
Figure S6.1 Dependence of ligation activity on zinc concentration at different concentrations of βME. 
Ligase 10C was originally stored in 10 mM βME which resulted in a final concentration of 2 mM in the 
ligation assay. At this concentration βME competes with the ligase for the binding of zinc as seen in the 
shifted zinc optimum compared to a low βME sample (0.1 mM). 
 
 
Figure S6.2 Inhibition of ligase 10C by pyrophosphate at different concentrations of zinc. The 
pyrophosphate inhibition curve was measured at 120 μM and 400 μM Zn2+ to determine if pyrophosphate 
was inhibiting ligase 10C through competition with zinc binding. When the curves are normalized to 
account for the reduced activity of ligase 10C at 400 μM zinc the 50% inhibition concentration remains the 
same.  
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Table S6.1 Oligonucleotides used in this chapter 
Name Sequence 
Substrates for 
optimization of 
ligation yields and 
inhibition screen 
PPP-RNA 5ꞌ - PPP-GGAGACUCUUU 
RNA-OH 5ꞌ - CUAACGUUCGA 
DNA Splint 5ꞌ - GAGTCTCCTCGAACGT 
Ligation of PPP-
RNA for 
sequencing 
21 nt PPP-RNA 5ꞌ - PPP-GGAGACTCTTCTAACGTTCGG 
5ꞌ Adaptor 5ꞌ - GUUCAGAGUUCUACAGUCCGACGAUC 
5ꞌ Adaptor splint 5ꞌ - GTCTCCGATCGTCGGACTGTAGAACTCTGAAC 
3ꞌ Adaptor 5ꞌ - GGAUGGAAUUCUCGGGUGCCAAGG 
3ꞌ Adaptor splint 5ꞌ - CCTTGGCACCCGAGAATTCCATCCCCGAAC 
Primers for 
sequencing 
RT primer 5ꞌ - GCCTTGGCACCCGAGAATTCCA 
PCR fwd. primer 
5ꞌ – AATGATACGGCGACCACCGAGATCTACACGTT 
CAGAGTTCTACAGTCCGA 
PCR rev. primer 
5ꞌ – CAAGCAGAAGACGGCATACGAGATCGTGATGT 
GACTGGAGTTCCTTGGCACCCGAGAATTCCA 
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Conclusions and Future Directions 
 
 Artificial enzymes hold the potential to solve innumerable challenges in the field 
of biotechnology. New enzymes can make chemical transformations specific, cheap and 
environmentally friendly with applications in drug synthesis and bulk synthesis of 
commodity chemicals. [1-3] New enzymes can also enable new forms of labeling of 
biomolecules with applications ranging from research to medicine.[1, 4-6] The ultimate 
goal of the field of artificial enzyme design is to develop a rapid reliable process to 
generate custom catalysts that are sufficiently active, selective and stable to be a viable 
commercial product. Generating such an enzyme de novo using a single approach may 
not be possible in the near future. In contrast, optimizing existing enzymes is now a well-
established procedure due to advances in directed evolution which have improved 
success rates and decreased costs. Therefore, artificial enzymes generated by rational 
design or de novo selection that may initially only exhibit low levels of activity could be 
evolved further with more standard directed evolution.  
 An important question for the de novo selection of artificial enzymes is how to 
best construct the most promising libraries of protein variants. Chapter 2 described the 
construction of a (β/α)8 barrel library that was enriched for folded proteins because 
folding is generally considered to be a prerequisite for enzyme activity. We also created a 
“control” library that was based on the same scaffold protein, but had not undergone any 
folding selection. Our results show clearly that the control library contains about 50 times 
fewer folded proteins, but as the control library took only a fraction of the time to 
develop it might still represent the better choice for developing protein libraries in the 
future. The folding-selected and control libraries should be used in parallel in multiple 
enzyme selections to compare the number of enzymes identified, their stability and level 
of activity. In addition to comparing these two (β/α)8 barrel libraries, it could also be 
useful to explore alternative library assembly strategies. To make the folding-enriched 
library we ultimately chose to subject the L1-4 sub-library (the first half of the barrel) to 
2 rounds of folding selection prior to recombining it with the other half. This was done 
because the first round of selection of L1-4 had a survival rate that was only about 2-fold 
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greater than background. We also considered performing a folding selection on the L1-2 
and L3-4 libraries first, recombining them, and then selecting the L1-4 library for folding, 
but the amount of additional work that would have been needed made us decide against 
constructing another library to test both approaches. Ultimately, we decided that selecting 
for folding of multiple loops together in a single experiment was more important as this 
examines the loops in the context of one another. However, it would be interesting to 
determine how such a change in the library construction protocol would affect overall 
stability and loop composition. 
 Ligase 10C is the most active and best characterized 5ꞌ-triphosphate-dependent 
RNA ligase we have isolated to date. The 3D-structure described in chapter 4 shows that 
ligase 10C adopts a highly dynamic fold that has not been found in nature. As ligase 10C 
has not been subjected to millions of years of Darwinian evolution, this unusual protein 
structure might serve as a model for primordial enzymes. The ligase is also several orders 
of magnitude slower than the average natural enzyme, [7] with a turnover of about one 
per hour. Evolving ligase 10C to have activity comparable to native enzymes represents 
an unprecedented opportunity to monitor the evolution from a very early state. In addition 
to studying the mechanisms of enzyme evolution, further evolution could help explain 
some features of the unusual protein fold. We demonstrated in chapter 3 that ligase 10C 
is a 10 kDa protein that exhibits impressive thermostability with a Tm of 72°C and has 
activity at 65°C. Thermostability and flexibility are not typically observed in a single 
protein structure so examining this further may add to our understanding of protein 
folding mechanisms. 
 A key validation of developing artificial enzymes is to demonstrate utility of the 
catalyst. The work described in chapters 5 and 6 confirmed that ligase 10C is an attractive 
enzyme for the detection and sequence analysis of RNA with a 5ꞌ-triphosphate. This 
interest largely stems from the broad sequence specificity exhibited by ligase 10C which 
should enable the linking of any RNA with a 5ꞌ-triphosphate. This property of ligase 10C 
was not explicitly selected for in our experiments as only a single set of selection 
substrates was used, but our overall selection strategy may have promoted this result. In 
our selection, both enzyme and substrate are physically linked providing a high local 
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concentration of both compounds. We hypothesized that displaying the substrate in this 
manner reduces the selective pressure to evolve high substrate binding which would 
correlate to reduced substrate specificity. Alternatively, the library we utilized may have 
only contained relatively primitive artificial ligases which were all incapable of specific 
substrate recognition. In either case, preserving this broad specificity will be an important 
goal in any future evolution experiments.  
 In the near future, two primary goals of the Seelig lab will be to continue to 
evolve ligase 10C for increased activity and begin enzyme selections with the (β/α)8 
barrel libraries. For the ligation protocols described in chapters 5 and 6, molar excess of 
ligase 10C was added to substrate to compensate for the low enzyme activity and reduce 
ligation time. We chose this route because we can easily produce ligase 10C in large 
amounts and it worked sufficiently well in our experiments with well defined substrates, 
but increased activity will be valuable for improving applications in RNA deep 
sequencing and other fields. In addition, the Seelig lab will also be using the (β/α)8 barrel 
libraries to select for alternative 5ꞌ-triphosphate-dependent RNA ligases. While it is 
reasonable to expect that ligase 10C can be further evolved and optimized, ligases from 
the (β/α)8 barrel library might be more structured and a better platform for rapid 
evolution. We also have plans to select for Diels-Alderase enzymes from the (β/α)8 barrel 
library which is a valuable reaction from classic organic synthesis. 
 There are many additional reactions which would be attractive targets for an 
enzyme selection. For example, the Friedel-Crafts reactions are a synthetically valuable 
family of reactions that removes a halogen from an organic molecule to create a reactive 
carbocation to form new carbon-carbon bonds. [8] These reactions are usually performed 
in anhydrous solvents to generate the carbocation intermediate, but an enzyme could 
potentially be used instead to form and protect the carbocation in an aqueous 
environment. Assuming such an enzyme could be developed with good regioselectivity, 
it could be very valuable alternative in organic synthesis. Other synthetically useful 
reactions that would be amenable to our mRNA display selection strategy are Suzuki 
cross coupling (with the addition of Pd
2+
 to the selection buffer as a potential co-factor) 
[9] as well as a wide variety of SN2 chemistry. SN2 reactions might not initially appear to 
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be a good target for enzymes as nucleophilic substitution is one of the most basic 
reactions in organic chemistry, but enzymes could potentially achieve regiospecificity of 
the reaction in complex substrates where many alternative substitution sites are present.  
 In conclusion, the selection of new artificial enzymes by mRNA display is an 
exciting new technology for the field of biotechnology. My thesis research has expanded 
the methods available for mRNA display selection by creating a highly diverse protein 
library and developed an application for an artificial RNA ligase that was isolated 
through de novo selection. While I did not get to select for a new enzyme myself, the 
folding enriched (β/α)8 barrel library will hopefully be a valuable source of new enzymes 
in the future. The characterization of ligase 10C was originally intended to be a small 
portion of my thesis, however, after we learned that RNA biologists lacked robust tools to 
study RNA with a 5ꞌ-triphosphate, our priorities shifted to focus more of our resources on 
developing ligase 10C as a tool for this field. The next challenge for mRNA display 
selections is to branch out to new reactions and to isolate new enzymes that can catalyze 
them. The goal is not just to make new artificial enzymes, but to further demonstrate the 
capabilities of the method. What is needed now is to invest the time and resources to 
perform the necessary selections. 
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